
<html lang="en"     class="pb-page"  data-request-id="92527223-682b-43e9-9260-fb21baded921"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.9b00041;issue:issue:10.1021/jmcmar.2019.62.issue-10;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors" /></meta><meta name="dc.Creator" content="Timo  Heinrich" /></meta><meta name="dc.Creator" content="Jeyaprakashnarayanan  Seenisamy" /></meta><meta name="dc.Creator" content="Beatrix  Blume" /></meta><meta name="dc.Creator" content="Jörg  Bomke" /></meta><meta name="dc.Creator" content="Michel  Calderini" /></meta><meta name="dc.Creator" content="Uwe  Eckert" /></meta><meta name="dc.Creator" content="Manja  Friese-Hamim" /></meta><meta name="dc.Creator" content="Rainer  Kohl" /></meta><meta name="dc.Creator" content="Martin  Lehmann" /></meta><meta name="dc.Creator" content="Birgitta  Leuthner" /></meta><meta name="dc.Creator" content="Djordje  Musil" /></meta><meta name="dc.Creator" content="Felix  Rohdich" /></meta><meta name="dc.Creator" content="Frank T.  Zenke" /></meta><meta name="dc.Description" content="Co- and post-translational processing are crucial maturation steps to generate functional proteins. MetAP-2 plays an important role in this process, and inhibition of its proteolytic activity has b..." /></meta><meta name="Description" content="Co- and post-translational processing are crucial maturation steps to generate functional proteins. MetAP-2 plays an important role in this process, and inhibition of its proteolytic activity has b..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 2, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00041" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00041" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00041" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00041" /></link>
        
    
    

<title>Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00041" /></meta><meta property="og:title" content="Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0016.jpeg" /></meta><meta property="og:description" content="Co- and post-translational processing are crucial maturation steps to generate functional proteins. MetAP-2 plays an important role in this process, and inhibition of its proteolytic activity has been shown to be important for angiogenesis and tumor growth, suggesting that small-molecule inhibitors of MetAP-2 may be promising options for the treatment of cancer. This work describes the discovery and structure-based hit optimization of a novel MetAP-2 inhibitory scaffold. Of critical importance, a cyclic tartronic diamide coordinates the MetAP-2 metal ion in the active site while additional side chains of the molecule were designed to occupy the lipophilic methionine side chain recognition pocket as well as the shallow cavity at the opening of the active site. The racemic screening hit from HTS campaign 11a was discovered with an enzymatic IC50 of 150 nM. The resynthesized eutomer confirmed this activity and inhibited HUVEC proliferation with an IC50 of 1.9 μM. Its structural analysis revealed a sophisticated interaction pattern of polar and lipophilic contacts that were used to improve cellular potency to an IC50 of 15 nM. In parallel, the molecular properties were optimized on plasma exposure and antitumor efficacy which led to the identification of advanced lead 21." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00041"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00041">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00041&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00041&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00041&amp;href=/doi/10.1021/acs.jmedchem.9b00041" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 5025-5039</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00176" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00215" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Timo Heinrich</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Timo Heinrich</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#37435e5a58195f525e59455e545f775a5245545c50455842471954585a"><span class="__cf_email__" data-cfemail="f084999d9fde9895999e82999398b09d9582939b97829f8580de939f9d">[email protected]</span></a>. Phone: +49 61 51 72 65 89.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Timo++Heinrich">Timo Heinrich</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9120-8410" title="Orcid link">http://orcid.org/0000-0001-9120-8410</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jeyaprakashnarayanan Seenisamy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jeyaprakashnarayanan Seenisamy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Syngene International Limited, Biocon Park, Plot 2&3, Bommasandra-Jigani Link Road, 560 099 Bangalore, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jeyaprakashnarayanan++Seenisamy">Jeyaprakashnarayanan Seenisamy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Beatrix Blume</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Beatrix Blume</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Beatrix++Blume">Beatrix Blume</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jörg Bomke</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jörg Bomke</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%B6rg++Bomke">Jörg Bomke</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michel Calderini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michel Calderini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michel++Calderini">Michel Calderini</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Uwe Eckert</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Uwe Eckert</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Uwe++Eckert">Uwe Eckert</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Manja Friese-Hamim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Manja Friese-Hamim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Manja++Friese-Hamim">Manja Friese-Hamim</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rainer Kohl</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rainer Kohl</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rainer++Kohl">Rainer Kohl</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Martin Lehmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martin Lehmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Lehmann">Martin Lehmann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Birgitta Leuthner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Birgitta Leuthner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Birgitta++Leuthner">Birgitta Leuthner</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Djordje Musil</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Djordje Musil</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Djordje++Musil">Djordje Musil</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Felix Rohdich</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Felix Rohdich</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Felix++Rohdich">Felix Rohdich</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Frank T. Zenke</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Frank T. Zenke</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Merck Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Frank+T.++Zenke">Frank T. Zenke</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00041&amp;href=/doi/10.1021%2Facs.jmedchem.9b00041" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 5025–5039</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 2, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 January 2019</li><li><span class="item_label"><b>Published</b> online</span>2 April 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 May 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00041" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00041</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5025%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DTimo%2BHeinrich%252C%2BJeyaprakashnarayanan%2BSeenisamy%252C%2BBeatrix%2BBlume%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D10%26contentID%3Dacs.jmedchem.9b00041%26title%3DDiscovery%2Band%2BStructure-Based%2BOptimization%2Bof%2BNext-Generation%2BReversible%2BMethionine%2BAminopeptidase-2%2B%2528MetAP-2%2529%2BInhibitors%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5039%26publicationDate%3DMay%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00041"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2370</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00041" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Timo&quot;,&quot;last_name&quot;:&quot;Heinrich&quot;},{&quot;first_name&quot;:&quot;Jeyaprakashnarayanan&quot;,&quot;last_name&quot;:&quot;Seenisamy&quot;},{&quot;first_name&quot;:&quot;Beatrix&quot;,&quot;last_name&quot;:&quot;Blume&quot;},{&quot;first_name&quot;:&quot;Jörg&quot;,&quot;last_name&quot;:&quot;Bomke&quot;},{&quot;first_name&quot;:&quot;Michel&quot;,&quot;last_name&quot;:&quot;Calderini&quot;},{&quot;first_name&quot;:&quot;Uwe&quot;,&quot;last_name&quot;:&quot;Eckert&quot;},{&quot;first_name&quot;:&quot;Manja&quot;,&quot;last_name&quot;:&quot;Friese-Hamim&quot;},{&quot;first_name&quot;:&quot;Rainer&quot;,&quot;last_name&quot;:&quot;Kohl&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Lehmann&quot;},{&quot;first_name&quot;:&quot;Birgitta&quot;,&quot;last_name&quot;:&quot;Leuthner&quot;},{&quot;first_name&quot;:&quot;Djordje&quot;,&quot;last_name&quot;:&quot;Musil&quot;},{&quot;first_name&quot;:&quot;Felix&quot;,&quot;last_name&quot;:&quot;Rohdich&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;T. Zenke&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;5025-5039&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00041&quot;},&quot;abstract&quot;:&quot;Co- and post-translational processing are crucial maturation steps to generate functional proteins. MetAP-2 plays an important role in this process, and inhibition of its proteolytic activity has been shown to be important for angiogenesis and tumor growth, suggesting that small-molecule inhibitors of MetAP-2 may be promising options for the treatment of cancer. This work describes the discovery and structure-based hit optimization of a novel MetAP-2 inhibitory scaffold. Of critical importance, a cyclic tartronic diamide coordinates the MetAP-2 metal ion in the active site while additional side chains of the molecule were designed to occupy the lipophilic methionine side chain recognition pocket as well as the shallow cavity at the opening of the active site. The racemic screening hit from HTS campaign 11a was discovered with an enzymatic IC50 of 150 nM. The resynthesized eutomer confirmed this activity and inhibited HUVEC proliferation with an IC50 of 1.9 μM. Its structural analysis revealed a sophisticated &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00041&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00041" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00041&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00041" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00041&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00041" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00041&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00041&amp;href=/doi/10.1021/acs.jmedchem.9b00041" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00041" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00041" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00041%26sid%3Dliteratum%253Aachs%26pmid%3D30939017%26genre%3Darticle%26aulast%3DHeinrich%26date%3D2019%26atitle%3DDiscovery%2Band%2BStructure-Based%2BOptimization%2Bof%2BNext-Generation%2BReversible%2BMethionine%2BAminopeptidase-2%2B%2528MetAP-2%2529%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D10%26spage%3D5025%26epage%3D5039%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=290865" title="Nitrogen">Nitrogen</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291774" title="Nuclear magnetic resonance spectroscopy">Nuclear magnetic resonance spectroscopy</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/jmcmar.2019.62.issue-10/20190523/jmcmar.2019.62.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Co- and post-translational processing are crucial maturation steps to generate functional proteins. MetAP-2 plays an important role in this process, and inhibition of its proteolytic activity has been shown to be important for angiogenesis and tumor growth, suggesting that small-molecule inhibitors of MetAP-2 may be promising options for the treatment of cancer. This work describes the discovery and structure-based hit optimization of a novel MetAP-2 inhibitory scaffold. Of critical importance, a cyclic tartronic diamide coordinates the MetAP-2 metal ion in the active site while additional side chains of the molecule were designed to occupy the lipophilic methionine side chain recognition pocket as well as the shallow cavity at the opening of the active site. The racemic screening hit from HTS campaign <b>11a</b> was discovered with an enzymatic IC<sub>50</sub> of 150 nM. The resynthesized eutomer confirmed this activity and inhibited HUVEC proliferation with an IC<sub>50</sub> of 1.9 μM. Its structural analysis revealed a sophisticated interaction pattern of polar and lipophilic contacts that were used to improve cellular potency to an IC<sub>50</sub> of 15 nM. In parallel, the molecular properties were optimized on plasma exposure and antitumor efficacy which led to the identification of advanced lead <b>21</b>.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25184" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25184" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Methionine aminopeptidase-2 (MetAP-2) is responsible for cleaving N-terminal methionine residues of proteins which is an important step of protein maturation during protein synthesis. Inhibition of MetAP-2 effectively impairs angiogenesis and tumor growth making it an attractive target for anticancer therapy.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Recently, analogues of the natural product MetAP-2 inhibitor fumagillin have been evaluated in clinical trials in oncology and obesity.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> These fumagillin analogues are known to covalently bind MetAP-2 and have to be administered subcutaneously or intravenously and, thus, have limited therapeutic utility.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> One fumagillin analogue, TNP-470, was extensively evaluated in clinical trials but was finally discontinued, probably due to unfavorable pharmacokinetics as well as neurotoxicological side effects which were considered to be drug-related.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> However, it is conceivable that noncovalent, non-fumagillin small-molecule inhibitors of MetAP-2 may have different tolerability in a clinical setting. The chemical diversity of small-molecule MetAP-2 inhibitors described until now is quite broad, and X-ray crystallography has helped to identify critical aspects of how MetAP-2 inhibitors bind in the proteolytic cleft and to the catalytically important metal ions. <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> depicts the ligands for which the binding mode has been identified by X-ray structure analyses. The center(s) reported to coordinate the metal ion(s) are marked in red (distance < 3 Å).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reversible MetAP-2 inhibitors. X-ray structure analyses published. Metal cofactor binding atoms marked in red; PDB codes added: 1 (SB-587094) <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OAZ">2OAZ</a>; 2 (A-357300) <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R58">1R58</a>; 3 (LAF-153) <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QZY">1QZY</a>; 4—<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JFR">5JFR</a>; 5 (A-849519) <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YW9">1YW9</a>; and 6—<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LYX">5LYX</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This collection shows that one to three heteroatoms can bind to the metal ions<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> in the active site of MetAP-2, and the arrangement of either oxygen or nitrogen or both in one scaffold is accomplished with diverse chemical matter. For the triazole <b>1</b> (SB-587094), it was shown that both of the adjacent nitrogens are necessary to achieve single-digit nanomolar biochemical inhibition constant (<i>K</i><sub>i</sub>) values with cobalt as the cofactor. Methylation of either nitrogen spoils affinity significantly.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The 2-hydroxy-3-aminoamide grouping of the bestatin<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> like <b>2</b> (A-357300) interacts with the active site Mn<sup>2+</sup> metal ions,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and the 2-hydroxy substituent is bridging between the ions. The thioether-containing side chain largely fills the adjacent hydrophobic site, while the 3-chlorophenyl aromatic group lies face to face with the His339 imidazole. An IC<sub>50</sub> value of 110 nM in the enzyme assay was reported for this inhibitor.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The <i>t</i>-butyl group of bengamide analogue <b>3</b> (LAF-153) extends into the innermost portion of the cleft, whereas the lactam ring is coordinated in the shallow pocket at the surface of the enzyme. All three hydroxyl groups coordinate to the two cobalt ions in the published structure.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10−12)</a> In contrast to these very flexible open-chain MetAP-2 inhibitors, compound <b>4</b> from Takeda is much more rigid as two heterocyclic moieties are linked via just one rotatable bond. One nitrogen of the pyrazole interacts directly with one metal ion, while the other protonated nitrogen builds up a water-mediated interaction with the other manganese ion. The phenyl ring of the core is well situated to make an edge-to-face interaction with the aromatic side chain of Tyr444. The 7-fluoro substituent protrudes into the lipophilic pocket occupied by the thioether of the endogenous substrates, making the ligand very shape-complementary with the target. The aza-benzimidazole substituent at the N-4 position points into a hydrophobic space between Tyr444 and His339 side chains. This compound was reported with a pIC<sub>50</sub> of 8.3.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The carboxylate <b>5</b> (A-849519) was published with two-digit nanomolar IC<sub>50</sub> in enzyme inhibition assay. Only one oxygen of the acid function is in direct contact to one of the manganese ions, but the other heteroatom, like in the case of pyrazole <b>1</b>, is binding to a water molecule positioned over both metal ions.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> For the substituted triazolo-triazine <b>6</b> as well as for analogous-derivatized purines, it was demonstrated that both southern nitrogens are in direct contact to manganese ions, even though the assignment changes (180° flip).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> In addition to these published MetAP-2 co-structures of reversible ligands, further literature-known inhibitors were synthesized and crystallized to extend the structural knowledge of reversible MetAP-2 inhibitors (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Reversible MetAP-2 inhibitors. Synthesis and structural analyses performed in-house. PDB codes added: <b>7</b> (JNJ-4929821) <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEJ">6QEJ</a>, <b>8</b> (GSK-2229238) <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEI">6QEI</a>, and <b>9</b> (X = Cl; clioquinol) <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEH">6QEH</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As <b>1</b>, <b>7</b> (JNJ-4929821)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> contains a 4<i>H</i>-[1,2,4]-triazole as a metal-coordinating heterocycle, but <b>8</b> (GSK-2229238)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> is the first carboxamide described as MetAP-2 inhibitor. The terminal triazole from <b>7</b> superimposes quite well with disubstituted derivative <b>1</b>, supporting the hypothesis that the adjacent nitrogens are necessary for MetAP-2 binding. The carboxamide in <b>8</b> is substantially differently oriented than the carboxylate of <b>5</b>. Only the oxygen of the amide function is binding to one metal ion, but the nitrogen is not involved in any water-mediated hydrogen bond network. It is in 3.35 Å distance to the imidazole of His331. Clioquinol <b>9</b> and nitro analogue nitroxoline <b>10</b> (X = NO<sub>2</sub>; APL-1202) are known antibiotics for the treatment of urinary tract infections and are described to inhibit MetAP-2 activity.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> Nitroxoline <b>10</b> is reported with an IC<sub>50</sub> value of 55 nM in the enzymatic MetAP-2 inhibition assay and interferes in HUVEC (human umbilical vein endothelial cells) proliferation, but only with micromolar potency (IC<sub>50</sub>: 1.9 μM). In the context of repurposing activities, clinical investigations are on-going to develop <b>10</b> for the treatment of invasive bladder cancer.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> The hydroxyquinoline coordinates both metal ions with the oxygen binding to the more buried ion in 2 Å distance and the quinoline nitrogen to the second ion in 2.51 Å distance as found for <b>9</b>. The chlorine is directed into the lipophilic substrate recognition pocket and is in van der Waals (vdW) contacts to Ala414 (4.32 Å), His231 (3.82 Å), and His382 (4.18). During in-house work with purine-based MetAP-2 inhibitors, it was not possible to optimize biochemical activity of compounds based on purine and its related scaffolds like <b>6</b> to a low nanomolar level. More importantly, the relatively weak enzymatic potency did not translate into favorable HUVEC proliferation inhibition in a consistent manner, considered to be required to elicit significant in vivo efficacy (tumor growth inhibition).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Accordingly, focus was switched to another HTS hit series comprised during a screening campaign not taken into account during first result evaluations. This hit matter was reconsidered because of missing compelling alternatives. Insufficient purity was the reason for initial deprioritization, even though sub-micromolar activity was measured (IC<sub>50</sub> of 150 nM for the most potent derivative). Accordingly, a more detailed analysis of the series was conducted, and it became obvious that these hits relinquished a consistent pattern responsible for their failure in post-HTS control. In all cases, the detected molecular mass was 16 units larger than the mass for the registered structure. Oxidation was responsible for this deviation between expected and observed molecular mass, and NMR analysis revealed the position of the oxidized center (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Stored α-amidated pyrrolidinone <b>11</b> was oxidized to the cyclic tartronic diamide <b>11a</b> under storage in DMSO over approximately 2 years.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Cα of the pyrrolidinone in <b>11</b> is substituted with an amide residue, activating this carbon for oxidation. The screening sample had been stored for 2 years as dimethyl sulfoxide (DMSO) stock solution in a sealed tube at −20 °C. Obviously, these conditions were not sufficient to prevent quantitative oxidation. Registration analytics of the compound confirmed the envisioned original structure of <b>11</b>, and a newly synthesized batch did not show any activity in the biochemical assay. The dedicated synthesized compound <b>11a</b> delivered an IC<sub>50</sub> of 57 nM, confirming the initial screening result. Attempts to mimic the oxidation of <b>11</b> to <b>11a</b> during storage by stirring the reduced precursor <b>11</b> in DMSO at a higher temperature for a couple of days were not successful (no oxidation could be detected). The compound had been included in many HTS initiatives shortly before the MetAP-2 screen and afterward but never showed any activity. This suggested a very high overall target selectivity. Thus, persistence and serendipity helped to identify the starting point for the herein outlined optimization.</div><div class="NLM_p">The structural analysis of hit <b>11a</b> challenges virtually every atom of the ligand. Our systematic optimization was graded by pragmatic considerations and scaffold dissections (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Screening hit <i>rac</i>-<b>11a</b> with indications of different parts of the molecule. The first optimization cycle focused on the amide residue highlighted by a blue circle; second improvement round considered the N-lactam residue marked with a red circle. The investigation of lactam size and additional substitutions (brown circle) as well as the heteroatoms (indicated with arrows) are not discussed here.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15123" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15123" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All compounds described herein belong to the same pyrrolidinone class but were prepared via alternative approaches, depending on the optimization purpose. The preparation of optimized amides followed the procedure out-lined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Approach to Optimize Amide Residue R<sub>1</sub>. Derivatives from <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) ACN, aniline, 60 °C, 12 h, 85%; (b) EtOH, SOCl<sub>2</sub>, 0 °C—reflux, 4 h, N<sub>2</sub>; 92% (c) CeCl<sub>3</sub>–(H<sub>2</sub>O)<sub>7</sub>, <sup><i>i</i></sup>PrOH, O<sub>2</sub>, 12 h, RT; Chiralpak AD-H; (d) LiOH, THF/H<sub>2</sub>O, 4 h, RT; 84% (e) R<sub>1</sub>-NH<sub>2</sub>, EDCI, HOBt, 160 °C, MW, 20 min 40–80%.</p></p></figure><div class="NLM_p">This approach started with the reaction of cyclopropyl Meldrum’s acid <b>12</b> with aniline to give <i>N</i>-phenyl-pyrrolidinone-3-carboxylic acid <b>13</b> which was then transferred into the corresponding ethyl ester <b>14</b> with thionyl chloride in ethanol. C3 oxidation of the pyrrolidinone-3-carboxylate <b>14</b> was achieved with cerium chloride in isopropanol. The functionalized pyrrolidinone was separated into the enantiomers <i>S</i>-<b>15</b> and <i>R</i>-<b>15</b> via chiral chromatography, and the desired enantiomer <i>R</i>-<b>15</b> was saponified with lithium hydroxide in a tetrahydrofuran (THF)/water mixture of 3:1 to the corresponding acid <b>16</b>. The hydroxy acid <b>16</b> was coupled under standard conditions with amines to the amides <b>11a–11r</b>.</div><div class="NLM_p">The second optimization round focused on the lactam nitrogen substituent. In this context, an alternative synthesis was established. In the initial approach, aniline was reacted with Meldrum’s acid, introducing the lactam substituent in the first reaction. However, this procedure was considered to be unpractical for an optimization of the lactam nitrogen residue which should be added in the last step of the synthesis. Accordingly, the sequence outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> using the identified 3-chloro-5-fluoro-benzylamine as suitable residue R<sub>1</sub> was established.</div><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Approach to Optimize Lactam Residue R<sub>2</sub>; Derivatives from <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and Conditions: (a) BOC<sub>2</sub>O, DMAP, ACN, 3 h, RT, 70%; (b) benzyl chloroformate, LiHMDS, THF, 2 h, −78 °C—RT, 42%; (c) Pd/charcoal, methanol, H<sub>2</sub>, 2 bar, 2 h RT, 86%; (d) 3-F, 5-Cl benzylamine, T3P, TEA, DCM, 5 h, 0 °C—RT, 86%; (e) TFA, DCM, 3 h, 0 °C, 90%; (f) MMPP, DMF, 4 h, 70 °C, 37%; (g) R<sub>2</sub>-halide, K<sub>2</sub>CO<sub>3</sub>, CuI, <i>N</i>,<i>N</i>′-diemethyl-ethane-1,2-diamine, dioxane, 2 h, 140 °C, MW; (h) Chrialpak AD-H.</p></p></figure><div class="NLM_p last">Commercially available pyrrolidinone <b>17</b> was first BOC-protected. Different options were worked out to introduce the carboxylic moiety in position 3. Reproducible results were obtained by deprotonation with lithium bis(trimethylsilyl)amide (LiHMDS) and quenching with benzyl chloroformate. Hydrogenation of the benzyl ester, subsequent amidation of the acid with 3-fluoro, 5-chloro benzylamine in the presence of 2,4,6-tripropyl-[1,3,5,2,4,6]trioxatriphosphinane 2,4,6-trioxide (T3P), and deprotection of the lactam nitrogen proved to be necessary to oxidize the chiral carbon with magnesium monoperoxyphthalate hexahydrate (MMPP) to give the key intermediate <b>18</b>. Established Buchwald conditions were used to arylate the lactam nitrogen. The racemic products from this approach were separated into the enantiomers via chiral chromatography, giving the final products <b>11ra–11rj</b>, <b>20</b>, and <b>21</b>.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13201" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13201" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">For the determination of potency of MetAP2 inhibitors, an enzyme-coupled assay to measure the proteolysis of a tripeptide substrate (Met-Ala-Ser) was established. Recombinant purified His-TEV-MetAP-2 (AA2-478) with manganese as a co-factor was used.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Proliferation of HUVEC primary endothelial cells was applied as mechanistical assay to assess compound potency in the cellular environment.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">Crystallization of the human MetAP-2 protein fragment comprising amino acid residues 108–478 had been established during earlier work;<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> therefore, this tool could be used to understand the binding mode of <b>11a</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> and <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray structure analysis of <b>11a</b> in MetAP-2; (A) 2D plot to show relevant polar interactions, indicated with dashed lines, oxygen-manganese contacts in purple, heteroatom-His<sup>imidazole</sup> in green, and distances are given in Ångstrom; (B) conformation of <b>11a</b> in the active site; interacting imidazoles of His331 and His339 and the manganese ions are pointed out (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEG">6QEG</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. X-ray structure analysis of <b>11a</b> in MetAP-2: (A) 2D plot to show relevant lipophilic interactions, indicated with dashed lines, and distances are given in Ångstrom; (B) identical view on the conformation of <b>11a</b> in the active site as in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B; the lipophilic trait of the protein surface is color-coded. Brown indicates a lipophilic surface and green, a polar one (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEG">6QEG</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The schematic 2D plot of <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A depicts the polar interactions of <b>11a</b> with the protein. The oxygen at Cα of the tartonic diamide coordinates the two manganese ions in the active site of MetAP-2. The distance to the first, less buried ion is 2.36 Å and that to the second ion, which is located deeper in the pocket, is 2.08 Å. The lactam oxygen is also in close contact to the first metal ion with 2.68 Å, and the amide oxygen binds to the second ion with a distance of 2.32 Å. The three oxygens of α-hydroxy-malonic diamide form a unique metal binding element that is unprecedented for MetAP-2 inhibitors.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The binding of compound <b>11a</b> to MetAP-2 is characterized by additional polar interactions. In addition to its metal coordination, the lactam oxygen interacts with the protons from His339-imidazole (2.70 Å) and His331-imidazole (3.31 Å). The amide NH is in H-bond distance to His231 side chain (3 Å). The high electron density of this imidazole is documented by its nucleophilic attack on the epoxide of covalently binding fumagillin-type natural products and derivatives.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a><a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B shows the active site of MetAP-2 with <b>11a</b>. The lactam ring is the planar template of this MetAP-2 inhibitor class from which the residues are positioned for relevant protein interaction. The N-phenyl ring of compound <b>11a</b> covers the entrance to the active site and is rotated by 62.2° out of the lactam plane. The hydroxy function is pointing downward and is coordinated to both manganese ions in the active site. The amide residue is pointing upward and is allowing the thiophene-ethyl residue to orient itself in the substrate recognition area of MetAP-2.</div><div class="NLM_p"><a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A illustrates the vdW distances of ligand <b>11a</b> to the amino acid side chains in the active site. The thiophene is located in the nonpolar area that accommodates the methionine side chain upon hydrolysis of natural substrates. Not only the side chains of Ala414 and Ile338 are in vdW contacts with the thiophene but also the imidazole of His231. In addition, this imidazole has also lipophilic interactions with the ethyl bridge between the amide nitrogen and the thiophene. These observations of polar and lipophilic interactions of the imidazole heterocycle of His231 demonstrate that this is the most crucial amino acid for inhibitor recognition. The lactam N-phenyl ring of <b>11a</b> faces an amphiphilic surrounding. The properties of the bottom part of the active site (as oriented in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B) are driven by the backbone-oxygen and -nitrogen of Asn329. These heteroatoms are responsible for constituting a polar region, whereas the protein surface in the upper right region is lipophilic due to the domination of the methyl and isobutyl side chains of Ala230, Leu447, and Leu328 (not explicitly indicated in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). The protein surface around the unsubstituted carbons C4 and C5 of the lactam ring of <b>11a</b> is amphiphilic too. Carbon C5 is in vdW contact with the side chains of Ala230 (3.49 Å) and Phe399 (3.9 Å). Carbon C4 is pointing toward a polar cavity that occupies two crystal water molecules (not shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>), and this carbon is virtually without any measurable interaction.</div><div class="NLM_p">The structural analysis indicates that the <i>S</i>-enantiomer (<i>S</i>-<b>11a</b>) is bound to the protein. Accordingly, <i>rac</i>-<b>11a</b> was separated into the enantiomers via chiral chromatography on a SFC device. Both enantiomers were assessed in the enzyme inhibition assay, and the eutomer was found with an IC<sub>50</sub> value of 0.050 μM. Our structural analyses (NMR, X-ray) indicated that the stereochemistry of the active isomer is confirmed to have <i>S</i> configuration at the chiral carbon (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). <i>R</i>-<b>11a</b> inhibits MetAP-2 with an IC<sub>50</sub> of 17 μM, which is >200 times less active than the <i>S</i> enantiomer. During the optimization process, we continued to separate enantiomers via chiral chromatography from racemic syntheses, but for production of larger compound quantities, we established an asymmetric synthesis route for the most efficient drug production.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Initial SAR of the Amide Residue<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0013.gif" alt="" id="gr13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Values are mean of three repetitions.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">NT: not tested.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">ND: no IC<sub>50</sub> detectable.</p></div></div><div></div></div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Amide Chain Length and Substitution</h3><div class="NLM_p">The easily adjustable and deeply buried amide residue was considered at first during optimization, as a strong impact on potency was anticipated. The residue attached to the lactam nitrogen deemed to play an important role for binding affinity too. Though not as submerged as the amide substituent, the X-ray analysis revealed contacts for the phenyl ring with the protein surface as insinuated above (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> and <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B). This awareness suggested a dedicated optimization of the lactam N-substituent during second approach.</div><div class="NLM_p">The expansion of the thiophene with a methyl group beside the sulfur (<b>11b</b>) should fill in the pocket superior to the unsubstituted thiophene of <b>11a</b>. Apparently, the contrary is the case as the methylated analogue <b>11b</b> of the original hit <b>11a</b> is four times less active (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p">Comparison of <b>11a</b> with a published structure of methionine in MetAP-2 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1wkm">1wkm</a>) revealed differences in the positions of the sulfur atoms of the thiophene in <b>11a</b> and of the thioether from the methionine side chain of about 3 Å (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00041/suppl_file/jm9b00041_si_002.pdf" class="ext-link">Supporting Information</a>, Figure S1). It was anticipated that shortening the ethyl linker between the amide nitrogen and the thiophene should allow for better substrate mimicking and pocket occupancy. The truncated linker in <b>11c</b> was less potent than the methylated hit-derivative <b>11b</b>. Systematic methylation of thiophene carbons either confirmed (<b>11d</b>, <b>11f</b>) or even decreased activity (<b>11e</b>). Reduction of thiophene ring size by introduction of furan resulted in a three-fold less-potent compound (<b>11g</b>) compared to the screening hit. Further five-membered rings with up to three heteroatoms and an array of substituents were investigated, but for none, the activity could be optimized. Hence, these derivatives are not discussed in detail here. The saturated amide residue of <b>11h</b> was by a factor of three less active as <b>11a</b> and does not suggest that reduction of aryl load is beneficial for increased potency. This observation was confirmed by additional analogues which are not outlined explicitly. Neither five-membered aromatic nor saturated linear nor cyclic moieties allowed a potency increase and consequently, larger residues were investigated (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The unsubstituted benzyl derivative <b>11i</b> was also not a very promising residue as it showed an IC<sub>50</sub> of 440 nM which was factor eight less potent than screening hit <b>11a</b>. Systematic permutation of one chlorine atom on the benzyl ring proved that ortho (<b>11j</b>) and meta (<b>11k</b>) substitution delivered more potent compounds than para substitution, with an IC<sub>50</sub> of 5.3 μM for the latter and sub-micromolar IC<sub>50</sub> for the other two. Accordingly, further investigations focused on the ortho and meta positions. Also, with fluorine as substituent, the meta (<b>11n</b>) substitution showed slightly higher potency than the ortho (<b>11m</b>) position. The activity in the HUVEC proliferation assay was also better for the ortho-substituted isomers compared to their meta analogues (<b>11j</b> vs <b>11k</b> and <b>11m</b> vs <b>11n</b>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Second SAR of the Amide Residue<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0014.gif" alt="" id="gr14" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Values are mean of three repetitions.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">ND: no IC<sub>50</sub> detectable.</p></div></div><div></div></div><div class="NLM_p">It was expected that the fluorine substitution of the benzylic moiety should be favorable in terms of compound properties compared to aliphatic moieties. Nevertheless, meta-methyl benzylamide <b>11o</b> was prepared as favorable lipophilic contacts had been anticipated. Surprisingly, <b>11o</b> had reduced biochemical and cellular activity compared to meta-F derivative <b>11n</b>. This observation motivated the further analyses of halogen substitutions. The introduction of a second meta halogen improved biochemical activity. In the enzymatic testing, the bis-chloro (<b>11p</b>) and bis-fluoro (<b>11q</b>) benzylamides proved to be as active as the fluoro-, chloro-mixed analogue <b>11r</b>. This similarity was confirmed in the antiproliferative activity in the HUVEC assay. All three bishalogen-substituted benzylamides (<b>11p</b>, <b>11q</b>, and <b>11r</b>) impaired HUVEC proliferation with a low three-digit nanomolar IC<sub>50</sub>.</div><div class="NLM_p">The structural analysis of “stopover” <b>11r</b> from the first optimization cycle clearly demonstrates how both halogen substituents are involved in vdW interactions in the lipophilic pocket (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). The fluorine atom (cyan) is pointing upward and toward the protein surface. It is involved in lipophilic interactions with the methylene group of His382 (3.41 Å) and the methyl side chain of Ala414 (3.22 Å). The chlorine atom (light green) is pointing downward to be in contact with the imidazole side chain of His339 (3.51 Å). In addition, this chlorine is sandwiched between the side chains of Ile338 (3.68 Å) and Tyr444 (3.50 Å).</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. X-ray structure analysis of the optimized amide residue in <b>11r</b>. Depicted are only the distances of the halogens (F, cyan; Cl, light green) on the benzylamide to the amino acid side chains of MetAP-2 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEF">6QEF</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The oxygen atom of the alcohol function is coordinating the two manganese ions with distances of 2.08 and 2.19 Å, respectively, virtually identical to the position of this oxygen of the initial screening hit (distances of oxygen to metal ions are not explicitly shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). The N-phenyl subsituent of compound <b>11r</b> is rotated by 52.4° out of the lactam plane.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Lactam Residue</h3><div class="NLM_p">Benzylamide <b>11r</b> was considered to be a good starting point for optimizing the lactam nitrogen substituent (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The unsubstituted building block <b>18</b> was still active and inhibited the isolated enzyme with an IC<sub>50</sub> in the sub-micromolar range. Replacement of the proton with a methyl group (<b>19</b>) had virtually no effect on biochemical activity. The sub-micromolar activity of <b>18</b> and <b>19</b> in the enzyme assay clearly indicates the importance of tartronic-diamide motive for strong binding to MetAP-2. Subsequent efforts focused on exploring the phenyl ring SAR through systematic evaluation of electron-donating and electron-withdrawing substituents (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of the N-Lactam Residue<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0015.gif" alt="" id="gr15" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Values are mean of three repetitions.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">ND: no IC<sub>50</sub> detectable.</p></div></div><div></div></div><div class="NLM_p">Even though all ortho-substituted derivatives (2-Me <b>11ra</b>, 2-CN <b>11rd</b>) were still sub-micromolar active in the enzyme assay, their cellular activity was hardly measurable. The meta and para methyl isomers <b>11rb</b> and <b>11rc</b> were equally potent having nanomolar IC<sub>50</sub> values in the biochemical and cellular assays. The polar cyano moiety was also not discriminating between the two positions, as the meta derivative <b>11re</b> was as potent as the para isomer <b>11rf</b>. Cellular potency of these derivatives (<b>11ra–11rf</b>) was in all cases less favorable compared to the unsubstituted compound <b>11r</b>. The structural analysis of <b>11a</b> had disclosed that the carboxamide side chain of Asn329 is responsible for a polar protein surface in the bottom area depicted in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B. This observation served as rationale to provide a functionality capable of H-bonding interaction to this amide group. The donor/acceptor orientation of the amide residue of Asn329 should be flexible to allow for optimal interaction. Based on this prerequisite and the anticipated distance, an amide was considered to be a good H-bonding partner.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Both para and meta position phenyl carboxamides (<b>11ri</b>, <b>11rj</b>) and acetamides (<b>11rg</b>, <b>11rh</b>) were examined. While the enzyme data for these derivatives were not significantly differentiated, <i>para</i>-acetamide <b>11rh</b> led to the best cellular response with an IC<sub>50</sub> in the two-digit nanomolar range. Reduction of conformational flexibility of the amide should minimize entropic penalties and should reduce rotational freedom contributing to improved binding. Accordingly, the donor-/acceptor-substitution pattern was captured in the oxindole <b>20</b> and the more expanded analogue <b>21</b>. The biochemical data looked quite the same for the open chain (<b>11rh</b>) and both cyclic derivatives (<b>20</b>, <b>21</b>), so that the working hypothesis to improve enzyme inhibition had to be challenged. Surprisingly, a remarkable difference (factor of 10) was observed in the effect of <b>20</b> versus <b>21</b> on HUVEC proliferation for these compounds. Efficient cellular growth impairment was achieved with the 2-oxo-tetrahydro-quinolinyl substitution of <b>21</b>. The reason for the better proliferation inhibition can only be hypothesized, but different binding kinetics might be responsible. The enzyme used for in vitro enzyme inhibition is a recombinant His-tagged form and may behave differently than the native, full-length MetAP-2 protein. Because a quite decent concentration of the MetAP-2 enzyme had to be applied in the biochemical assay, the measured IC<sub>50</sub> values might already have reached the resolution for high-potency compounds. In addition, MetAP-2 associates with ribosomal subunits which may influence the conformation of the protein and consequently, the potency of certain MetAP-2 inhibitors in cells. These factors may account for some of the discrepancies observed between enzyme and HUVEC proliferation inhibition. The optimized ligand was crystallized together with MetAP-2, and the structural examination of <b>21</b> is depicted in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>.</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. X-ray structure analysis of <b>21</b> with focus on the additional polar interaction of the tetrahydroquinone-NH with the ASN329 side chain amide of MetAP-2 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QED">6QED</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, only the additional polar interaction between lactam N–H with the oxygen of the Asn329 side chain amide is shown. The H-bond (3.06 Å) is probably contributing to the interaction of <b>21</b> with MetAP-2.</div><div class="NLM_p">For the covalent binding of irreversible inhibitors to the imidazole of His231, the nature of the metal ion is of limited relevance. The ion might only function as Lewis acid, coordinating to the spiro-epoxide oxygen to facilitate the His231-imidazole attack.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> All reversible ligands coordinate the metal-ion cofactor. Accordingly, identification of physiological metal cofactors for MetAP-2 is critical because literature-known inhibitors like A-310840 (3-{[(naphthalen-2-yl)methyl]sulfanyl}-4<i>H</i>-1,2,4-triazole) differentiate this enzyme with different metal cofactors with potencies varying up to 1000-fold. In vitro investigations of eight different metal ions on purified recombinant human MetAP-2 demonstrated that manganese, as well as cobalt, maximally stimulates MetAP-2 activity, indicating that either manganese or cobalt might be the MetAP-2 cofactor in vivo.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> As such, compound <b>21</b> was evaluated in the enzyme assay with both manganese and cobalt to determine if the hydroxymalonic motif discriminates between the two metals. Derivative <b>21</b> was found to be similarly active under cobalt and manganese assay conditions: IC<sub>50</sub> = 160 nM vs 74 nM. Like other compounds from this new MetAP-2 binding class, the development candidate is not active in the MetAP-1 enzyme assay.</div><div class="NLM_p">The p<i>K</i><sub>a</sub><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> of <b>21</b> was determined to be around 11, and the log <i>D</i><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> at pH 7.4 is 2, explaining the good solubility profile in biorelevant media (FaSSIF: 158 μg/mL; FeSSIF: 334 μg/mL). A favorable molecular weight of 431 Da and a tPSA of 99 contribute to good passive permeability and acceptable efflux in the Caco-2 assay (<i>a</i> > <i>b</i>: 16 × 10<sup>–6</sup> cm/s; ER: 5). The metabolic stability in liver microsomes from mouse and human was <10 μL/min/mg protein, qualifying the compound for further in vivo PK profiling. After iv dosing in mice, the compound showed favorable PK characteristics, that is, clearance (CL), volume of distribution (Vss), and half-life (<i>t</i><sup>1/2</sup>) were determined to be 0.18 L/h/kg, 0.78 L/kg, and 3 h, respectively. The oral bioavailability was 35% at 0.5 mg/kg and increased to ∼100% at 50 mg/kg, suggesting the saturation of a clearance mechanism (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). The favorable potency and PK data of <b>21</b> prompted us to investigate its tumor growth inhibition potential in vivo.</div><figure id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Dose-normalized plasma concentrations of <b>21</b> after 0.2 mg/kg iv and 50 mg/kg post dosing.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For investigating in vivo efficacy of <b>21,</b> the human glioblastoma U87-MG model was used. The tumor cells were subcutaneously injected in nude mice. Once tumors were established with a mean tumor volume of 300 mm<sup>3</sup>, the animals were orally treated daily with different doses of <b>21</b> (5, 10, and 20 mg/kg QD). The results are shown in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>.</div><figure id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0002.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. In vivo tumor growth inhibition of <b>21</b> in the human U87-MG glioblastoma model. Tumor volumes for the 12-day treatment period (volumes for the individual animals at the end of the study are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.9b00041/suppl_file/jm9b00041_si_002.pdf" class="ext-link">Supporting Information</a>, Figure S2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Dose-dependent antitumor activity could be shown with compound <b>21</b>. Best efficacy was achieved at doses of 10 and 20 mg/kg daily (T/C value of 45%), while the lowest dose of 5 mg/kg resulted in a T/C value of 78%. Applying the highest daily dose but using an alternative scheduling (10 mg/kg BID) did not enhance the antitumor activity. All regimens were well tolerated, and no body weight loss was observed during the treatment period of 12 days (data not shown).</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36678" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36678" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The antiangiogenic properties of the natural product fumagillin were discovered already in 1990.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> However, it took seven additional years until the molecular target of this compound class could be identified.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Since then, many covalent and reversible ligands were investigated to understand the target biology and develop new drugs for indications with high medical need-like cancer or obesity. Compelling data render MetAP-2 to be also a promising drug target for oncology. All clinical investigations in oncology so far were only considering derivatives of fumagillin were discontinued because of unknown reasons. Using a structure-based approach, the successful optimization of the screening hit <b>11a</b> resulted in the advanced lead <b>21</b> which was well tolerated and showed antitumor efficacy in a mouse glioblastoma model. Furthermore, derivative <b>21</b> set the basis for further optimizations to establish clinical compound M8891.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55380" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55380" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Chemistry</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> General Information</h4><div class="NLM_p last">All reactions were carried out under the nitrogen atmosphere or in sealed vials unless noted otherwise. Dry solvents and reagents were of commercial quality and were used as purchased. Reactions were magnetically stirred and monitored by thin-layer chromatography (TLC) using Merck silica gel 60 F254 by fluorescence quenching under UV light or by high-pressure liquid chromatography with subsequent mass detection (LCMS) detection, except if indicated otherwise.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> LCMS Analysis</h4><div class="NLM_p">Method A: A-0.1% TFA in H<sub>2</sub>O, B-0.1% TFA in ACN: flow: 2.0 mL/min, column: XBridge C8 (50 × 4.6 mm, 3.5 μm), +ve mode; method B: A-0.1% HCOOH, B-methanol: flow: 1.0 mL/min, column: eclipse plus C18 (50 × 4.6 mm); method C: A-0.1% HCOOH, B-acetonitrile: flow: 1.0 mL/min, column: Atlantis dC18 (50 × 4.6 mm) +ve mode. HPLC analysis: A-0.1% TFA in H<sub>2</sub>O, B-0.1% TFA in ACN: flow: 2.0 mL/min, column: XBridge C8 (50 × 4.6 mm, 3.5 μm). Chiral HPLC analysis: method A: mobile phase: 0.1% DEA in hexane/IPA = 60:40, column: Chiralpak AD-H (250 × 4.6) mm, 5 μm, flow: 1.0 mL/min; method B: mobile phase: <i>n</i>-heptane/IPA = 60:40, column: Chiralpak AD-H (250 × 4.6) mm, 5 μm, flow: 1.0 mL/min; method C: mobile phase: 0.1% TFA in hexane/IPA = 80:20, column: Chiralcel OJ-H (250 × 4.6) mm, 5 μm, flow: 1.0 mL/min; method D: mobile phase: heptane/IPA = 50:50, column: Chiralpak AD-H (250 × 4.6) mm, 5 μm, flow rate: 0.8 mL/min; method E: mobile phase: 0.1% DEA in hexane/IPA = 70:30, column: Chiralpak AD-H (250 × 4.6) mm, 5 μm, flow: 1.0 mL/min; method F: mobile phase: 0.1% DEA in hexane/IPA = 70:30, column: Chiralpak OD-H (250 × 4.6) mm, 5 μm, flow: 1.0 mL/min; method G: mobile phase: hexane/IPA = 70:30, column: Chiralpak AD-H (250 × 4.6) mm, 5 μm, flow rate: 1.0 mL/min.</div><div class="NLM_p last">Retention times (Rts) are given in minutes. In addition, TLC plates were stained using phosphomolybdic acid or potassium permanganate stain. Chromatographic purification of products (flash chromatography) was performed on Isco Combiflash systems using Redisep columns and ethyl acetate/heptanes gradients. Concentration under reduced pressure was determined by rotary evaporation at 40 °C at appropriate pressure unless otherwise stated. The purity of the compounds reported in the manuscript was established through HPLC-MS methodology. HPLC analyses were run according to the LCMS method. <sup>1</sup>H NMR (in DMSO-<i>d</i><sub>6</sub>) and mass spectra are in agreement with the structures and were recorded on a Bruker NMR 400 MHz spectrometer, if not stated differently, (tetramethylsilane as an internal standard) and Vacuum Generators VG 70-70 or 70-250 at 70 eV, respectively. Elemental analyses (obtained with a PerkinElmer 240 BCHN analyzer) for the final products were within 0.4% of calculated values if not stated otherwise. All compounds reported in the manuscript have a purity ≥95% unless noted otherwise.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> (<i>S</i>)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic Acid (2-Thiophen-2-yl-ethyl)-amide (<i>S</i>-<b>11a</b>)</h4><div id="sec5_1_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i18" class="anchor-spacer"></div><h5 class="article-section__title" id="_i18"> Synthesis of 2-oxo-1-phenyl-<i>N</i>-[2-(thiophen-2-yl)ethyl]pyrrolidine-3-carboxamide</h5><div class="NLM_p last">1-Phenyl-2-oxo-3-pyrrolidine carboxylic acid (200 mg, 0.95 mmol), 2-(thiophen-2-yl)-ethan-1-amine hydrochloride (155 mg, 0.95 mmol), EDCI (549 mg, 2.84 mmol), HOBt (192 mg, 1.42 mmol), and TEA (132 μL, 0.95 mmol) were dissolved in dimethylformamide (DMF) (5 mL) and heated in the microwave to 160 °C for 5 min. After the addition of water, the precipitate was filtered and dried, giving the product in 80% (239 mg) yield as a colorless solid.</div></div><div id="sec5_1_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19"> Synthesis of 3-hydroxy-2-oxo-1-phenyl-<i>N</i>-[2-(thiophen-2-yl)ethyl]pyrrolidine-3-carboxamide</h5><div class="NLM_p">2-Oxo-1-phenyl-<i>N</i>-[2-(thiophen-2-yl)ethyl]pyrrolidine-3-carboxamide (100 mg, 0.32 mmL), <i>tert</i>-butyl hydro peroxide (70% in water, 62 mg, 0.48 mmol), and sodium ethylate (20% in ethanol, 182 μL, 0.48 mmol) were mixed with <i>tert</i>-butanol (10 mL) and heated to 90 °C for 4 h. After concentration in vacuum, the residue was distributed between ethyl acetate and water, the organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and filtered, and after removal of the solvent, it was purified by chromatography, giving the product in 54% (57 mg) yield. 3-Hydroxy-2-oxo-1-phenyl-<i>N</i>-[2-(thiophen-2-yl)ethyl]pyrrolidine-3-carboxamide (40 mg) was separated into the enantiomers via chiral HPLC (ChiralCel OH; <i>n</i>-heptane/methanol = 7:3, giving <i>S</i>-<b>11a</b> in 51% (20 mg) yield. Rt 7.19 min. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.08 (t, <i>J</i> = 5.9, 1H), 7.71 (s, 1H), 7.69 (d, <i>J</i> = 8.8, 1H), 7.48–7.37 (m, 2H), 7.33 (dt, <i>J</i> = 10.3, 5.1, 1H), 7.23–7.13 (m, 1H), 6.96 (dd, <i>J</i> = 5.0, 3.5, 1H), 6.90 (t, <i>J</i> = 7.1, 1H), 6.61 (d, <i>J</i> = 17.5, 1H), 3.91–3.80 (m, 2H), 3.48–3.38 (m, 1H), 3.33–3.22 (m, 3H), 2.98 (t, <i>J</i> = 7.3, 2H), 2.58–2.52 (m, 1H), 2.10 (m, 1H); HRMS calcd for C<sub>17</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub>S (M + H<sup>+</sup>), 331.1111; found, 331.1118. <i>R</i>-<b>11a</b> was also obtained in 51% (20 mg) yield. Rt 15.21 min. HRMS calcd for C<sub>17</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub>S (M + H<sup>+</sup>), 331.1111; found, 331.1119.</div><div class="NLM_p">Compounds <b>11b–11r</b> were prepared as described below:</div><div class="NLM_p last">To a solution of (<i>R</i>)-3-hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic acid <b>16</b> (800 mg, 3.62 mmol) and the respective amine (4.34 mmol) in dry DMF were added EDCI (2.07 g, 10.86 mmol) and HOBt (731 mg, 5.43 mmol). The reaction mass was heated for 20 min at 160 °C under microwave. After completion of the reaction, DMF was removed under vacuum. The residue was diluted with water and extracted with ethyl acetate. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure. The crude was purified by flash column chromatography to afford the title compounds.</div></div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> (<i>S</i>)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic Acid [2-(5-Methyl-thiophen-2-yl)-ethyl]-amide (<b>11b</b>)</h4><div class="NLM_p">The title compound was obtained in 15% (12 mg) yield as a light brown solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): δ 8.07 (t, <i>J</i> = 5.9, 1H), 7.73–7.65 (m, 2H), 7.40 (dd, <i>J</i> = 10.8, 5.3, 2H), 7.17 (t, <i>J</i> = 7.4, 1H), 6.64 (d, <i>J</i> = 3.3, 1H), 6.63 (s, 1H), 6.59 (dd, <i>J</i> = 3.3, 1.1, 1H), 3.91–3.75 (m, 2H), 3.30–3.33 (m, 1H), 3.15 (m, 1H), 2.85 (t, <i>J</i> = 7.4, 2H), 2.53 (m, 1H), 2.34 (s, 3H), 2.07 (dt, <i>J</i> = 12.9, 8.0, 1H). LCMS: (method A) 345.3 (M + H), Rt 3.85 min, 99.16 (max), 98.99 (254 nm); HPLC: Rt 3.92 min, 98.77 (max), 98.67 (254 nm); HRMS calcd for C<sub>18</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub>S (M + H<sup>+</sup>), 345.1267; found, 345.1274.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (<i>S</i>)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic Acid (Thiophen-2-ylmethyl)-amide (<b>11c</b>)</h4><div class="NLM_p">The title compound was obtained in 47% (44 mg) yield as an off-white solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): δ 8.58 (t, <i>J</i> = 6.2, 1H), 7.70 (d, <i>J</i> = 1.1, 1H), 7.68 (d, <i>J</i> = 1.0, 1H), 7.45–7.33 (m, 3H), 7.22–7.14 (m, 1H), 6.99–6.87 (m, 2H), 6.66 (s, 1H), 4.44 (d, <i>J</i> = 6.4, 2H), 3.91–3.78 (m, 2H), 2.59–2.52 (m, 1H), 2.09 (dt, <i>J</i> = 12.9, 8.5, 1H). LCMS: (method A) 317 (M + H), Rt 3.34 min, 96.06 (max), 98.75 (254 nm); HPLC: Rt 3.28 min, 98.41 (max), 99.10 (254 nm); chiral HPLC: (method B) Rt 6.57 min, area % 99.05 (210 nm); HRMS calcd for C<sub>16</sub>H<sub>16</sub>N<sub>2</sub>O<sub>3</sub>S (M + H<sup>+</sup>), 317.0954; found, 317.0966.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (<i>S</i>)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic Acid (3-Methyl-thiophen-2-ylmethyl)-amide (<b>11d</b>)</h4><div class="NLM_p">The title compound was obtained in 46% (45 mg) yield as an off-white solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): δ 8.45 (t, <i>J</i> = 6.1, 1H), 7.74–7.66 (m, 2H), 7.46–7.37 (m, 2H), 7.25 (d, <i>J</i> = 5.1, 1H), 7.22–7.14 (m, 1H), 6.79 (d, <i>J</i> = 5.1, 1H), 6.64 (s, 1H), 4.39 (dd, <i>J</i> = 15.2, 6.4, 1H), 4.33 (dd, <i>J</i> = 15.4, 6.4, 1H), 3.84 (ddd, <i>J</i> = 14.2, 9.2, 3.7, 2H), 2.60–2.52 (m, 1H), 2.16 (s, 3H), 2.09 (dt, <i>J</i> = 12.9, 8.5, 1H). LCMS: (method A) 331 (M + H), Rt 3.52 min, 96.54 (max), 95.65 (254 nm); HPLC: (method A) Rt 3.65 min, 96.02 (max), 94.41 (254 nm); HRMS calcd for C<sub>17</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub>S (M + H<sup>+</sup>), 331.1111; found, 331.1117.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<i>S</i>)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic Acid (4-Methyl-thiophen-2-ylmethyl)-amide (<b>11e</b>)</h4><div class="NLM_p">The title compound was obtained in 52% (43 mg) yield as an off-white solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): δ 8.52 (t, <i>J</i> = 6.2, 1H), 7.70 (dd, <i>J</i> = 5.4, 3.4, 2H), 7.44–7.37 (m, 2H), 7.22–7.14 (m, 1H), 6.94–6.90 (m, 1H), 6.76 (s, 1H), 6.66 (s, 1H), 4.45–4.30 (m, 2H), 3.93–3.78 (m, 2H), 2.56–2.51 (m, 1H), 2.13 (s, 3H), 2.12–2.05 (m, 1H). LCMS: (method A) 331 (M + H), Rt 3.74 min, 92.09 (max), 92.33 (254 nm); HPLC: Rt 3.66 min, 96.29(max), 96.27 (254 nm); HRMS calcd for C<sub>17</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub>S (M + H<sup>+</sup>), 331.1111; found, 331.1121.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>S</i>)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic Acid (5-Methyl-thiophen-2-ylmethyl)-amide (<b>11f</b>)</h4><div class="NLM_p">The title compound was obtained in 44% (37 mg) yield as an off-white solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): δ 8.48 (t, <i>J</i> = 6.2, 1H), 7.69 (dd, <i>J</i> = 8.7, 1.1, 2H), 7.44–7.36 (m, 2H), 7.23–7.09 (m, 1H), 6.71 (d, <i>J</i> = 3.3, 1H), 6.65 (s, 1H), 6.63–6.54 (m, 1H), 4.44–4.28 (m, 2H), 3.92–3.76 (m, 2H), 2.57–2.51 (m, 1H), 2.36 (d, <i>J</i> = 0.8, 3H), 2.15–2.04 (m, 1H). LCMS: (method C) 331 (M + H), Rt 2.52 min, 91.54 (max); HPLC: Rt 3.65 min, 92.26 (max), 90.62 (254 nm); HRMS calcd for C<sub>17</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub>S (M + H<sup>+</sup>), 331.1111; found, 331.1118.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>S</i>)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic Acid (2-Furan-2-yl-ethyl)-amide (<b>11g</b>)</h4><div class="NLM_p">The title compound was obtained in 51% (50 mg) yield as a white solid</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): δ 8.06 (t, <i>J</i> = 5.9, 1H), 7.70 (t, <i>J</i> = 1.5, 1H), 7.68 (t, <i>J</i> = 1.6, 1H), 7.52 (dd, <i>J</i> = 1.8, 0.7, 1H), 7.44–7.37 (m, 2H), 7.22–7.14 (m, 1H), 6.62 (s, 1H), 6.35 (dd, <i>J</i> = 3.1, 1.9, 1H), 6.16 (dd, <i>J</i> = 3.1, 0.7, 1H), 3.92–3.76 (m, 2H), 3.40 (td, <i>J</i> = 13.7, 7.4, 1H), 2.79 (t, <i>J</i> = 7.3, 2H), 2.53 (dd, <i>J</i> = 6.7, 3.6, 1H), 2.15–2.00 (m, 1H). HRMS calcd for C<sub>17</sub>H<sub>19</sub>N<sub>2</sub>O<sub>4</sub> (M + H<sup>+</sup>), 315.1339; found, 315.1348.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>S</i>)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic Acid (2-Cyclopentyl-ethyl)-amide (<b>11h</b>)</h4><div class="NLM_p">The title compound was obtained in 53% (38 mg) yield as an off-white solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): δ 8.72 (t, <i>J</i> = 6.4, 1H), 7.69 (dd, <i>J</i> = 8.7, 1.0, 2H), 7.45–7.33 (m, 2H), 7.27 (dt, <i>J</i> = 8.8, 2.1, 1H), 7.18 (dd, <i>J</i> = 13.0, 4.5, 2H), 7.10 (d, <i>J</i> = 9.0, 1H), 6.76 (s, 1H), 4.38 (dd, <i>J</i> = 15.7, 6.6, 1H), 4.24 (dd, <i>J</i> = 15.9, 6.0, 1H), 3.89–3.82 (m, 2H), 2.62–2.54 (m, 1H), 2.12 (dt, <i>J</i> = 12.9, 7.6, 1H); LCMS: (method A) 317.0 (M + H), Rt 4.03 min, 96.61 (max), 98.74 (254 nm); HPLC: Rt 4.1 min, 97.63 (max), 98.56 (254 nm); chiral HPLC: (method G) Rt 5.52 min area % 100 (210 nm); HRMS calcd for C<sub>18</sub>H<sub>25</sub>N<sub>2</sub>O<sub>3</sub> (M + H<sup>+</sup>), 317.186; found, 317.1868.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>S</i>)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic Acid Benzylamide (<b>11i</b>)</h4><div class="NLM_p">The title compound was obtained in 15% (12 mg) yield as a light brown solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): δ 8.51 (t, <i>J</i> = 6.0, 1H), 7.69 (dd, <i>J</i> = 8.6, 0.9, 2H), 7.45–7.34 (m, 2H), 7.32–7.24 (m, 4H), 7.20 (dt, <i>J</i> = 14.8, 4.6, 2H), 6.68 (s, 1H), 4.33 (dd, <i>J</i> = 15.1, 6.5, 1H), 4.27 (dd, <i>J</i> = 15.1, 6.2, 1H), 3.92–3.74 (m, 2H), 2.63–2.52 (m, 2H), 2.11 (dt, <i>J</i> = 12.9, 7.9, 1H); LCMS: (method A) 311.3 (M + H), Rt 3.29 min, 99.74 (max), 99.55 (254 nm); HPLC: (method A) Rt 3.93 min, 98.92 (max), 99.61 (254 nm); chiral HPLC: (method E) Rt 8.81 min area % 100 (210 nm); HRMS calcd for C<sub>18</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub> (M + H<sup>+</sup>), 311.139; found, 311.1399.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>S</i>)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic Acid 2-Chloro-benzylamide (<b>11j</b>)</h4><div class="NLM_p">The title compound was obtained in 37% (26 mg) yield as brown gum.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): δ 8.59 (t, <i>J</i> = 6.3, 1H), 7.70 (dt, <i>J</i> = 9.0, 1.7, 2H), 7.44–7.24 (m, 6H), 7.21–7.14 (m, 1H), 6.79 (s, 1H), 4.41 (dd, <i>J</i> = 16.2, 6.5, 1H), 4.31 (dd, <i>J</i> = 16.1, 6.1, 1H), 3.86 (dd, <i>J</i> = 8.5, 5.6, 2H), 2.65–2.57 (m, 1H), 2.14 (dt, <i>J</i> = 12.9, 7.7, 1H); HRMS calcd for C<sub>18</sub>H<sub>18</sub>ClN<sub>2</sub>O<sub>3</sub> (M + H<sup>+</sup>), 345.1; found, 345.1004.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>S</i>)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic Acid 3-Chloro-benzylamide (<b>11k</b>)</h4><div class="NLM_p">The title compound was obtained in 34% (27 mg) yield as a brown solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): δ 8.65 (t, <i>J</i> = 6.2, 1H), 7.69 (dd, <i>J</i> = 8.7, 1.1, 2H), 7.43–7.37 (m, 2H), 7.33 (t, <i>J</i> = 7.6, 2H), 7.27 (dd, <i>J</i> = 6.6, 2.1, 1H), 7.22 (d, <i>J</i> = 7.5, 1H), 7.18 (dd, <i>J</i> = 10.5, 4.2, 1H), 6.73 (s, 1H), 4.35 (dd, <i>J</i> = 15.2, 6.6, 1H), 4.25 (dd, <i>J</i> = 15.4, 6.1, 1H), 3.90–3.80 (m, 2H), 2.61–2.54 (m, 1H), 2.11 (dt, <i>J</i> = 13.0, 7.8, 1H); LCMS: (method A) 345 (M + H), Rt 3.86 min, 93.21 (max), 98.65 (254 nm); HPLC: Rt 3.93 min, 90.93 (max), 98.60 (254 nm); chiral HPLC: (method D) Rt 8.26 min, area % 93.34 (210 nm); HRMS calcd for C<sub>18</sub>H<sub>18</sub>ClN<sub>2</sub>O<sub>3</sub> (M + H<sup>+</sup>), 345.1; found, 345.1004.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>S</i>)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic Acid 4-Chloro-benzylamide (<b>11l</b>)</h4><div class="NLM_p">The title compound was obtained in 37% (27 mg) yield as an off-white solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): δ 8.60 (t, <i>J</i> = 6.3, 1H), 7.69 (dt, <i>J</i> = 8.9, 1.7, 2H), 7.43–7.33 (m, 4H), 7.31–7.25 (m, 2H), 7.21–7.13 (m, 1H), 6.70 (s, 1H), 4.31 (dd, <i>J</i> = 15.2, 6.5, 1H), 4.24 (dd, <i>J</i> = 15.2, 6.2, 1H), 3.91–3.76 (m, 2H), 2.56 (ddd, <i>J</i> = 12.8, 7.1, 4.4, 1H), 2.17–2.04 (m, 1H); HRMS calcd for C<sub>18</sub>H<sub>18</sub>ClN<sub>2</sub>O<sub>3</sub> (M + H<sup>+</sup>), 345.1; found, 345.1004.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>S</i>)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic Acid 2-Fluoro-benzylamide (<b>11m</b>)</h4><div class="NLM_p">The title compound was obtained in 25% (17 mg) yield as brown gum.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): δ 8.53 (t, <i>J</i> = 6.3, 1H), 7.73–7.66 (m, 2H), 7.43–7.37 (m, 2H), 7.34 (t, <i>J</i> = 7.8, 1H), 7.31–7.25 (m, 1H), 7.20–7.11 (m, 3H), 6.73 (s, 1H), 4.38 (dd, <i>J</i> = 15.6, 6.4, 1H), 4.31 (dd, <i>J</i> = 15.5, 5.9, 1H), 3.91–3.80 (m, 2H), 2.58 (ddd, <i>J</i> = 12.9, 7.0, 4.5, 1H), 2.12 (dt, <i>J</i> = 13.0, 7.7, 1H); HRMS calcd for C<sub>18</sub>H<sub>18</sub>FN<sub>2</sub>O<sub>3</sub> (M + H<sup>+</sup>), 329.1296; found, 329.1303.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>S</i>)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic Acid 3-Fluoro-benzylamide (<b>11n</b>)</h4><div class="NLM_p">The title compound was obtained in 44% (34 mg) yield as a brown solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): δ 8.64 (t, <i>J</i> = 6.4, 1H), 7.69 (dd, <i>J</i> = 8.7, 1.1, 2H), 7.43–7.37 (m, 2H), 7.33 (td, <i>J</i> = 7.9, 6.1, 1H), 7.21–7.14 (m, 1H), 7.10 (d, <i>J</i> = 7.4, 2H), 7.08–6.99 (m, 2H), 6.73 (s, 1H), 4.37 (dd, <i>J</i> = 15.5, 6.6, 1H), 4.26 (dd, <i>J</i> = 15.4, 6.1, 1H), 3.92–3.75 (m, 2H), 2.63–2.54 (m, 1H), 2.12 (dt, <i>J</i> = 12.9, 7.7, 1H). LCMS: (method A) 329 (M + H), Rt 3.50 min, 94.01 (max), 96.23 (254 nm); HPLC: Rt 3.66 min, 91.55 (max), 94.61 (254 nm); chiral HPLC: (method D) Rt 7.14 min, area % 93.67 (210 nm); HRMS calcd for C<sub>18</sub>H<sub>18</sub>FN<sub>2</sub>O<sub>3</sub> (M + H<sup>+</sup>), 329.1296; found, 329.1305.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>S</i>)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic Acid 3-Methyl-benzylamide (<b>11o</b>)</h4><div class="NLM_p">The title compound was obtained in 10% (7 mg) yield as a light brown solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): δ 8.46 (t, <i>J</i> = 6.2, 1H), 7.70 (d, <i>J</i> = 7.8, 2H), 7.46–7.35 (m, 2H), 7.17 (t, <i>J</i> = 7.3, 2H), 7.07 (d, <i>J</i> = 4.4, 2H), 7.02 (d, <i>J</i> = 7.8, 1H), 6.68 (s, 1H), 4.29 (dd, <i>J</i> = 15.0, 6.5, 1H), 4.23 (dd, <i>J</i> = 15.1, 6.2, 1H), 3.96–3.74 (m, 2H), 2.64–2.52 (m, 1H), 2.26 (s, 3H), 2.11 (dt, <i>J</i> = 12.8, 7.8, 1H). LCMS: (method A) 325.3 (M + H), Rt 3.74 min, 99.67 (max), 99.56 (254 nm); HPLC: Rt 3.78 min, 98.77 (max), 99.48 (254 nm); HRMS calcd for C<sub>19</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub> (M + H<sup>+</sup>), 325.1547; found, 325.1557.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>S</i>)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic Acid 3,5-Dichloro-benzylamide (<b>11p</b>)</h4><div class="NLM_p">The title compound was obtained in 40% (35 mg) yield as a brown solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): δ 8.74 (t, <i>J</i> = 6.4, 1H), 7.70 (dd, <i>J</i> = 8.7, 1.0, 2H), 7.45 (t, <i>J</i> = 1.9, 1H), 7.44–7.36 (m, 2H), 7.32 (d, <i>J</i> = 1.9, 2H), 7.18 (t, <i>J</i> = 7.4, 1H), 6.77 (s, 1H), 4.37 (dd, <i>J</i> = 15.6, 6.7, 1H), 4.23 (dd, <i>J</i> = 15.7, 6.0, 1H), 3.90–3.78 (m, 2H), 2.63–2.53 (m, 1H), 2.12 (dt, <i>J</i> = 13.0, 7.7, 1H); LCMS: (method A) 379 (M + H), Rt 4.43 min, 92.92 (max), 96.66 (254 nm); HPLC: Rt 4.43 min, 96.87 (max), 98.91 (254 nm); HRMS calcd for C<sub>18</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>3</sub> (M + H<sup>+</sup>), 379.0611; found, 379.0621.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>S</i>)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic Acid 3,5-Difluoro-benzylamide (<b>11q</b>)</h4><div class="NLM_p">The title compound was obtained in 56% (54 mg) yield as an off-white solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO): δ 8.72 (t, <i>J</i> = 6.4, 1H), 7.73–7.67 (m, 2H), 7.43–7.37 (m, 2H), 7.18 (dd, <i>J</i> = 10.5, 4.2, 1H), 7.06 (tt, <i>J</i> = 9.4, 2.4, 1H), 7.00–6.95 (m, 2H), 6.77 (s, 1H), 4.39 (dd, <i>J</i> = 15.9, 6.8, 1H), 4.24 (dd, <i>J</i> = 15.8, 6.0, 1H), 3.86 (dd, <i>J</i> = 8.0, 5.7, 2H), 2.63–2.55 (m, 1H), 2.18–2.07 (m, 1H). LCMS: (method A) 347.2 (M + H), Rt 3.86 min, 90.39 (max), 94.47 (254 nm); HPLC: Rt 3.82 min, 92.48 (max), 92.88 (254 nm); chiral HPLC: (method B) Rt 5.14 min area % 99.84 (210 nm); HRMS calcd for C<sub>18</sub>H<sub>17</sub>F<sub>2</sub>N<sub>2</sub>O<sub>3</sub> (M + H<sup>+</sup>), 347.1202; found, 347.1206.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>S</i>)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>11r</b>)</h4><div class="NLM_p">The title compound was obtained in 55% (43 mg) yield as an off-white solid.</div><div class="NLM_p"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.72 (t, <i>J</i> = 6.36 Hz, 1H), 7.69 (d, <i>J</i> = 7.84 Hz, 2H), 7.40 (t, <i>J</i> = 8.36 Hz, 2H), 7.28–7.25 (m, 1H), 7.20–7.16 (m, 2H), 7.11–7.09 (m, 1H), 6.76 (s, 1H), 4.41–4.35 (m, 1H), 4.27–4.22 (m, 1H), 3.86 (t, <i>J</i> = 7.44 Hz, 2H), 2.62–2.55 (m, 1H), 2.16–2.09 (m, 1H). LCMS: (method A) 363 (M + H), Rt 4.02 min, 97.87 (max); 99.35 (254 nm). HPLC: Rt 4.12 min, 97.88 (max); 99.35 (254 nm). Chiral HPLC: (method C) Rt (min): 12.10 area % 100. HRMS calcd for C<sub>18</sub>H<sub>17</sub>ClFN<sub>2</sub>O<sub>3</sub> (M + H<sup>+</sup>), 363.0906; found, 363.0907.</div><div class="NLM_p last">Compounds <b>11ra–11rj</b> were prepared according to the following general protocol: (<i>R</i>)-3-hydroxy-2-oxo-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide (<i>R</i>-<b>18</b>; 70 mg; 0.24 mmol) and the respective aryl halogenide (0.29 mmol) were dissolved in dry 1,4-dioxan (4 mL) and purged with nitrogen for 10 min. Then, K<sub>2</sub>CO<sub>3</sub> (101 mg; 0.73 mmol), CuI (186 mg; 0.98 mmol), and <i>N</i>,<i>N</i>′-dimethylethylendiamin (0.13 mL; 1.22 mmol) were added to the reaction mixture and heated to 100 °C for 2 days. Then, the reaction was filtered and washed with DCM and MeOH. The filtrate was extracted with DCM/water. The organic layer was dried over MgSO<sub>4</sub>, filtered, and evaporated in vacuo. The product was purified on prep. HPLC.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>S</i>)-3-Hydroxy-2-oxo-1-<i>o</i>-tolyl-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>11ra</b>)</h4><div class="NLM_p">The title compound was obtained in 23% (43 mg) yield as a white solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.69 (t, <i>J</i> = 6.4, 1H), 7.32–7.17 (m, 6H), 7.11 (d, <i>J</i> = 9.7, 1H), 6.70 (s, 1H), 4.41 (dd, <i>J</i> = 15.9, 6.7, 1H), 4.24 (dd, <i>J</i> = 15.8, 6.0, 1H), 3.68 (dd, <i>J</i> = 8.3, 5.3, 2H), 2.65–2.57 (m, 1H), 2.19 (dt, <i>J</i> = 13.0, 7.6, 1H), 2.11 (s, 3H); LCMS: (method A) 377.0 (M + H), Rt 4.16 min, 96.51 (max), 96.73 (220 nm). HPLC: Rt 4.97 min, 99.09 (max), 98.88 (220 nm); chiral HPLC (after prep): (method B) Rt 5.15 min; area % 99.16; HRMS calcd for C<sub>19</sub>H<sub>19</sub>ClFN<sub>2</sub>O<sub>3</sub> (M + H<sup>+</sup>), 377.1063; found, 377.1068.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>S</i>)-3-Hydroxy-2-oxo-1-<i>m</i>-tolyl-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>11rb</b>)</h4><div class="NLM_p">The title compound was obtained in 9% (24 mg) yield as colorless gum.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.72 (t, <i>J</i> = 6.3, 1H), 7.50 (d, <i>J</i> = 6.5, 2H), 7.31–7.24 (m, 2H), 7.20 (s, 1H), 7.10 (d, <i>J</i> = 9.7, 1H), 7.00 (d, <i>J</i> = 7.3, 1H), 6.74 (s, 1H), 4.38 (dd, <i>J</i> = 15.8, 6.7, 1H), 4.23 (dd, <i>J</i> = 15.7, 6.0, 1H), 3.83 (dd, <i>J</i> = 8.0, 5.6, 2H), 2.63–2.53 (m, 1H), 2.11 (dt, <i>J</i> = 13.0, 7.6, 1H); LCMS: (method A) 377.0 (M + H), Rt 4.16 min, 96.51 (max), 96.73 (220 nm). HPLC: Rt 4.44 min, 96.29 (max), 97.81 (254 nm); chiral HPLC (after prep): (method B) Rt 5.18 min, area % 99.85; HRMS calcd for C<sub>19</sub>H<sub>19</sub>ClFN<sub>2</sub>O<sub>3</sub> (M + H<sup>+</sup>), 377.1063; found, 377.1069.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>S</i>)-3-Hydroxy-2-oxo-1-<i>p</i>-tolyl-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>11rc</b>)</h4><div class="NLM_p">The title compound was obtained in 15% (32 mg) yield as a white solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.72 (t, <i>J</i> = 6.4, 1H), 7.60–7.55 (m, 2H), 7.27 (dt, <i>J</i> = 8.8, 2.2, 1H), 7.20 (dd, <i>J</i> = 4.9, 3.3, 3H), 7.10 (d, <i>J</i> = 9.7, 1H), 6.73 (s, 1H), 4.37 (dd, <i>J</i> = 15.8, 6.7, 1H), 4.23 (dd, <i>J</i> = 15.8, 6.0, 1H), 3.82 (dd, <i>J</i> = 7.5, 6.1, 2H), 2.63–2.54 (m, 1H), 2.28 (s, 3H), 2.10 (dt, <i>J</i> = 13.0, 7.6, 1H); LCMS: (method A) 377 (M + H), Rt 4.40 min, 97.39(max), 98.43 (254 nm); HPLC: (method A) Rt 4.42 min, 98.42 (max), 98.40 (254 nm); HRMS calcd for C<sub>19</sub>H<sub>19</sub>ClFN<sub>2</sub>O<sub>3</sub> (M + H<sup>+</sup>), 377.1063; found, 377.1064.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>S</i>)-1-(2-Cyano-phenyl)-3-hydroxy-2-oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>11rd</b>)</h4><div class="NLM_p">The title compound was obtained in 9% (18 mg) yield as an off-white solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.74 (t, <i>J</i> = 6.5, 1H), 7.92 (dd, <i>J</i> = 8.0, 1.5, 1H), 7.84–7.74 (m, 1H), 7.51 (ddd, <i>J</i> = 6.3, 3.7, 1.1, 2H), 7.27 (dd, <i>J</i> = 8.8, 2.2, 1H), 7.21 (s, 1H), 7.11 (d, <i>J</i> = 8.8, 1H), 6.87 (s, 1H), 4.39 (dd, <i>J</i> = 15.7, 7.0, 1H), 4.26 (dd, <i>J</i> = 15.8, 6.2, 1H), 3.97–3.76 (m, 3H), 2.69–2.56 (m, 2H), 2.28–2.14 (m, 1H). LCMS: (method A) 388.0 (M + H), Rt 3.83 min, 96.26 (max), 97.18 (254 nm); HPLC: (method A) Rt 3.87 min, 97.15 (max), 97.21 (254 nm); chiral HPLC (after prep): (method B) Rt (min): 5.85 area % 97.80; HRMS calcd for C<sub>19</sub>H<sub>16</sub>ClFN<sub>3</sub>O<sub>3</sub> (M + H<sup>+</sup>), 388.0859; found, 388.0861.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>S</i>)-1-(3-Cyano-phenyl)-3-hydroxy-2-oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>11re</b>)</h4><div class="NLM_p">The title compound was obtained in 12% (11 mg) yield as brown gum.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.78 (t, <i>J</i> = 6.3, 1H), 8.16 (s, 1H), 8.08 (dt, <i>J</i> = 7.4, 2.0, 1H), 7.68–7.59 (m, 2H), 7.27 (dd, <i>J</i> = 8.8, 2.0, 1H), 7.19 (s, 1H), 7.09 (d, <i>J</i> = 9.5, 1H), 6.86 (s, 1H), 4.38 (dd, <i>J</i> = 15.6, 6.7, 1H), 4.24 (dd, <i>J</i> = 15.7, 6.0, 1H), 3.96–3.84 (m, 2H), 2.59 (ddd, <i>J</i> = 11.8, 7.1, 4.5, 1H), 2.14 (dt, <i>J</i> = 13.1, 7.9, 1H). LCMS: (method A) 388.3 (M + H), Rt 5.43 min, 96.54(max), 93.54(254 nm); HPLC: (method A) Rt 4.16 min, 94.60 (max), 92.61 (254 nm); chiral HPLC (after prep): (method B) Rt (min): 6.39, area % 99.39; HRMS calcd for C<sub>19</sub>H<sub>16</sub>ClFN<sub>3</sub>O<sub>3</sub> (M + H<sup>+</sup>), 388.0859; found, 388.0863.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (<i>S</i>)-1-(4-Cyano-phenyl)-3-hydroxy-2-oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>11rf</b>)</h4><div class="NLM_p">The title compound was obtained in 4% (9 mg) yield as a green solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.79 (s, 1H), 7.91 (q, <i>J</i> = 9.1, 4H), 7.27 (d, <i>J</i> = 8.7, 1H), 7.19 (s, 1H), 7.08 (s, 1H), 6.88 (s, 1H), 4.37 (dd, <i>J</i> = 15.6, 6.2, 2H), 4.23 (dd, <i>J</i> = 15.7, 5.8, 2H), 3.90 (dd, <i>J</i> = 11.5, 5.7, 2H), 2.63–2.57 (m, 2H), 2.15 (dt, <i>J</i> = 11.6, 7.4, 2H). LCMS: (method B) 388.3 (M-H), Rt 3.53 min, 90.47 (max), 90.32 (254 nm); HPLC: (method A) Rt 4.15 min, 90.20 (max), 94.77 (254 nm); chiral HPLC (after prep): (method A) Rt 13.77 min; area % 97.70; HRMS calcd for C<sub>19</sub>H<sub>16</sub>ClFN<sub>3</sub>O<sub>3</sub> (M + H<sup>+</sup>), 388.0859; found, 388.0859.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1-(3-Acetylamino-phenyl)-3-hydroxy-2-oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>11rg</b>)</h4><div class="NLM_p">The title compound was obtained in 12% (26 mg) yield as a white solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.02 (s, 1H), 8.73 (s, 1H), 7.93 (s, 1H), 7.48–7.43 (m, 1H), 7.34–7.24 (m, 3H), 7.20 (s, 1H), 7.09 (d, <i>J</i> = 9.7, 1H), 6.78 (s, 1H), 4.38 (dd, <i>J</i> = 15.7, 6.2, 1H), 4.24 (dd, <i>J</i> = 15.7, 5.3, 1H), 3.81 (dd, <i>J</i> = 8.3, 5.6, 2H), 2.62–2.53 (m, 1H), 2.12 (m, 1H), 2.03 (s, 3H). LCMS: (method A) 420 (M + H), Rt 3.51 min, 98.57 (max), 98.89 (254 nm); HPLC: (method A) Rt 3.46 min, 99.18 (max), 99.45 (254 nm); HRMS calcd for C<sub>20</sub>H<sub>20</sub>ClFN<sub>3</sub>O<sub>4</sub> (M + H<sup>+</sup>), 420.1121; found, 420.1125.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (<i>S</i>)-1-(4-Acetylamino-phenyl)-3-hydroxy-2-oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>11rh</b>)</h4><div class="NLM_p">The title compound was obtained in 7% (4 mg) yield as a pale brown solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.96 (s, 1H), 8.71 (t, <i>J</i> = 6.5, 1H), 7.66–7.55 (m, 4H), 7.27 (d, <i>J</i> = 8.5, 1H), 7.20 (s, 1H), 7.09 (d, <i>J</i> = 9.2, 1H), 6.73 (s, 1H), 4.38 (dd, <i>J</i> = 15.4, 6.6, 1H), 4.23 (dd, <i>J</i> = 15.7, 5.9, 1H), 3.81 (t, <i>J</i> = 6.8, 2H), 2.62–2.53 (m, 2H), 2.16–2.05 (m, 2H), 2.02 (s, 3H). LCMS: (method A) 420.0 (M + H), Rt 3.34 min, 97.16 (max), 97.53 (254 nm); HPLC: (method A) Rt 3.41 min, 99.24 (max), 99.56 (254 nm); HRMS calcd for C<sub>20</sub>H<sub>20</sub>ClFN<sub>3</sub>O<sub>4</sub> (M + H<sup>+</sup>), 420.1121; found, 420.1128.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (<i>S</i>)-1-(3-Carbamoyl-phenyl)-3-hydroxy-2-oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>11ri</b>)</h4><div class="NLM_p">The title compound was obtained in 30% (108 mg) yield as a white solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.75 (t, <i>J</i> = 6.4, 1H), 8.07–8.00 (m, 2H), 7.99–7.93 (m, 1H), 7.67 (d, <i>J</i> = 7.9, 1H), 7.48 (t, <i>J</i> = 8.0, 1H), 7.42 (s, 1H), 7.27 (dt, <i>J</i> = 8.8, 2.2, 1H), 7.20 (s, 1H), 7.10 (d, <i>J</i> = 9.7, 1H), 6.80 (s, 1H), 4.38 (dd, <i>J</i> = 15.8, 6.7, 1H), 4.25 (dd, <i>J</i> = 15.7, 6.0, 1H), 3.94–3.86 (m, 2H), 2.64–2.56 (m, 1H), 2.14 (dt, <i>J</i> = 13.0, 7.6, 1H). LCMS: (method A) 406 (M + H), Rt 3.23 min, 95.75 (max), 97.17 (254 nm); HPLC: (method A) Rt 3.37 min, 96.31 (max), 97.52 (254 nm); chiral HPLC (after prep): (method B) Rt 5.78 min; area % 97.96; HRMS calcd for C<sub>19</sub>H<sub>18</sub>ClFN<sub>3</sub>O<sub>4</sub> (M + H<sup>+</sup>), 406.0964; found, 406.0965.</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (<i>S</i>)-1-(4-Carbamoyl-phenyl)-3-hydroxy-2-oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>11rj</b>)</h4><div class="NLM_p">The title compound was obtained in 2% (4 mg) yield as an off-white solid.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.76 (t, <i>J</i> = 6.4, 1H), 7.95 (br s, 1H), 7.91 (d, <i>J</i> = 8.8, 2H), 7.79 (d, <i>J</i> = 8.9, 2H), 7.33 (br s, 1H), 7.27 (d, <i>J</i> = 8.7, 1H), 7.20 (s, 1H), 7.10 (d, <i>J</i> = 9.2, 1H), 6.82 (s, 1H), 4.38 (dd, <i>J</i> = 15.8, 6.9, 1H), 4.24 (dd, <i>J</i> = 15.8, 6.0, 1H), 3.89 (dd, <i>J</i> = 9.3, 5.1, 2H), 3.37 (m, 1H), 2.64–2.55 (m, 2H), 2.19–2.08 (m, 1H). LCMS: (method A) 406 (M + H), Rt 3.24 min, 91.44 (max), 94.05 (254 nm); HPLC: (method A) Rt 3.20 min, 92.44 (max), 95.13 (254 nm); HRMS calcd for C<sub>19</sub>H<sub>18</sub>ClFN<sub>3</sub>O<sub>4</sub> (M + H<sup>+</sup>), 406.0964; found, 406.0969.</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-Oxo-1-phenyl-pyrrolidine-3-carboxylic Acid (<b>13</b>)</h4><div class="NLM_p last">Meldrum’s acid <b>12</b> (10 g, 58.76 mmol) and aniline (10.9 g, 117.53 mmol) were mixed at rt and stirred for 12 h. The reaction mixture was basified with 10% NaOH solution and again acidified with conc. HCl. The precipitate was filtered through vacuum and dried to afford the title compound in 96% yield (11.5 g, yellow liquid). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.28 (br s, 1H), 7.64–7.62 (m, 2H), 7.40–7.36 (m, 2H), 7.18–7.13 (m, 1H), 3.90–3.81 (m, 2H), 3.61–3.56 (m, 1H), 2.36–2.27 (m, 2H) LCMS: (method A) 206.3 (M + H<sup>+</sup>), Rt 2.43 min, 93.18% (max).</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-Oxo-1-phenyl-pyrrolidine-3-carboxylic Acid Ethyl Ester (<b>14</b>)</h4><div class="NLM_p last">To a solution of 2-oxo-1-phenyl-pyrrolidine-3-carboxylic acid <b>13</b> (11 g, 53.65 mmol) in dry ethanol (150 mL) was added thionyl chloride (25.5 g, 214.6 mmol) slowly at 0 °C under nitrogen. The reaction mass slowly warmed to rt and was refluxed for 4 h under nitrogen. After the completion of the reaction, the reaction mixture was concentrated under reduced pressure to remove the solvent. The crude mixture was diluted with water, basified with 10% NaHCO<sub>3</sub> solution, and was extracted with ethyl acetate. The organic layer was separated and washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to afford the title compound in 92% (11.5 g) yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.64–7.62 (m, 2H), 7.40–7.36 (m, 2H), 7.18–7.14 (m, 1H), 4.18–4.12 (m, 2H), 3.90–3.83 (m, 2H), 3.73 (t, <i>J</i> = 8.88 Hz, 1H), 2.39–2.31 (m, 2H), 1.21 (t, <i>J</i> = 7.12 Hz, 3H). LCMS: (method A) 234 (M + H<sup>+</sup>), Rt 3.46 min, 98.34% (max); 97.54 (254 nm).</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (<i>R</i>)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic Acid Ethyl Ester (<i>R</i>-<b>15</b>)</h4><div class="NLM_p">To 2-oxo-1-phenyl-pyrrolidine-3-carboxylic acid ethyl ester <b>14</b> (11.5 g, 49.35 mmol) in IPA (100 mL) was added cerium chloride heptahydrate (4.84 g, 49.65 mmol), the reaction mixture was degassed with O<sub>2</sub> for 15 min and allowed to stir for 12 h under O<sub>2</sub> atmosphere. After completion of the reaction as confirmed from TLC, the solvent was removed, and the crude was purified by flash column chromatography. 3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic acid ethyl ester (12 g) was analyzed in chiral HPLC, and then both enantiomers were separated by chiral prep. HPLC: (Chiralpak AD-H (250 × 4.6) mm, 5 μm; <i>n</i>-hexane/IPA = 60:40). The first peak eluted at Rt 7.35 min (6.5 g) and the second at Rt 10.0 min (5 g).</div><div class="NLM_p last">Deconvolution of the enantiomers revealed in retro perspective that the later eluting peak was the desired <i>R</i> enantiomer. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.68–7.65 (m, 2H), 7.43–7.39 (m, 2H), 7.21–7.17 (m, 1H), 6.55 (s, 1H), 4.20–4.10 (m, 2H), 3.89–3.83 (m, 2H), 2.50–2.48 (m, 1H), 2.52–2.13 (m, 1H), 1.18 (t, <i>J</i> = 7.12 Hz, 3H). LCMS: (method A) 250.3 (M + H), Rt. 2.96 min, 99.11% (max). HPLC: Rt 3.04 min, 98.34% (max), 97.20% (254 nm). Chiral HPLC (crude): (method A) Rt (min): 7.35 and 10.00 min, area % 49.55/50.45. Chiral HPLC (after prep): (method B) Rt 11.65 min, area 99.7%.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (<i>R</i>)-3-Hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic Acid (<b>16</b>)</h4><div class="NLM_p last">To a solution of (<i>R</i>)-3-hydroxy-2-oxo-1-phenyl-pyrrolidine-3-carboxylic acid ethyl ester (<i>R</i>-<b>15</b>, 3.5 g, 14.05 mmol) in THF/H<sub>2</sub>O (3:1) was added LiOH·H<sub>2</sub>O (2.36 g, 56.19 mmol) and stirred for 4 h. After completion of the reaction, the solvent was removed by vacuum and acidified with HCl (1.5 N). The aqueous solution was extracted with ethyl acetate and dried over sodium sulfate. The solvent was evaporated under vacuum to afford the title compound in 84% yield (2.6 g, brown solid). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.69–7.66 (m, 2H), 7.42–7.37 (m, 2H), 7.20–7.16 (m, 1H), 3.86–3.82 (m, 2H), 2.56–2.53 (m, 1H), 2.15–2.08 (m, 1H). LCMS: (method A) 222 (M + H), Rt. 2.07 min, 98.67 (max); 98.71 (254 nm). HPLC: Rt 2.16 min, 98.66 (max); 98.89 (254 nm). Chiral HPLC (after prep): (method C) Rt 12.10 min, area % 100.</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Synthesis of Building Block <i>R</i>-<b>18</b></h4><div id="sec5_1_35_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> Synthesis of 2-Oxo-pyrrolidine-1-carboxylic Acid <i>tert</i>-Butyl Ester</h5><div class="NLM_p last">To a solution of 2-pyrrolidinone <b>17</b> (60 g, 368 mmol) in dry acetonitrile (600 mL) was added DMAP (4.39 g, 36.8 mmol). Then, BOC<sub>2</sub>O (200 g, 460 mmol) was added slowly at 0 °C. The reaction was slowly warmed to rt and stirred for additional 3 h under nitrogen. After completion of the reaction, the solvent was removed completely under reduced pressure, and the crude was suspended with water, extracted with ethyl acetate and washed with 1.5 N HCl solution. The organic layer was separated, dried over NaSO<sub>4</sub>, and concentrated under reduced pressure. The obtained brown liquid was purified by column chromatography (60–120 mesh) with 30% ethyl acetate in petrol ether to afford 92 g (70%) of the title compound as a pale yellow liquid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 3.64–3.60 (m, 2H), 2.40–2.36 (m, 2H), 1.91–1.83 (m, 2H), 1.43 (s, 9H).</div></div><div id="sec5_1_35_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> Synthesis of 2-Oxo-pyrrolidine-1,3-dicarboxylic Acid 3-Benzyl Ester 1-<i>tert</i>-Butyl Ester</h5><div class="NLM_p last">To a solution of 2-oxo-pyrrolidine-1-carboxylic acid <i>tert</i>-butyl ester (50 g, 270 mmol) in dry THF (500 mL) was added LiHMDS (1 M in THF; 540 mL, 540 mmL) at −78 °C under nitrogen slowly. After the addition was completed, stirring was continued at −78 °C for another hour. Then, benzyl chloroformate (50% solution in toluene; 90 mL, 270 mmol) was added dropwise at −78 °C under nitrogen. The reaction mass was slowly warmed to rt and stirred for 1 h at that temperature. The reaction was quenched with ice and extracted with ethyl acetate. The organic layer was washed with 10% NaHCO<sub>3</sub> and brine. The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub>, and was concentrated under reduced pressure. The crude obtained was made into slurry with petrol ether, and the obtained solid was filtered through vacuum. The yellow crude was further purified by column chromatography (60–120 mesh) with 40% ethyl acetate in petrol ether to afford 37 g (43%) of the title compound as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.38–7.33 (m, 5H), 5.20–5.13 (m, 2H), 3.80–3.69 (m, 2H), 3.62–3.55 (m, 1H), 2.24–2.14 (m, 2H), 1.44 (s, 9H).</div></div><div id="sec5_1_35_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> Synthesis of 2-Oxo-pyrrolidine-1,3-dicarboxylic Acid 1-<i>tert</i>-Butyl Ester</h5><div class="NLM_p last">To a solution of 2-Oxo-pyrrolidine-1,3-dicarboxylic acid 3-benzyl ester 1-<i>tert</i>-butyl ester (37 g, 116 mmol) in dry methanol (400 mL) was added Pd/C (10%; 3.7 g), and the suspension was stirred at rt under hydrogen atmosphere. The reaction mass was filtered through Celite. The filtrate was evaporated under reduced pressure to afford 24 g (90%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.94 (s, 1H), 3.72–3.66 (m, 1H), 3.62–3.50 (m, 2H), 2.23–2.18 (m, 2H), 1.44 (s, 9H).</div></div><div id="sec5_1_35_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> Synthesis of 3-(3-Chloro-5-fluoro-benzylcarbamoyl)-2-oxo-pyrrolidine-1-carboxylic Acid <i>tert</i>-Butyl Ester</h5><div class="NLM_p last">To a solution of 2-Oxo-pyrrolidine-1,3-dicarboxylic acid 1-<i>tert</i>-butyl ester (6 g; 26 mmol) and 3-chloro-5-fluoro benzylamine (5 g; 31.4 mmol) in dry 1,2-dichloroethane (DCE) (60 mL) were added TEA (11 mL) and T3P (25 mL; 78 mmol) under ice-cooled conditions. The reaction was stirred at rt for 1 h under nitrogen. After the reaction was completed, it was diluted with DCE and washed with 10% NaHCO<sub>3</sub> and brine. The organic layer was separated, dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure. The obtained crude was purified by column chromatography (60–120 mesh) 40% ethyl acetate in petrol ether giving the product in 87% yield (8.4 g) as colorless solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.92–8.03 (m, 1H), 7.31–7.28 (m, 1H), 7.23 (s, 1H), 7.14–7.12 (m, 1H), 4.44–4.39 (m, 1H), 4.27–4.22 (m, 1H), 3.73–3.52 (m, 3H), 2.17–2.10 (m, 2H), 1.45 (s, 9H).</div></div><div id="sec5_1_35_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> Synthesis of 2-Oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide</h5><div class="NLM_p last">To a solution of 3-(3-chloro-5-fluoro-benzylcarbamoyl)-2-oxo-pyrrolidine-1-carboxylic acid <i>tert</i>-butyl ester (8.4 g, 22.7 mmol) in dry 1,4-dioxane (70 mL) was added a saturated solution of HCl in dioxane (100 mL) under ice-cooled conditions. The reaction was warmed slowly to rt and stirred for additional 2 h under nitrogen. After completion of the reaction, the liquid phase was concentrated to dryness under reduced pressure. The obtained solid was washed with petrol ether and dried over Na<sub>2</sub>SO<sub>4</sub> to afford 6 g (86%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.62–8.60 (m, 1H), 7.86 (s, 1H), 7.28–7.25 (m, 2H), 7.17–7.14 (m, 1H), 4.46–4.41 (m, 1H), 4.24–4.19 (m, 1H), 3.25–3.18 (m, 2H), 2.32–2.27 (m, 1H), 2.18–2.14 (m, 1H).</div></div><div id="sec5_1_35_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> Synthesis of 3-Hydroxy-2-oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>18</b>)</h5><div class="NLM_p">To a solution of 2-oxo-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide (6 g, 19 mmol) in dry <i>tert</i>-butanol (60 mL) were added sodium ethoxide (20% in ethanol; 20 mL, 58 mmol) and <i>tert</i>-butyl hydro peroxide (70% aq. solution; 7.7 mL, 58 mmol) slowly under ice-cooled conditions. After the addition was completed, the reaction was refluxed at 75 °C for 1 h. The reaction was evaporated to dryness under reduced pressure. The obtained crude was diluted with water and extracted with ethyl acetate. The combined organic layer was dried over sodium sulfate and concentrated under reduced pressure. The obtained pale yellow solid was washed with DCE to afford 2.7 g (48%) of the title compound as a white solid which was confirmed as the racemic mixture by chiral HPLC analysis. LCMS: mass found (M + H<sup>+</sup>, 287.0). Method A: Rt 2.69 min, area % 97.74 (max), 97.48 (220 nm) HPLC: Rt 2.71 min, area % 99.12 (max), 9.06 (220 nm).</div><div class="NLM_p last">The racemate was separated into the enantiomers via chiral chromatography, giving the 1.3 g of the desired <i>R</i>-<b>18</b>. Chiral HPLC: Chiralcel OJ-H (250 × 4.6) mm, 5 μm, mobile phase: 0.1% DEA in hexane/IPA = 90:10, flow: 1.0 mL/min, Rt 13.23 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.55 (t, <i>J</i> = 6.40 Hz, 1H), 7.99 (s, 1H), 7.27–7.24 (m, 1H), 7.20 (s, 1H), 7.11–7.08 (m, 1H), 6.38 (s, 1H), 4.39–4.34 (m, 1H), 4.24–4.18 (m, 1H), 3.23–3.20 (m, 2H), 2.51–2.45 (m, 1H), 2.02–1.97 (m, 1H); HRMS calcd for C<sub>12</sub>H<sub>13</sub>ClFN<sub>2</sub>O<sub>3</sub> (M + H<sup>+</sup>), 287.0593; found, 287.0603.</div></div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (3<i>S</i>)-<i>N</i>-[(3-Chloro-5-fluorophenyl)methyl]-3-hydroxy-1-methyl-2-oxopyrrolidine-3-carboxamide (<b>19</b>)</h4><div id="sec5_1_36_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> Synthesis of 1-Methyl-2-oxo-pyrrolidine-3-carboxylic Acid Ethyl Ester</h5><div class="NLM_p last">To a solution of N-methyl pyrrolidone (5 g, 50 mmol) in dry THF (50 mL) was added lithium bistrimethyl silyl amide (1 M in THF, 100 mL, 100 mmol) slowly at −78 °C under nitrogen. After addition was completed, stirring was continued at −78 °C for another 1 h. Then, ethyl chloroformate (5.73 mL, 60 mmol) was added dropwise at −78 °C under nitrogen. The reaction mass slowly warmed to rt and was stirred for 1 h. The reaction was quenched with ice and extracted with ethyl acetate. The organic layer was washed with 10% sodium bicarbonate and brine. The organic layer was dried over sodium sulfate and concentrated under reduced pressure to afford the title compound as a brown liquid in 48% yield (4.1 g). LCMS: (method A) 172.2 (M + H<sup>+</sup>); Rt 0.98 min, 91.54 (max).</div></div><div id="sec5_1_36_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> Synthesis of 1-Methyl-2-oxo-pyrrolidine-3-carboxylic Acid</h5><div class="NLM_p last">To a solution of 1-methyl-2-oxo-pyrrolidine-3-carboxylic acid ethyl ester (1.6 g, 9.35 mmol) in THF/H<sub>2</sub>O (3:1) was added LiOH·H<sub>2</sub>O (1.57 g, 37.4 mmol), and the mixture was stirred for 4 h. After completion of the reaction, the solvent was removed by vacuum and acidified with 1.5 N HCl. The aqueous solution was extracted with ethyl acetate and dried over sodium sulfate. The solvent was evaporated under vacuum to afford the title compound as a brown solid in 30% yield (400 mg). LCMS: (method C) 144.2 (M + H), Rt. 0.83 min, 90.22%.</div></div><div id="sec5_1_36_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> Synthesis of 1-Methyl-2-oxo-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide</h5><div class="NLM_p last">To a solution of 1-methyl-2-oxo-pyrrolidine-3-carboxylic acid (400 mg, 2.79 mmol) and 3-chloro-5-fluoro benzylamine (0.448 mg, 2.79 mmol) in dry DCE (60 mL) were added TEA (1.16 mL, 8.39 mmol) and T3P (2.67 g, 8.39 mmol) under ice-cooled conditions. The reaction mass was stirred at rt for 1 h under nitrogen. The reaction was diluted with DCE and extracted with 10% NaHCO<sub>3</sub> and brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure. The crude obtained was purified by column chromatography (60–120 mesh). The product was eluted with 50% ethyl acetate in petrol ether to afford the title compound in 51% yield (400 mg). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.66 (t, <i>J</i> = 6.9 Hz, 1H), 7.29–7.24 (m, 2H), 7.17–7.14 (m, 1H), 4.46–4.24 (m, 1H), 4.23–4.19 (m, 1H), 3.34–3.29 (m, 3H), 2.74 (s, 3H), 2.22–2.19 (m, 1H), 2.13–2.10 (m, 1H).</div></div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (<i>S</i>)-<i>N</i>-[(3-Chloro-5-fluorophenyl)methyl]-3-hydroxy-1-methyl-2-oxopyrrolidine-3-carboxamide (<b>19</b>)</h4><div class="NLM_p last">To a solution of 1-methyl-2-oxo-pyrrolidine-3-carboxylic acid 3-chloro-5-fluoro-benzylamide (400 mg, 1.4 mmol) in dry <i>tert</i>-butanol (10 mL) were added sodium ethoxide (20% in ethanol; 1.9 mL, 5.6 mmol) and <i>tert</i>-butyl hydro peroxide (70% aq. solution; 0.72 mL, 5.6 mmol) slowly under ice-cooled conditions. After the addition was completed, the reaction mass was refluxed at 75 °C for 1 h. The reaction mass was evaporated completely under reduced pressure. The obtained residue was diluted with water and extracted with ethyl acetate (5 times). The combined organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure. The obtained pale yellow solid was washed with DCE to afford the title compound as a white solid which was found to be a racemic mixture as analyzed by chiral HPLC and was then separated by chiral prep. HPLC to afford the required isomer in 39% yield (69 mg) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO): δ 8.59 (t, <i>J</i> = 6.4, 1H), 7.31–7.23 (m, 1H), 7.19 (s, 1H), 7.09 (d, <i>J</i> = 9.8, 1H), 6.46 (s, 1H), 4.36 (dd, <i>J</i> = 15.7, 6.8, 1H), 4.21 (dd, <i>J</i> = 15.8, 5.8, 1H), 2.76 (s, 3H), 2.45–2.40 (m, 1H), 2.00–1.88 (m, 1H). LCMS: (method A) 301 (M + H), Rt 2.93 min, 98.94 (max), 99.00 (254 nm). HPLC: Rt 2.86 min, 96.37 (max), 96.56 (254 nm); HRMS calcd for C<sub>13</sub>H<sub>15</sub>ClFN<sub>2</sub>O<sub>3</sub> (M + H<sup>+</sup>), 301.075; found, 301.0756.</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (<i>S</i>)-3-Hydroxy-2-oxo-1-(2-oxo-2,3-dihydro-1<i>H</i>-indol-5-yl)-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>20</b>)</h4><div class="NLM_p last">The title compound was prepared as described for compounds <b>11ra–11rj</b> in 30% yield (33.4 mg). Rt 6.16 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.36 (s, 1H), 8.66 (t, <i>J</i> = 6.4 Hz, 1H), 7.56 (d, <i>J</i> = 2.1 Hz, 1H), 7.41 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 7.26 (dt, <i>J</i> = 8.8, 2.2 Hz, 1H), 7.21 (d, <i>J</i> = 1.7 Hz, 1H), 7.10 (ddd, <i>J</i> = 9.7, 2.4, 1.4 Hz, 1H), 6.83 (d, <i>J</i> = 8.4 Hz, 1H), 6.68 (s, 1H), 4.39 (dd, <i>J</i> = 15.8, 6.7 Hz, 1H), 4.25 (dd, <i>J</i> = 15.7, 6.0 Hz, 1H), 3.80 (dd, <i>J</i> = 7.7, 5.9 Hz, 2H), 3.50 (s, 2H), 2.58 (dt, <i>J</i> = 12.9, 5.8 Hz, 1H), 2.11 (dt, <i>J</i> = 12.9, 7.6 Hz, 1H); <sup>13</sup>C NMR (176 MHz, DMSO-<i>d</i><sub>6</sub>): δ 175.70, 171.21, 170.28, 162.19, 160.79, 143.67, 143.62, 140.06, 133.06, 133.00, 132.67, 125.65, 122.48, 122.46, 118.97, 116.65, 113.56, 113.42, 112.12, 112.00, 108.26, 78.59, 44.97, 40.50, 35.42, 30.96. HRMS calcd for C<sub>20</sub>H<sub>18</sub>ClFN<sub>3</sub>O<sub>4</sub> (M + H<sup>+</sup>), 418.0964; found, 418.097.</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (<i>S</i>)-3-Hydroxy-2-oxo-1-(2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-pyrrolidine-3-carboxylic Acid 3-Chloro-5-fluoro-benzylamide (<b>21</b>)</h4><div class="NLM_p">The title compound was prepared as described for compounds <b>11ra–11rj</b> in 17% yield (35 mg).</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.06 (s, 1H), 10.10 (s, 1H), 8.70 (t, <i>J</i> = 6.3, 1H), 7.65 (s, 1H), 7.47 (s, 1H), 7.43 (dd, <i>J</i> = 8.6, 2.4, 1H), 7.27 (dt, <i>J</i> = 8.7, 2.1, 1H), 7.20 (s, 1H), 7.09 (d, <i>J</i> = 8.9, 1H), 7.03 (s, 2H), 6.85 (d, <i>J</i> = 8.6, 1H), 6.72 (s, 1H), 4.37 (dd, <i>J</i> = 15.7, 6.8, 1H), 4.23 (dd, <i>J</i> = 15.7, 6.1, 1H), 3.79 (t, <i>J</i> = 6.8, 1H), 2.87 (t, <i>J</i> = 7.6, 1H), 2.61–2.52 (m, 1H), 2.43 (dd, <i>J</i> = 8.3, 6.7, 2H), 2.09 (dt, <i>J</i> = 12.9, 7.6, 1H). LCMS: (method A) 432 (M + H), Rt 3.36 min, 91.39 (max), 92.24 (254 nm); HPLC: Rt 3.47 min, 93.70 (max), 93.73 (254 nm); chiral HPLC (after prep) (method B) Rt 9.77 min, area % 100; HRMS calcd for C<sub>21</sub>H<sub>20</sub>ClFN<sub>3</sub>O<sub>4</sub> (M + H<sup>+</sup>), 432.1121; found, 432.1129.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Biological Assays</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Biochemical Activity Testing of MetAP-2</h4><div class="NLM_p">MetAP-2 activity was determined by an enzyme-coupled assay using tripeptide Met-Ala-Ser (MAS) as the substrate and recombinant human MetAP-2 (His-Tev-MetAP-2, prepared at Merck). The released methionine is converted by <span class="smallcaps smallerCapital">l</span>-amino acid oxidase (AAO) to oxidized methionine, and hydrogen peroxide is released. In the second step, horseradish peroxidase catalyzes the oxidation of the leuko dye dianisidine to oxidized dianisidine using hydrogen peroxide as the cosubstrate. The produced dianisidine ox was detected photometrically as increase in absorbance at 450 nm. Met-AP2 activity was determined in a kinetic measurement mode. The release of one molecule methionine corresponds to the production of one molecule dianisidine ox. The MetAP2 enzymatic activity is directly corresponding to the increase in absorbance per time.</div><div class="NLM_p last">In detail, the assay was performed in 384-well microtiter plate (Greiner 78110 MTP, transparent) in a total reaction volume of 50 μL at 22 °C. N-terminal His tag human rec MetAP2 (0.35 μg) (prepared in-house, AA 2–478, final concentration (fc) 123 nM), 1 unit horse radish peroxidase (Roche, Mannheim), 0.02 unit AAO (Merck, Darmstadt), and 0.6 mM dianisidine (Merck, Darmstadt, dissolved in 50 mM HCl, 10% DMSO) were incubated in the absence or presence of the test compound (10 dilution concentrations) in 100 mM Hepes, 50 mM NaCl, 50 μM MnCl<sub>2</sub> at pH 7.0 for 15 min at 22 °C. The reaction was started by the addition of 500 μM (fc) MAS peptide (Merck, Darmstadt). After mixing, the first absorbance measurement was performed on an Envision multimode reader (PerkinElmer, Waltham) at a wavelength of 450 nm. The reaction was incubated at 22 °C for additional 45 min, and the second absorbance measurement was performed. The increase of absorbance per time was determined. The control value used was the inhibitor-free reaction with 0.5% DMSO (fc). As pharmacological inhibitor control, Fumagillin (Merck, Darmstadt) in an fc of 5 μM was used. The inhibitory values (IC<sub>50</sub>) were determined using the program ASSAY ANALYZER from GeneData (Basel, Switzerland).</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> HUVEC Proliferation Assay</h4><div class="NLM_p last">Proliferation of HUVEC primary endothelial cells was used as cell-based mechanistical assay.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Applying the CyQUANT Direct Cell Proliferation Assay (Invitrogen C35011) which is based on a cell-permeant fluorescent DNA-binding dye, DNA content is used as a direct measure for the cell number. Pooled HUVEC cells (Promocell C-12203) are cultivated in the medium supplied by Promocell (Cat No C-22020) for a maximum of four passages. For the assay, 500 cells/well are seeded into black 384-well culture plates with a clear bottom in 70 μL culture medium and incubated for 6 hours at 37 °C, 5% CO<sub>2</sub>. Prediluted test compounds (10 μL) are added, and cells are incubated for 3 days at 37 °C, 5% CO<sub>2</sub> before measurement of DNA content. The CyQUANT detection reagent is prepared according to manufacturer’s protocol, 20 μL/well was added and incubated at 37 °C, 5% CO2 for at least 1 h before measurement of fluorescence at the EnVision multimode reader (PerkinElmer, Waltham) with an excitation of 480 nm and an emission of 535 nm (bottom read mode). The assay is performed as dose response with 10 compound dilutions. Inhibitory values (IC<sub>50</sub>) were determined using the program ASSAY ANALYZER from GeneData (Basel, Switzerland).</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Efficacy Testing in Vivo (All Animal Experiments Performed in the Manuscript Were Conducted in Compliance with Institutional Guidelines)</h4><div class="NLM_p">The human U87-MG cell line (derived from malignant glioma, ATCC: HTB-14) used was directly prepared from frozen cell batches for tumor cell inoculation. Cell vials were rapidly thawed at 37 °C. Cell suspension of all vials was transferred into a sterile 50 mL centrifuge tube (Falcon). The tube was filled with PBS (w/o Ca/Mg) up to 50 mL, and mixed, and cell number and viability were measured with ViCell (Automated Cell Viability Analyzer; Beckman Coulter). Cell suspension was centrifuged for 5 min at 1000<i>g</i> and adjusted to 10 × 10<sup>6</sup> viable cells/ml using PBS (w/o Ca/Mg). Cell suspension (100 μL) was subcutaneously inoculated in the right flank of nude mice. In the present study, female CD-1 nude mice, aged 6–7 weeks, were used. CD-1 nude mice are an outbred strain provided by Charles River Laboratories (CRL), Sulzfeld, Germany. The mice were housed and maintained under aseptic conditions in facilities approved by the German Association for Accreditation of Laboratory Animal Care and in accordance with current regulations and standards of the German Animal Protection Law, and their use was approved by local responsible authorities.</div><div class="NLM_p">Animal identification: All animals were individually identified using subcutaneously implanted electronic NONATEC transponders (LUTRONIC, Luxemburg). Implantation was performed on the back by a hypodermic needle (18 gauge) after sterilization of the skin with 70% alcohol. An electronic reader allowed the identification of each individual animal with the corresponding code number.</div><div class="NLM_p last">Pharmaceutical formulation: <b>21</b> was dissolved in 0.5%Methocel/0.25%Tween20 in Milli-Q water and stored at 4 °C. Compound solution has been freshly prepared all 3–4 days. Treatment: On treatment days, the solution was allowed to return to room temperature followed by per os administration of 200 μL per 20 g mouse. Tumor volume and body weight measurements and calculations: When the tumors reached a mean tumor volume typically of 300–400 mm<sup>3</sup>, the animals were assigned to treatment groups (8 or 10 animals/group). Tumor length (<i>L</i>) and width (<i>W</i>) were measured twice weekly by calipers. The tumor volume was calculated using the formula <i>L</i> × <i>W</i><sup>2</sup>/2. Body weight was monitored twice weekly. All animal data were collected in an electronical data collection system. T/C value: The effect of a treatment on tumor growth was assessed at the end of each study by calculating the % T/C value according to following formulas: % T/C (for mean values > 0): [(end tumor volume treatment – start tumor volume treatment)/(end tumor volume control – start tumor volume control)] × 100]</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00041" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21244" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21244" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00041" class="ext-link">10.1021/acs.jmedchem.9b00041</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00041/suppl_file/jm9b00041_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Additional graphics superimposition of <b>11a</b> with methionine; individual tumor volumes from the in vivo experiment; X-ray structure generation (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00041/suppl_file/jm9b00041_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00041/suppl_file/jm9b00041_si_001.csv">jm9b00041_si_001.csv (2.87 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00041/suppl_file/jm9b00041_si_002.pdf">jm9b00041_si_002.pdf (181.95 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last"><b>1</b> (SB-587094): <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OAZ">2OAZ</a>; <b>2</b> (A-357300): <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R58">1R58</a>; <b>3</b> (LAF-153): <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QZY">1QZY</a>; <b>4</b>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JFR">5JFR</a>; <b>5</b> (A-849519): <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YW9">1YW9</a>; <b>6</b>: 5LYX7 (JNJ-4929821): <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEJ">6QEJ</a>; <b>8</b> (GSK-2229238): <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEI">6QEI</a>; <b>9</b> (X = Cl; clioquinol): <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEH">6QEH</a>; <b>11a</b>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEG">6QEG</a>; 11r: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEF">6QEF</a>; <b>21</b>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QED">6QED</a> Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.9b00041" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75152" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75152" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timo Heinrich</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9120-8410" title="Orcid link">http://orcid.org/0000-0001-9120-8410</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2f5b46424001474a46415d464c476f424a5d4c44485d405a5f014c4042"><span class="__cf_email__" data-cfemail="94e0fdf9fbbafcf1fdfae6fdf7fcd4f9f1e6f7fff3e6fbe1e4baf7fbf9">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeyaprakashnarayanan Seenisamy</span> - <span class="hlFld-Affiliation affiliation">Syngene
International Limited, Biocon Park, Plot 2&3, Bommasandra-Jigani Link Road, 560 099 Bangalore, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beatrix Blume</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jörg Bomke</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michel Calderini</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Uwe Eckert</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manja Friese-Hamim</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rainer Kohl</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Lehmann</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Birgitta Leuthner</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Djordje Musil</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Felix Rohdich</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank T. Zenke</span> - <span class="hlFld-Affiliation affiliation">Merck
Healthcare, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, Germany</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">meldrum’s acid</td><td class="NLM_def"><p class="first last">6,6-dimethyl-5,7-dioxaspiro[2.5]octane-4,8-dione</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">HUVEC</td><td class="NLM_def"><p class="first last">human umbilical vein endothelial cells</p></td></tr><tr><td class="NLM_term">vdW</td><td class="NLM_def"><p class="first last">van der Waals</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last"><i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimid hydrochloride</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazol hydrate</p></td></tr><tr><td class="NLM_term">MMPP</td><td class="NLM_def"><p class="first last">magnesium monoperoxyphthalat</p></td></tr><tr><td class="NLM_term">p<i>K</i><sub>a</sub></td><td class="NLM_def"><p class="first last">logarithmic acid dissociation constant</p></td></tr><tr><td class="NLM_term">T/C</td><td class="NLM_def"><p class="first last">ratio of tumor size for the treatment (T) and control (C) group</p></td></tr><tr><td class="NLM_term">T3P</td><td class="NLM_def"><p class="first last">propylphosphonic anhydride</p></td></tr><tr><td class="NLM_term">BOC<sub>2</sub>O</td><td class="NLM_def"><p class="first last">di-<i>tert</i>-butyl decarbonate</p></td></tr><tr><td class="NLM_term">Rt</td><td class="NLM_def"><p class="first last">retention time</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethyl amine</p></td></tr><tr><td class="NLM_term">IPA</td><td class="NLM_def"><p class="first last">isopropylamine</p></td></tr><tr><td class="NLM_term">LiHMDS</td><td class="NLM_def"><p class="first last">lithium bistrimethyl silyl amide</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41024" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41024" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-P.</span></span> <span> </span><span class="NLM_article-title">The development of MetAP-2 inhibitors in cancer treatment</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1021</span>– <span class="NLM_lpage">1035</span>, <span class="refDoi"> DOI: 10.2174/092986712799320709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.2174%2F092986712799320709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=22229417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=1021-1035&author=S.-Q.+Yinauthor=J.-J.+Wangauthor=C.-M.+Zhangauthor=Z.-P.+Liu&title=The+development+of+MetAP-2+inhibitors+in+cancer+treatment&doi=10.2174%2F092986712799320709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The development of MetAP-2 inhibitors in cancer treatment</span></div><div class="casAuthors">Yin, S.-Q.; Wang, J.-J.; Zhang, C.-M.; Liu, Z.-P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1021-1035</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Methionine aminopeptidases (MetAPs), which remove methionine residue from newly synthesized polypeptide chains, are a class of metalloproteases ubiquitously distributed in both eukaryotes and prokaryotes.  MetAP-2 inhibition can induce G1 cell cycle arrest, cytostasis in tumor cells in vitro and inhibition of tumor growth in vivo.  The discovery of fumagillin with potent antiangiogenic and antiproliferative activities promoted the development of fumagillin analogs as a novel class of anticancer agents.  Early drug discovery efforts have focused on analogs of fumagillin, which irreversibly inhibit MetAP-2 through covalent modification of an epoxide.  Several fumagillin analogs, like CKD-732, TNP-470, and PPI-2458, were found to be potent selective inhibitors of MetAP-2 (proteolytic activity) and endothelial cell proliferation.  Further, they have entered in clin. trials for the treatment of different types of tumors.  Recently, attention was paid to reversible human MetAP-2 inhibitors, such as bengamides, 2-hydroxy-3-aminoamides, anthranilic acid sulfonamides, and triazole analogs, which have demonstrated their potential to inhibit angiogenesis and tumor growth in vivo as well.  This review article mainly discussed the development of MetAP-2 inhibitors in cancer therapy and also summarized their structure-activity relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9_jcycw6lErVg90H21EOLACvtfcHk0ljaOQnPO28DdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSqtro%253D&md5=6bd1db81df9913ecd2b4cf14f3567677</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F092986712799320709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712799320709%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DS.-Q.%26aulast%3DWang%26aufirst%3DJ.-J.%26aulast%3DZhang%26aufirst%3DC.-M.%26aulast%3DLiu%26aufirst%3DZ.-P.%26atitle%3DThe%2520development%2520of%2520MetAP-2%2520inhibitors%2520in%2520cancer%2520treatment%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D1021%26epage%3D1035%26doi%3D10.2174%2F092986712799320709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ehlers, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furness, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philip Robinson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aribser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillip
Bowen, J.</span></span> <span> </span><span class="NLM_article-title">Methionine aminopeptidase type-2 inhibitors targeting angiogenesis</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1478</span>– <span class="NLM_lpage">1488</span>, <span class="refDoi"> DOI: 10.2174/1568026615666150915121204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.2174%2F1568026615666150915121204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=26369821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlCgs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=1478-1488&author=T.+Ehlersauthor=S.+Furnessauthor=T.+Philip+Robinsonauthor=H.+A.+Zhongauthor=D.+Goldsmithauthor=J.+Aribserauthor=J.+Phillip%0ABowen&title=Methionine+aminopeptidase+type-2+inhibitors+targeting+angiogenesis&doi=10.2174%2F1568026615666150915121204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Methionine AminoPeptidase Type-2 Inhibitors Targeting Angiogenesis</span></div><div class="casAuthors">Ehlers, Tedman; Furness, Scott; Robinson, Thomas Philip; Zhong, Haizhen A.; Goldsmith, David; Aribser, Jack; Bowen, J. Phillip</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1478-1488</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Angiogenesis has been identified as a crucial process in the development and spread of cancers.  There are many regulators of angiogenesis which are not yet fully understood.  Methionine aminiopeptidase is a metalloenzyme with two structurally distinct forms in humans, Type-1 (MetAP-1) and Type-2 (MetAP-2).  It has been shown that small mol. inhibitors of MetAP-2 suppress endothelial cell proliferation.  The initial discovery by Donald Ingber of MetAP-2 inhibition as a potential target in angiogenesis began with a fortuitous observation similar to the discovery of penicillin activity by Sir Alexander Fleming.  From a drug design perspective, MetAP-2 is an attractive target.  Fumagillin and ovalicin, known natural products, bind with IC50 values in low nanomolar concns.  Crystal structures of the bound complexes provide 3-dimensional coordinates for advanced computational studies.  More recent discoveries have shown other biol. activities for MetAP-2 inhibition, which has generated new interests in the design of novel inhibitors.  Semisynthetic fumagillin derivs. such as AGM-1470 (TNP-470) have been shown to have better drug properties, but have not been very successful in clin. trials.  The rationale and development of novel multicyclic analogs of fumagillin are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpug7-9kSnRkLVg90H21EOLACvtfcHk0lhtDcfeGmiJaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlCgs74%253D&md5=8d7bec6aeacb7f9d75cfab8372cf4c7e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F1568026615666150915121204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026615666150915121204%26sid%3Dliteratum%253Aachs%26aulast%3DEhlers%26aufirst%3DT.%26aulast%3DFurness%26aufirst%3DS.%26aulast%3DPhilip%2BRobinson%26aufirst%3DT.%26aulast%3DZhong%26aufirst%3DH.%2BA.%26aulast%3DGoldsmith%26aufirst%3DD.%26aulast%3DAribser%26aufirst%3DJ.%26aulast%3DPhillip%2BBowen%26aufirst%3DJ.%26atitle%3DMethionine%2520aminopeptidase%2520type-2%2520inhibitors%2520targeting%2520angiogenesis%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D1478%26epage%3D1488%26doi%3D10.2174%2F1568026615666150915121204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCandless, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanovski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salehi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stafford, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abuzzahab, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viskochil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitman, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Styne, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roof, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dykens, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheimann, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malloy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, M. G.</span></span> <span> </span><span class="NLM_article-title">Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial</span>. <i>Diabetes, Obes. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1751</span>– <span class="NLM_lpage">1761</span>, <span class="refDoi"> DOI: 10.1111/dom.13021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1111%2Fdom.13021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=28556449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslyhsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=1751-1761&author=S.+E.+McCandlessauthor=J.+A.+Yanovskiauthor=J.+Millerauthor=C.+Fuauthor=L.+M.+Birdauthor=P.+Salehiauthor=C.+L.+Chanauthor=D.+Staffordauthor=M.+J.+Abuzzahabauthor=D.+Viskochilauthor=M.+Anguloauthor=S.+E.+Myersauthor=B.+Y.+Whitmanauthor=D.+Styneauthor=E.+Roofauthor=E.+M.+Dykensauthor=A.+O.+Scheimannauthor=J.+Malloyauthor=D.+Zhuangauthor=K.+Taylorauthor=T.+E.+Hughesauthor=D.+D.+Kimauthor=M.+G.+Butler&title=Effects+of+MetAP2+inhibition+on+hyperphagia+and+body+weight+in+Prader-Willi+syndrome%3A+A+randomized%2C+double-blind%2C+placebo-controlled+trial&doi=10.1111%2Fdom.13021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial</span></div><div class="casAuthors">McCandless, Shawn E.; Yanovski, Jack A.; Miller, Jennifer; Fu, Cary; Bird, Lynne M.; Salehi, Parisa; Chan, Christine L.; Stafford, Diane; Abuzzahab, M. Jennifer; Viskochil, David; Barlow, Sarah E.; Angulo, Moris; Myers, Susan E.; Whitman, Barbara Y.; Styne, Dennis; Roof, Elizabeth; Dykens, Elisabeth M.; Scheimann, Ann O.; Malloy, Jaret; Zhuang, Dongliang; Taylor, Kristin; Hughes, Thomas E.; Kim, Dennis D.; Butler, Merlin G.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, Obesity and Metabolism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1751-1761</span>CODEN:
                <span class="NLM_cas:coden">DOMEF6</span>;
        ISSN:<span class="NLM_cas:issn">1462-8902</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims : There are no treatments for the extreme hyperphagia and obesity in Prader-Willi syndrome (PWS).  The bestPWS clin. trial assessed the efficacy, safety and tolerability of the methionine aminopeptidase 2 (MetAP2) inhibitor, beloranib.  Materials and Methods : Participants with PWS (12-65 years old) were randomly assigned (1:1:1) to biweekly placebo, 1.8 mg beloranib or 2.4 mg beloranib injection for 26 wk at 15 US sites.  Co-primary endpoints were the changes in hyperphagia [measured by Hyperphagia Questionnaire for Clin. Trials (HQ-CT); possible score 0-36] and wt. by intention-to-treat. registration: NCT02179151.  Results : One-hundred and seven participants were included in the intention-to-treat anal.: placebo (n = 34); 1.8 mg beloranib (n = 36); or 2.4 mg beloranib (n = 37).  Improvement (redn.) in HQ-CT total score was greater in the 1.8 mg (mean difference -6.3, 95% CI -9.6 to -3.0; P = .0003) and 2.4 mg beloranib groups (-7.0, 95% CI -10.5 to -3.6; P = .0001) vs placebo.  Compared with placebo, wt. change was greater with 1.8 mg (mean difference - 8.2%, 95% CI -10.8 to -5.6; P < .0001) and 2.4 mg beloranib (-9.5%, 95% CI -12.1 to -6.8; P < .0001).  Injection site bruising was the most frequent adverse event with beloranib.  Dosing was stopped early due to an imbalance in venous thrombotic events in beloranib-treated participants (2 fatal events of pulmonary embolism and 2 events of deep vein thrombosis) compared with placebo.  Conclusions : MetAP2 inhibition with beloranib produced statistically significant and clin. meaningful improvements in hyperphagia-related behaviors and wt. loss in participants with PWS.  Although investigation of beloranib has ceased, inhibition of MetAP2 is a novel mechanism for treating hyperphagia and obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp647p2aRQ4MrVg90H21EOLACvtfcHk0lhtDcfeGmiJaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslyhsbvJ&md5=682a6297a51b90a1cba2e06cf4c7d968</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fdom.13021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fdom.13021%26sid%3Dliteratum%253Aachs%26aulast%3DMcCandless%26aufirst%3DS.%2BE.%26aulast%3DYanovski%26aufirst%3DJ.%2BA.%26aulast%3DMiller%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DC.%26aulast%3DBird%26aufirst%3DL.%2BM.%26aulast%3DSalehi%26aufirst%3DP.%26aulast%3DChan%26aufirst%3DC.%2BL.%26aulast%3DStafford%26aufirst%3DD.%26aulast%3DAbuzzahab%26aufirst%3DM.%2BJ.%26aulast%3DViskochil%26aufirst%3DD.%26aulast%3DAngulo%26aufirst%3DM.%26aulast%3DMyers%26aufirst%3DS.%2BE.%26aulast%3DWhitman%26aufirst%3DB.%2BY.%26aulast%3DStyne%26aufirst%3DD.%26aulast%3DRoof%26aufirst%3DE.%26aulast%3DDykens%26aufirst%3DE.%2BM.%26aulast%3DScheimann%26aufirst%3DA.%2BO.%26aulast%3DMalloy%26aufirst%3DJ.%26aulast%3DZhuang%26aufirst%3DD.%26aulast%3DTaylor%26aufirst%3DK.%26aulast%3DHughes%26aufirst%3DT.%2BE.%26aulast%3DKim%26aufirst%3DD.%2BD.%26aulast%3DButler%26aufirst%3DM.%2BG.%26atitle%3DEffects%2520of%2520MetAP2%2520inhibition%2520on%2520hyperphagia%2520and%2520body%2520weight%2520in%2520Prader-Willi%2520syndrome%253A%2520A%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520trial%26jtitle%3DDiabetes%252C%2520Obes.%2520Metab.%26date%3D2017%26volume%3D19%26spage%3D1751%26epage%3D1761%26doi%3D10.1111%2Fdom.13021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kudelka, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verschraegen, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piamsomboon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Termrungruanglert, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieback, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeckle, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loyer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mante, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mavligit, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Killian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutterman, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavanagh, J. J.</span></span> <span> </span><span class="NLM_article-title">A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix</span>. <i>Clin Cancer Res</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1501</span>– <span class="NLM_lpage">1505</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1997&pages=1501-1505&author=A.+P.+Kudelkaauthor=T.+Levyauthor=C.+F.+Verschraegenauthor=C.+L.+Edwardsauthor=S.+Piamsomboonauthor=W.+Termrungruanglertauthor=R.+S.+Freedmanauthor=A.+L.+Kaplanauthor=D.+G.+Kiebackauthor=C.+A.+Meyersauthor=K.+A.+Jaeckleauthor=E.+Loyerauthor=M.+Stegerauthor=R.+Manteauthor=G.+Mavligitauthor=A.+Killianauthor=R.+A.+Tangauthor=J.+U.+Guttermanauthor=J.+J.+Kavanagh&title=A+phase+I+study+of+TNP-470+administered+to+patients+with+advanced+squamous+cell+cancer+of+the+cervix"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKudelka%26aufirst%3DA.%2BP.%26aulast%3DLevy%26aufirst%3DT.%26aulast%3DVerschraegen%26aufirst%3DC.%2BF.%26aulast%3DEdwards%26aufirst%3DC.%2BL.%26aulast%3DPiamsomboon%26aufirst%3DS.%26aulast%3DTermrungruanglert%26aufirst%3DW.%26aulast%3DFreedman%26aufirst%3DR.%2BS.%26aulast%3DKaplan%26aufirst%3DA.%2BL.%26aulast%3DKieback%26aufirst%3DD.%2BG.%26aulast%3DMeyers%26aufirst%3DC.%2BA.%26aulast%3DJaeckle%26aufirst%3DK.%2BA.%26aulast%3DLoyer%26aufirst%3DE.%26aulast%3DSteger%26aufirst%3DM.%26aulast%3DMante%26aufirst%3DR.%26aulast%3DMavligit%26aufirst%3DG.%26aulast%3DKillian%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DR.%2BA.%26aulast%3DGutterman%26aufirst%3DJ.%2BU.%26aulast%3DKavanagh%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520phase%2520I%2520study%2520of%2520TNP-470%2520administered%2520to%2520patients%2520with%2520advanced%2520squamous%2520cell%2520cancer%2520of%2520the%2520cervix%26jtitle%3DClin%2520Cancer%2520Res%26date%3D1997%26volume%3D9%26spage%3D1501%26epage%3D1505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figg, W. D.</span></span> <span> </span><span class="NLM_article-title">TNP-470: an angiogenesis inhibitor in clinical development for cancer</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1383</span>– <span class="NLM_lpage">1396</span>, <span class="refDoi"> DOI: 10.1517/13543784.9.6.1383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1517%2F13543784.9.6.1383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=11060750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktFWjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=1383-1396&author=E.+A.+Krugerauthor=W.+D.+Figg&title=TNP-470%3A+an+angiogenesis+inhibitor+in+clinical+development+for+cancer&doi=10.1517%2F13543784.9.6.1383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">TNP-470: an angiogenesis inhibitor in clinical development for cancer</span></div><div class="casAuthors">Kruger, Erwin A.; Figg, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1383-1396</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 100 refs.  TNP-470, an analog of fumagillin, has been shown to inhibit angiogenesis in vitro and in vivo.  In 1992, TNP-470 entered clin. development for cancer as an anti-angiogenic agent.  It is currently in Phase I/II trials in Kaposi's sarcoma, renal cell carcinoma, brain cancer, breast cancer, cervical cancer and prostate cancer.  Terminal half-life values are short and have shown intermittent and intrapatient variation (range: 0.05 - 1.07 h).  Recently, mechanistic studies have identified cell cycle mediators and the protein methionine aminopeptidase-2 (MetAP-2) as mol. targets of TNP-470 and fumagillin.  In early clin. reports, TNP-470 is tolerated up to 177 mg/m2 with neurotoxic effects (fatigue, vertigo, ataxia, and loss of concn.) being the principal dose limiting toxicity (DLT).  Animal studies confirm some toxic effects on normal angiogenic processes such as the female reproductive system and wound healing, which will require caution and close monitoring in the clinic.  TNP-470 is one of the first anti-angiogenic compds. to enter clin. trials, making it a valuable prototype for future trials of angiogenesis inhibitors in oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6wwOg1czqDbVg90H21EOLACvtfcHk0lhI5vl1XoOazQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktFWjsb4%253D&md5=9963aa3a5d14aaccbbb22a8c4bfdd85f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F13543784.9.6.1383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.9.6.1383%26sid%3Dliteratum%253Aachs%26aulast%3DKruger%26aufirst%3DE.%2BA.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26atitle%3DTNP-470%253A%2520an%2520angiogenesis%2520inhibitor%2520in%2520clinical%2520development%2520for%2520cancer%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2000%26volume%3D9%26spage%3D1383%26epage%3D1396%26doi%3D10.1517%2F13543784.9.6.1383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniewski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkin, J.</span></span> <span> </span><span class="NLM_article-title">Physiologically relevant metal cofactor for methionine aminopeptidase-2 is manganese</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">5035</span>– <span class="NLM_lpage">5042</span>, <span class="refDoi"> DOI: 10.1021/bi020670c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi020670c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislSitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=5035-5042&author=J.+Wangauthor=G.+S.+Sheppardauthor=P.+Louauthor=M.+Kawaiauthor=C.+Parkauthor=D.+A.+Eganauthor=A.+Schneiderauthor=J.+Bouskaauthor=R.+Lesniewskiauthor=J.+Henkinauthor=J.+Henkin&title=Physiologically+relevant+metal+cofactor+for+methionine+aminopeptidase-2+is+manganese&doi=10.1021%2Fbi020670c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Physiologically Relevant Metal Cofactor for Methionine Aminopeptidase-2 Is Manganese</span></div><div class="casAuthors">Wang, Jieyi; Sheppard, George S.; Lou, Pingping; Kawai, Megumi; Park, Chang; Egan, David A.; Schneider, Andrew; Bouska, Jennifer; Lesniewski, Rick; Henkin, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5035-5042</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identity of the physiol. metal cofactor for human methionine aminopeptidase-2 (MetAP2) has not been established.  To examine this question, we first investigated the effect of eight divalent metal ions, including Ca2+, Co2+, Cu2+, Fe2+, Mg2+, Mn2+, Ni2+, and Zn2+, on recombinant human methionine aminopeptidase apoenzymes in releasing N-terminal methionine from three peptide substrates: MAS, MGAQFSKT, and 3H-MASK(biotin)G.  The activity of MetAP2 on either MAS or MGAQFSKT was enhanced 15-25-fold by Co2+ or Mn2+ metal ions in a broad concn. range (1-1000 μM).  In the presence of reduced glutathione to mimic the cellular environment, Co2+ and Mn2+ were also the best stimulators (∼30-fold) for MetAP2 enzyme activity.  To det. which metal ion is physiol. relevant, we then tested inhibition of intracellular MetAP2 with synthetic inhibitors selective for MetAP2 with different metal cofactors.  A-310840 below 10 μM did not inhibit the activity of MetAP2-Mn2+ but was very potent against MetAP2 with other metal ions including Co2+, Fe2+, Ni2+, and Zn2+ in the in vitro enzyme assays.  In contrast, A-311263 inhibited MetAP2 with Mn2+, as well as Co2+, Fe2+, Ni2+, and Zn2+.  In cell culture assays, A-310840 did not inhibit intracellular MetAP2 enzyme activity and did not inhibit cell proliferation despite its ability to permeate and accumulate in cytosol, while A-311263 inhibited both intracellular MetAP2 and proliferation in a similar concn. range, indicating cellular MetAP2 is functioning as a manganese enzyme but not as a cobalt, zinc, iron, or nickel enzyme.  We conclude that MetAP2 is a manganese enzyme and that therapeutic MetAP2 inhibitors should inhibit MetAP2-Mn2+.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnOVJL9uJhw7Vg90H21EOLACvtfcHk0lhI5vl1XoOazQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislSitrY%253D&md5=cb8ddc7017dc11f1327a0d83fcb2d417</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fbi020670c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi020670c%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DLou%26aufirst%3DP.%26aulast%3DKawai%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DEgan%26aufirst%3DD.%2BA.%26aulast%3DSchneider%26aufirst%3DA.%26aulast%3DBouska%26aufirst%3DJ.%26aulast%3DLesniewski%26aufirst%3DR.%26aulast%3DHenkin%26aufirst%3DJ.%26aulast%3DHenkin%26aufirst%3DJ.%26atitle%3DPhysiologically%2520relevant%2520metal%2520cofactor%2520for%2520methionine%2520aminopeptidase-2%2520is%2520manganese%26jtitle%3DBiochemistry%26date%3D2003%26volume%3D42%26spage%3D5035%26epage%3D5042%26doi%3D10.1021%2Fbi020670c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marino, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkpatrick, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattern, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tew, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomazek, T. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veber, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, S. K.</span></span> <span> </span><span class="NLM_article-title">Highly Potent Inhibitors of Methionine Aminopeptidase-2 Based on a 1,2,4-Triazole Pharmacophore†</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3777</span>– <span class="NLM_lpage">3785</span>, <span class="refDoi"> DOI: 10.1021/jm061182w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061182w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3777-3785&author=J.+P.+Marinoauthor=P.+W.+Fisherauthor=G.+A.+Hofmannauthor=R.+B.+Kirkpatrickauthor=C.+A.+Jansonauthor=R.+K.+Johnsonauthor=C.+Maauthor=M.+Matternauthor=T.+D.+Meekauthor=M.+D.+Ryanauthor=C.+Schulzauthor=W.+W.+Smithauthor=D.+G.+Tewauthor=T.+A.+Tomazekauthor=D.+F.+Veberauthor=W.+C.+Xiongauthor=Y.+Yamamotoauthor=K.+Yamashitaauthor=G.+Yangauthor=S.+K.+Thompson&title=Highly+Potent+Inhibitors+of+Methionine+Aminopeptidase-2+Based+on+a+1%2C2%2C4-Triazole+Pharmacophore%E2%80%A0&doi=10.1021%2Fjm061182w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm061182w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061182w%26sid%3Dliteratum%253Aachs%26aulast%3DMarino%26aufirst%3DJ.%2BP.%26aulast%3DFisher%26aufirst%3DP.%2BW.%26aulast%3DHofmann%26aufirst%3DG.%2BA.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DJohnson%26aufirst%3DR.%2BK.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DMattern%26aufirst%3DM.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DRyan%26aufirst%3DM.%2BD.%26aulast%3DSchulz%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DTomazek%26aufirst%3DT.%2BA.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DXiong%26aufirst%3DW.%2BC.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DThompson%26aufirst%3DS.%2BK.%26atitle%3DHighly%2520Potent%2520Inhibitors%2520of%2520Methionine%2520Aminopeptidase-2%2520Based%2520on%2520a%25201%252C2%252C4-Triazole%2520Pharmacophore%25E2%2580%25A0%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3777%26epage%3D3785%26doi%3D10.1021%2Fjm061182w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burley, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipscomb, W. N.</span></span> <span> </span><span class="NLM_article-title">Leucine aminopeptidase: bestatin inhibition and a model for enzyme-catalyzed peptide hydrolysis</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">6916</span>– <span class="NLM_lpage">6920</span>, <span class="refDoi"> DOI: 10.1073/pnas.88.16.6916</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1073%2Fpnas.88.16.6916" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=6916-6920&author=S.+K.+Burleyauthor=P.+R.+Davidauthor=W.+N.+Lipscomb&title=Leucine+aminopeptidase%3A+bestatin+inhibition+and+a+model+for+enzyme-catalyzed+peptide+hydrolysis&doi=10.1073%2Fpnas.88.16.6916"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.88.16.6916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.88.16.6916%26sid%3Dliteratum%253Aachs%26aulast%3DBurley%26aufirst%3DS.%2BK.%26aulast%3DDavid%26aufirst%3DP.%2BR.%26aulast%3DLipscomb%26aufirst%3DW.%2BN.%26atitle%3DLeucine%2520aminopeptidase%253A%2520bestatin%2520inhibition%2520and%2520a%2520model%2520for%2520enzyme-catalyzed%2520peptide%2520hydrolysis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1991%26volume%3D88%26spage%3D6916%26epage%3D6920%26doi%3D10.1073%2Fpnas.88.16.6916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BaMaung, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Searle, X. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniewski, R.</span></span> <span> </span><span class="NLM_article-title">3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">865</span>– <span class="NLM_lpage">868</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2003.12.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1016%2Fj.bmcl.2003.12.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=865-868&author=G.+S.+Sheppardauthor=J.+Wangauthor=M.+Kawaiauthor=N.+Y.+BaMaungauthor=R.+A.+Craigauthor=S.+A.+Ericksonauthor=L.+Lynchauthor=J.+Patelauthor=F.+Yangauthor=X.+B.+Searleauthor=P.+Louauthor=C.+Parkauthor=K.+H.+Kimauthor=J.+Henkinauthor=R.+Lesniewski&title=3-Amino-2-hydroxyamides+and+related+compounds+as+inhibitors+of+methionine+aminopeptidase-2&doi=10.1016%2Fj.bmcl.2003.12.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2003.12.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2003.12.031%26sid%3Dliteratum%253Aachs%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKawai%26aufirst%3DM.%26aulast%3DBaMaung%26aufirst%3DN.%2BY.%26aulast%3DCraig%26aufirst%3DR.%2BA.%26aulast%3DErickson%26aufirst%3DS.%2BA.%26aulast%3DLynch%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DSearle%26aufirst%3DX.%2BB.%26aulast%3DLou%26aufirst%3DP.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DHenkin%26aufirst%3DJ.%26aulast%3DLesniewski%26aufirst%3DR.%26atitle%3D3-Amino-2-hydroxyamides%2520and%2520related%2520compounds%2520as%2520inhibitors%2520of%2520methionine%2520aminopeptidase-2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D865%26epage%3D868%26doi%3D10.1016%2Fj.bmcl.2003.12.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Towbin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bair, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeCaprio, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinder, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morollo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schindler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Oostrum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Versace, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voshol, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zabludoff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, P. E.</span></span> <span> </span><span class="NLM_article-title">Proteomics-based Target Identification</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">52964</span>– <span class="NLM_lpage">52971</span>, <span class="refDoi"> DOI: 10.1074/jbc.m309039200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1074%2Fjbc.m309039200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=52964-52971&author=H.+Towbinauthor=K.+W.+Bairauthor=J.+A.+DeCaprioauthor=M.+J.+Eckauthor=S.+Kimauthor=F.+R.+Kinderauthor=A.+Morolloauthor=D.+R.+Muellerauthor=P.+Schindlerauthor=H.+K.+Songauthor=J.+van+Oostrumauthor=R.+W.+Versaceauthor=H.+Vosholauthor=J.+Woodauthor=S.+Zabludoffauthor=P.+E.+Phillips&title=Proteomics-based+Target+Identification&doi=10.1074%2Fjbc.m309039200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m309039200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m309039200%26sid%3Dliteratum%253Aachs%26aulast%3DTowbin%26aufirst%3DH.%26aulast%3DBair%26aufirst%3DK.%2BW.%26aulast%3DDeCaprio%26aufirst%3DJ.%2BA.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKinder%26aufirst%3DF.%2BR.%26aulast%3DMorollo%26aufirst%3DA.%26aulast%3DMueller%26aufirst%3DD.%2BR.%26aulast%3DSchindler%26aufirst%3DP.%26aulast%3DSong%26aufirst%3DH.%2BK.%26aulast%3Dvan%2BOostrum%26aufirst%3DJ.%26aulast%3DVersace%26aufirst%3DR.%2BW.%26aulast%3DVoshol%26aufirst%3DH.%26aulast%3DWood%26aufirst%3DJ.%26aulast%3DZabludoff%26aufirst%3DS.%26aulast%3DPhillips%26aufirst%3DP.%2BE.%26atitle%3DProteomics-based%2520Target%2520Identification%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D52964%26epage%3D52971%26doi%3D10.1074%2Fjbc.m309039200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.-Z.</span></span> <span> </span><span class="NLM_article-title">Structural analysis of bengamide derivatives as inhibitors of methionine aminopeptidases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8021</span>– <span class="NLM_lpage">8027</span>, <span class="refDoi"> DOI: 10.1021/jm3008695</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3008695" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8021-8027&author=W.+Xuauthor=J.-P.+Luauthor=Q.-Z.+Ye&title=Structural+analysis+of+bengamide+derivatives+as+inhibitors+of+methionine+aminopeptidases&doi=10.1021%2Fjm3008695"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm3008695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3008695%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DJ.-P.%26aulast%3DYe%26aufirst%3DQ.-Z.%26atitle%3DStructural%2520analysis%2520of%2520bengamide%2520derivatives%2520as%2520inhibitors%2520of%2520methionine%2520aminopeptidases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8021%26epage%3D8027%26doi%3D10.1021%2Fjm3008695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenney, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, P.</span></span> <span> </span><span class="NLM_article-title">The bengamides: A mini-review of natural sources, analogues, biological properties, biosynthetic origins, and future prospects</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">740</span>– <span class="NLM_lpage">755</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.6b00970</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.6b00970" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlGksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2017&pages=740-755&author=K.+N.+Whiteauthor=K.+Tenneyauthor=P.+Crews&title=The+bengamides%3A+A+mini-review+of+natural+sources%2C+analogues%2C+biological+properties%2C+biosynthetic+origins%2C+and+future+prospects&doi=10.1021%2Facs.jnatprod.6b00970"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The Bengamides: A Mini-Review of Natural Sources, Analogues, Biological Properties, Biosynthetic Origins, and Future Prospects</span></div><div class="casAuthors">White, Kimberly N.; Tenney, Karen; Crews, Phillip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">740-755</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A review.  This review focuses entirely on the natural bengamides and selected synthetic analogs that have inspired decades of research.  Bengamide A was first reported in 1986 from the sponge Jaspis cf. coriacea, and bengamide-contg. sponges have been gathered from many biogeog. sites.  In 2005, a terrestrial Gram-neg. bacterium, Myxococcus virescens, was added as a source for bengamides.  Biol. activity data using varying bengamide-based scaffolds has enabled fine-tuning of structure-activity relationships.  Mol. target finding contributed to the creation of a synthetic "lead" compd., LAF389, that was the subject of a phase I anticancer clin. trial.  Despite clin. trial termination, the bengamide compd. class is still attracting worldwide attention.  Future breakthroughs based on the bengamide scaffold are possible and could build on their nanomolar in vitro and pos. in vivo antiproliferative and antiangiogenic properties.  Bengamide mol. targets include methionine aminopeptidases (MetAP1 and MetAP2) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB).  A mixed PKS/NRPS biosynthetic gene cluster appears to be responsible for creation of the bengamides.  This review highlights that the bengamides have driven inspirational studies and that they will remain relevant for future research, even 30 years after the discovery of the first structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo05ZANtPfNc7Vg90H21EOLACvtfcHk0lg_td-8pmSQeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlGksLY%253D&md5=99921eaff0fdbd23dcba1d9289856c4c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.6b00970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.6b00970%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DK.%2BN.%26aulast%3DTenney%26aufirst%3DK.%26aulast%3DCrews%26aufirst%3DP.%26atitle%3DThe%2520bengamides%253A%2520A%2520mini-review%2520of%2520natural%2520sources%252C%2520analogues%252C%2520biological%2520properties%252C%2520biosynthetic%2520origins%252C%2520and%2520future%2520prospects%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2017%26volume%3D80%26spage%3D740%26epage%3D755%26doi%3D10.1021%2Facs.jnatprod.6b00970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McBride, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheruvallath, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komandla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderpool, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plonowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holub, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent, reversible MetAP-2 inhibitors via fragment-based drug discovery and structure-based drug design—Part 2</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2779</span>– <span class="NLM_lpage">2783</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.04.072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1016%2Fj.bmcl.2016.04.072" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=2779-2783&author=C.+McBrideauthor=Z.+Cheruvallathauthor=M.+Komandlaauthor=M.+Tangauthor=P.+Farrellauthor=J.+D.+Lawsonauthor=D.+Vanderpoolauthor=Y.+Wuauthor=D.+R.+Douganauthor=A.+Plonowskiauthor=C.+Holubauthor=C.+Larson&title=Discovery+of+potent%2C+reversible+MetAP-2+inhibitors+via+fragment-based+drug+discovery+and+structure-based+drug+design%E2%80%94Part+2&doi=10.1016%2Fj.bmcl.2016.04.072"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.04.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.04.072%26sid%3Dliteratum%253Aachs%26aulast%3DMcBride%26aufirst%3DC.%26aulast%3DCheruvallath%26aufirst%3DZ.%26aulast%3DKomandla%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DM.%26aulast%3DFarrell%26aufirst%3DP.%26aulast%3DLawson%26aufirst%3DJ.%2BD.%26aulast%3DVanderpool%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DPlonowski%26aufirst%3DA.%26aulast%3DHolub%26aufirst%3DC.%26aulast%3DLarson%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520potent%252C%2520reversible%2520MetAP-2%2520inhibitors%2520via%2520fragment-based%2520drug%2520discovery%2520and%2520structure-based%2520drug%2520design%25E2%2580%2594Part%25202%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D2779%26epage%3D2783%26doi%3D10.1016%2Fj.bmcl.2016.04.072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidanze, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BaMaung, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedrow, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolaczkowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantei, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palazzo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker-Garcia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettesheim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniewski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidsen, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, R. L.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: A structural basis for the reduction of albumin binding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3832</span>– <span class="NLM_lpage">3849</span>, <span class="refDoi"> DOI: 10.1021/jm0601001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0601001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFent74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3832-3849&author=G.+S.+Sheppardauthor=J.+Wangauthor=M.+Kawaiauthor=S.+D.+Fidanzeauthor=N.+Y.+BaMaungauthor=S.+A.+Ericksonauthor=D.+M.+Barnesauthor=J.+S.+Tedrowauthor=L.+Kolaczkowskiauthor=A.+Vasudevanauthor=D.+C.+Parkauthor=G.+T.+Wangauthor=W.+J.+Sandersauthor=R.+A.+Manteiauthor=F.+Palazzoauthor=L.+Tucker-Garciaauthor=P.+Louauthor=Q.+Zhangauthor=C.+H.+Parkauthor=K.+H.+Kimauthor=A.+Petrosauthor=E.+Olejniczakauthor=D.+Nettesheimauthor=P.+Hajdukauthor=J.+Henkinauthor=R.+Lesniewskiauthor=S.+K.+Davidsenauthor=R.+L.+Bell&title=Discovery+and+optimization+of+anthranilic+acid+sulfonamides+as+inhibitors+of+methionine+aminopeptidase-2%3A+A+structural+basis+for+the+reduction+of+albumin+binding&doi=10.1021%2Fjm0601001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Anthranilic Acid Sulfonamides as Inhibitors of Methionine Aminopeptidase-2: A Structural Basis for the Reduction of Albumin Binding</span></div><div class="casAuthors">Sheppard, George S.; Wang, Jieyi; Kawai, Megumi; Fidanze, Steve D.; BaMaung, Nwe Y.; Erickson, Scott A.; Barnes, David M.; Tedrow, Jason S.; Kolaczkowski, Lawrence; Vasudevan, Anil; Park, David C.; Wang, Gary T.; Sanders, William J.; Mantei, Robert A.; Palazzo, Fabio; Tucker-Garcia, Lora; Lou, Pingping; Zhang, Qian; Park, Chang H.; Kim, Ki H.; Petros, Andrew; Olejniczak, Edward; Nettesheim, David; Hajduk, Phillip; Henkin, Jack; Lesniewski, Richard; Davidsen, Steven K.; Bell, Randy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3832-3849</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Methionine aminopeptidase-2 (MetAP2) is a novel target for cancer therapy.  As part of an effort to discover orally active reversible inhibitors of MetAP2, a series of anthranilic acid sulfonamides with micromolar affinities for human MetAP2 were identified using affinity selection by mass spectrometry (ASMS) screening.  These micromolar hits were rapidly improved to nanomolar leads on the basis of insights from protein crystallog.; however, the compds. displayed extensive binding to human serum albumin and had limited activity in cellular assays.  Modifications based on structural information on the binding of lead compds. to both MetAP2 and domain III of albumin allowed the identification of compds. with significant improvements in both parameters, which showed good cellular activity in both proliferation and methionine processing assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogG0eQ-sDeVrVg90H21EOLACvtfcHk0lj0zI7nTrCBGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFent74%253D&md5=3d1a68c7397d9483647b0e099f3885cc</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm0601001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0601001%26sid%3Dliteratum%253Aachs%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKawai%26aufirst%3DM.%26aulast%3DFidanze%26aufirst%3DS.%2BD.%26aulast%3DBaMaung%26aufirst%3DN.%2BY.%26aulast%3DErickson%26aufirst%3DS.%2BA.%26aulast%3DBarnes%26aufirst%3DD.%2BM.%26aulast%3DTedrow%26aufirst%3DJ.%2BS.%26aulast%3DKolaczkowski%26aufirst%3DL.%26aulast%3DVasudevan%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DG.%2BT.%26aulast%3DSanders%26aufirst%3DW.%2BJ.%26aulast%3DMantei%26aufirst%3DR.%2BA.%26aulast%3DPalazzo%26aufirst%3DF.%26aulast%3DTucker-Garcia%26aufirst%3DL.%26aulast%3DLou%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DPetros%26aufirst%3DA.%26aulast%3DOlejniczak%26aufirst%3DE.%26aulast%3DNettesheim%26aufirst%3DD.%26aulast%3DHajduk%26aufirst%3DP.%26aulast%3DHenkin%26aufirst%3DJ.%26aulast%3DLesniewski%26aufirst%3DR.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26aulast%3DBell%26aufirst%3DR.%2BL.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520anthranilic%2520acid%2520sulfonamides%2520as%2520inhibitors%2520of%2520methionine%2520aminopeptidase-2%253A%2520A%2520structural%2520basis%2520for%2520the%2520reduction%2520of%2520albumin%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3832%26epage%3D3849%26doi%3D10.1021%2Fjm0601001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchstaller, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cezanne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bomke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friese-Hamim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knöchel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuthner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, F.</span></span> <span> </span><span class="NLM_article-title">Novel reversible methionine aminopeptidase-2 (MetAP-2) inhibitors based on purine and related bicyclic templates</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">556</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.12.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1016%2Fj.bmcl.2016.12.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=27998678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFamtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=551-556&author=T.+Heinrichauthor=H.-P.+Buchstallerauthor=B.+Cezanneauthor=F.+Rohdichauthor=J.+Bomkeauthor=M.+Friese-Hamimauthor=M.+Krierauthor=T.+Kn%C3%B6chelauthor=D.+Musilauthor=B.+Leuthnerauthor=F.+Zenke&title=Novel+reversible+methionine+aminopeptidase-2+%28MetAP-2%29+inhibitors+based+on+purine+and+related+bicyclic+templates&doi=10.1016%2Fj.bmcl.2016.12.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Novel reversible methionine aminopeptidase-2 (MetAP-2) inhibitors based on purine and related bicyclic templates</span></div><div class="casAuthors">Heinrich, Timo; Buchstaller, Hans-Peter; Cezanne, Bertram; Rohdich, Felix; Bomke, Joerg; Friese-Hamim, Manja; Krier, Mireille; Knoechel, Thorsten; Musil, Djordje; Leuthner, Birgitta; Zenke, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">551-556</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The natural product fumagillin 1 and derivs. like TNP-470 2 or beloranib 3 bind to methionine aminopeptidase 2 (MetAP-2) irreversibly.  This enzyme is crit. for protein maturation and plays a key role in angiogenesis.  In this paper we describe the synthesis, MetAP-2 binding affinity and structural anal. of reversible MetAP-2 inhibitors.  Optimization of enzymic activity of screening hit 10 (IC50: 1 μM) led to the most potent compd. 27 (IC50: 0.038 μM), with a concomitant improvement in LLE from 2.1 to 4.2.  Structural anal. of these MetAP-2 inhibitors revealed an unprecedented conformation of the His339 side-chain imidazole ring being co-planar sandwiched between the imidazole of His331 and the aryl-ether moiety, which is bound to the purine scaffold.  Systematic alteration and redn. of H-bonding capability of this metal binding moiety induced an unexpected 180° flip for the triazolo[1,5-a]pyrimdine bicyclic template.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_0XQ7H4uUXLVg90H21EOLACvtfcHk0lj0zI7nTrCBGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFamtLrN&md5=fb10c549d94343a4cc37da474b609b65</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.12.019%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DT.%26aulast%3DBuchstaller%26aufirst%3DH.-P.%26aulast%3DCezanne%26aufirst%3DB.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DBomke%26aufirst%3DJ.%26aulast%3DFriese-Hamim%26aufirst%3DM.%26aulast%3DKrier%26aufirst%3DM.%26aulast%3DKn%25C3%25B6chel%26aufirst%3DT.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DLeuthner%26aufirst%3DB.%26aulast%3DZenke%26aufirst%3DF.%26atitle%3DNovel%2520reversible%2520methionine%2520aminopeptidase-2%2520%2528MetAP-2%2529%2520inhibitors%2520based%2520on%2520purine%2520and%2520related%2520bicyclic%2520templates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D551%26epage%3D556%26doi%3D10.1016%2Fj.bmcl.2016.12.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garrabrant, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludovici, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tominovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoneaux, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galemmo, R.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. L.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibitors of methionine aminopeptidase type 2 (MetAP-2) fail to inhibit endothelial cell proliferation or formation of microvessels from rat aortic rings in vitro</span>. <i>Angiogenesis</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">91</span>, <span class="refDoi"> DOI: 10.1007/s10456-004-6089-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1007%2Fs10456-004-6089-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=91&author=T.+Garrabrantauthor=R.+Tumanauthor=D.+Ludoviciauthor=R.+Tominovichauthor=R.+Simoneauxauthor=R.+Galemmoauthor=D.+L.+Johnson&title=Small+molecule+inhibitors+of+methionine+aminopeptidase+type+2+%28MetAP-2%29+fail+to+inhibit+endothelial+cell+proliferation+or+formation+of+microvessels+from+rat+aortic+rings+in+vitro&doi=10.1007%2Fs10456-004-6089-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs10456-004-6089-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10456-004-6089-7%26sid%3Dliteratum%253Aachs%26aulast%3DGarrabrant%26aufirst%3DT.%26aulast%3DTuman%26aufirst%3DR.%26aulast%3DLudovici%26aufirst%3DD.%26aulast%3DTominovich%26aufirst%3DR.%26aulast%3DSimoneaux%26aufirst%3DR.%26aulast%3DGalemmo%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DD.%2BL.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520methionine%2520aminopeptidase%2520type%25202%2520%2528MetAP-2%2529%2520fail%2520to%2520inhibit%2520endothelial%2520cell%2520proliferation%2520or%2520formation%2520of%2520microvessels%2520from%2520rat%2520aortic%2520rings%2520in%2520vitro%26jtitle%3DAngiogenesis%26date%3D2004%26volume%3D7%26spage%3D91%26doi%3D10.1007%2Fs10456-004-6089-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hales, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S.</span></span> <span> </span><span class="NLM_article-title">Highlights from the society for medicines research symposium held on December 9, 2010 at Nhli, London UK</span>. <i>Drugs Future</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">549</span>, <span class="refDoi"> DOI: 10.1358/dof.2011.036.07.1622065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1358%2Fdof.2011.036.07.1622065" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=543-549&author=P.+Cowleyauthor=N.+Halesauthor=S.+Ward&title=Highlights+from+the+society+for+medicines+research+symposium+held+on+December+9%2C+2010+at+Nhli%2C+London+UK&doi=10.1358%2Fdof.2011.036.07.1622065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1358%2Fdof.2011.036.07.1622065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2011.036.07.1622065%26sid%3Dliteratum%253Aachs%26aulast%3DCowley%26aufirst%3DP.%26aulast%3DHales%26aufirst%3DN.%26aulast%3DWard%26aufirst%3DS.%26atitle%3DHighlights%2520from%2520the%2520society%2520for%2520medicines%2520research%2520symposium%2520held%2520on%2520December%25209%252C%25202010%2520at%2520Nhli%252C%2520London%2520UK%26jtitle%3DDrugs%2520Future%26date%3D2011%26volume%3D36%26spage%3D543%26epage%3D549%26doi%3D10.1358%2Fdof.2011.036.07.1622065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naber, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niggemann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, G.</span></span> <span> </span><span class="NLM_article-title">Review of the literature and individual patients’ data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infections</span>. <i>BMC Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">628</span>, <span class="refDoi"> DOI: 10.1186/s12879-014-0628-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1186%2Fs12879-014-0628-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=25427651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisV2nsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=628&author=K.+G.+Naberauthor=H.+Niggemannauthor=G.+Steinauthor=G.+Stein&title=Review+of+the+literature+and+individual+patients%E2%80%99+data+meta-analysis+on+efficacy+and+tolerance+of+nitroxoline+in+the+treatment+of+uncomplicated+urinary+tract+infections&doi=10.1186%2Fs12879-014-0628-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Review of the literature and individual patients' data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infections</span></div><div class="casAuthors">Naber, Kurt G.; Niggemann, Hiltrud; Stein, Gisela; Stein, Guenter</div><div class="citationInfo"><span class="NLM_cas:title">BMC Infectious Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">628/1-628/31, 31 pp.</span>CODEN:
                <span class="NLM_cas:coden">BIDMBJ</span>;
        ISSN:<span class="NLM_cas:issn">1471-2334</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Nitroxoline, a hydroxychinoline derivate, has been used for many years to treat urinary tract infections (UTI).  Many uncontrolled, but only few controlled clin. studies have been published.  Four so far unpublished, controlled clin. studies were meta-analyzed.  Methods: A narrative literature review was performed.  In addn. the individual patient data (IPD) of 466 females with uncomplicated UTI of four prospective, single blind, randomized, clin. studies with similar protocols using nitroxoline (250 mg tid) vs. cotrimoxazole (960 mg bid) or norfloxacin (400 mg bid) as controls for 5 days (sporadic UTI) or 10 days (recurrent UTI) were meta-analyzed.  The primary aim was eradication of bacteriuria 7-13 days after end of therapy (test of cure).  Clin. efficacy was detd. by elimination of symptoms and safety by adverse events and lab. tests.  Results: Reviewing a total of 26 uncontrolled, 2 controlled and one postmarketing studies including more than 11,000 patients, good efficacy and safety of nitroxoline could be confirmed.  In the four unpublished controlled studies a total of 234 patients were treated orally with nitroxoline and 232 with controls.  The safety of nitroxoline was very good and comparable to the controls (adverse events 9.4% vs 7.8%; p = 0.360).  In the mMITT set (at least one outcome result), in the PP set (test of cure outcome) and in the modified PP set (missing test of cure rated failure) more than 90% of the patients showed eradication of bacteriuria with nitroxoline, which also met statistical non-inferiority compared to the controls (10% non-inferiority margin) in all three evaluation sets.  The clin. efficacy was similar between the two treatment groups.  Conclusion: The IPD meta-anal. using objective parameters (elimination of bacteriuria) demonstrated equiv. efficacy (non-inferiority) of nitroxoline with the controls tested (cotrimoxazole, norfloxacin) in the treatment of uncomplicated UTI.  Considering the good safety and efficacy of nitroxoline as also shown in many uncontrolled and observational studies and the world wide increase of resistance of uropathogens against cotrimoxazole and fluoroquinolones, but not against nitroxoline within the last 20 years, nitroxoline should be reconsidered as one of the first line antibiotics for the treatment of uncomplicated UTI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1Bhs1PcsazrVg90H21EOLACvtfcHk0lidLWVHm9ty6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisV2nsro%253D&md5=850d3c4d28604d6b0d8b305957716886</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1186%2Fs12879-014-0628-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12879-014-0628-7%26sid%3Dliteratum%253Aachs%26aulast%3DNaber%26aufirst%3DK.%2BG.%26aulast%3DNiggemann%26aufirst%3DH.%26aulast%3DStein%26aufirst%3DG.%26aulast%3DStein%26aufirst%3DG.%26atitle%3DReview%2520of%2520the%2520literature%2520and%2520individual%2520patients%25E2%2580%2599%2520data%2520meta-analysis%2520on%2520efficacy%2520and%2520tolerance%2520of%2520nitroxoline%2520in%2520the%2520treatment%2520of%2520uncomplicated%2520urinary%2520tract%2520infections%26jtitle%3DBMC%2520Infect.%2520Dis.%26date%3D2014%26volume%3D14%26spage%3D628%26doi%3D10.1186%2Fs12879-014-0628-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shim, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacev, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhang, H.-e. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomper, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. O.</span></span> <span> </span><span class="NLM_article-title">Effect of nitroxoline on angiogenesis and growth of human bladder cancer</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">1855</span>– <span class="NLM_lpage">1873</span>, <span class="refDoi"> DOI: 10.1093/jnci/djq457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1093%2Fjnci%2Fdjq457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=21088277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2ku7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=1855-1873&author=J.+S.+Shimauthor=Y.+Matsuiauthor=S.+Bhatauthor=B.+A.+Nacevauthor=J.+Xuauthor=H.-e.+C.+Bhangauthor=S.+Dharaauthor=K.+C.+Hanauthor=C.+R.+Chongauthor=M.+G.+Pomperauthor=A.+Soauthor=J.+O.+Liu&title=Effect+of+nitroxoline+on+angiogenesis+and+growth+of+human+bladder+cancer&doi=10.1093%2Fjnci%2Fdjq457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Nitroxoline on Angiogenesis and Growth of Human Bladder Cancer</span></div><div class="casAuthors">Shim, Joong Sup; Matsui, Yoshiyuki; Bhat, Shridhar; Nacev, Benjamin A.; Xu, Jing; Bhang, Hyo-eun C.; Dhara, Surajit; Han, Kee Chung; Chong, Curtis R.; Pomper, Martin G.; So, Alan; Liu, Jun O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">1855-1873</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Angiogenesis plays an important role in tumor growth and metastasis; therefore, inhibition of angiogenesis is a promising strategy for developing new anticancer drugs.  Type 2 methionine aminopeptidase (MetAP2) protein is likely a mol. target of angiogenesis inhibitors.  Methods: Nitroxoline, an antibiotic used to treat urinary tract infections, was identified from a high-throughput screen of a library of 175 000 compds. for MetAP2 inhibitors and from a parallel screen using the Johns Hopkins Drug Library to identify currently used clin. drugs that can also inhibit human umbilical vein endothelial cells (HUVEC) proliferation.  To investigate the mechanism of action of nitroxoline, inhibition of MetAP2 activity and induction of senescence were assessed in HUVEC.  To test the antiangiogenic activity of nitroxoline, endothelial tube formation in Matrigel and microvessel formation in Matrigel plugs in vivo were assessed.  Antitumor efficacy of nitroxoline was evaluated in mouse models of human breast cancer xenograft (n = 10) and bladder cancer orthotopic xenograft (n = 11).  Furthermore, the mechanism of action of nitroxoline was investigated in vivo.  Results: Nitroxoline inhibited MetAP2 activity in vitro (half maximal inhibitory concn. [IC50] = 54.8 nM, 95% confidence interval [CI] = 22.6 to 132.8 nM) and HUVEC proliferation (IC50 = 1.9 μM, 95% CI = 1.54 to 2.39 μM).  Nitroxoline inhibited MetAP2 activity in HUVEC in a dose-dependent manner and induced premature senescence in a biphasic manner.  Nitroxoline inhibited endothelial tube formation in Matrigel and reduced microvessel d. in vivo.  Mice (five per group) treated with nitroxoline showed a 60% redn. in tumor vol. in breast cancer xenografts (tumor vol. on day 30, vehicle vs nitroxoline, mean = 215.4 vs 86.5 mm3, difference = 128.9 mm3, 95% CI = 32.9 to 225.0 mm3, P = .012) and statistically significantly inhibited growth of bladder cancer in an orthotopic mouse model (tumor bioluminescence intensities of vehicle [n = 5] vs nitroxoline [n = 6], P = .045).  Conclusion: Nitroxoline shows promise as a potential therapeutic antiangiogenic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWiEsBSL4ijrVg90H21EOLACvtfcHk0lidLWVHm9ty6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2ku7nK&md5=d9e652ba7ac541b50198c7b6fe7eab69</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjq457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjq457%26sid%3Dliteratum%253Aachs%26aulast%3DShim%26aufirst%3DJ.%2BS.%26aulast%3DMatsui%26aufirst%3DY.%26aulast%3DBhat%26aufirst%3DS.%26aulast%3DNacev%26aufirst%3DB.%2BA.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DBhang%26aufirst%3DH.-e.%2BC.%26aulast%3DDhara%26aufirst%3DS.%26aulast%3DHan%26aufirst%3DK.%2BC.%26aulast%3DChong%26aufirst%3DC.%2BR.%26aulast%3DPomper%26aufirst%3DM.%2BG.%26aulast%3DSo%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26atitle%3DEffect%2520of%2520nitroxoline%2520on%2520angiogenesis%2520and%2520growth%2520of%2520human%2520bladder%2520cancer%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2010%26volume%3D102%26spage%3D1855%26epage%3D1873%26doi%3D10.1093%2Fjnci%2Fdjq457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, S.</span></span> <span> </span><span class="NLM_article-title">Preclinical pharmacodynamic evaluation of antibiotic nitroxoline for anticancer drug repurposing</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3265</span>– <span class="NLM_lpage">3272</span>, <span class="refDoi"> DOI: 10.3892/ol.2016.4380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.3892%2Fol.2016.4380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=27123101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsVKkt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=3265-3272&author=Q.+Zhangauthor=S.+Wangauthor=D.+Yangauthor=K.+Panauthor=L.+Liauthor=S.+Yuan&title=Preclinical+pharmacodynamic+evaluation+of+antibiotic+nitroxoline+for+anticancer+drug+repurposing&doi=10.3892%2Fol.2016.4380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacodynamic evaluation of antibiotic nitroxoline for anticancer drug repurposing</span></div><div class="casAuthors">Zhang, Qi; Wang, Shanshan; Yang, Dexuan; Pan, Kevin; Li, Linna; Yuan, Shoujun</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3265-3272</span>CODEN:
                <span class="NLM_cas:coden">OLNEB5</span>;
        ISSN:<span class="NLM_cas:issn">1792-1082</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">The established urinary antibiotic nitroxoline has recently regained considerable attention, due to its potent activities in inhibiting angiogenesis, inducing apoptosis and blocking cancer cell invasion.  These features make nitroxoline an excellent candidate for anticancer drug repurposing.  To rapidly advance nitroxoline repurposing into clin. trials, the present study performed systemic preclin. pharmacodynamic evaluation of its anticancer activity, including a Me thiazolyl tetrazolium assay in vitro and an orthotopic urol. tumor assay in vivo.  The current study detd. that nitroxoline exhibits dose-dependent anti-cancer activity in vitro and in urol. tumor orthotopic mouse models.  In addn., it was demonstrated that the routine nitroxoline administration regimen used for urinary tract infections was effective and sufficient for urol. cancer treatment, and 2 to 4-fold higher doses resulted in obvious enhancement of anticancer efficacy without corresponding increases in toxicity.  Furthermore, nitroxoline sulfate, one of the most common metabolites of nitroxoline in the urine, effectively inhibited cancer cell proliferation.  This finding increases the feasibility of nitroxoline repurposing for urol. cancer treatment.  Due to the excellent anticancer activity demonstrated in the present study, and its well-known safety profile and pharmacokinetic properties, nitroxoline has been approved to enter into a phase II clin. trial in China for non-muscle invasive bladder cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoDjFV6BtN3LVg90H21EOLACvtfcHk0lidLWVHm9ty6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsVKkt70%253D&md5=d989f6769bee8bd9f3e0fb382f3253a9</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3892%2Fol.2016.4380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2016.4380%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DPan%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DYuan%26aufirst%3DS.%26atitle%3DPreclinical%2520pharmacodynamic%2520evaluation%2520of%2520antibiotic%2520nitroxoline%2520for%2520anticancer%2520drug%2520repurposing%26jtitle%3DOncol.%2520Lett.%26date%3D2016%26volume%3D11%26spage%3D3265%26epage%3D3272%26doi%3D10.3892%2Fol.2016.4380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">Study of APL-1202 in non-muscle invasive bladder cancer patients who are resistant to one induction course of BCG treatment (NMIBC); NCT03672240.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkin, J.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">465</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.1002/(sici)1097-4644(20000601)77:3<465::aid-jcb11>3.0.co;2-m</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1002%2F%28sici%291097-4644%2820000601%2977%3A3%3C465%3A%3Aaid-jcb11%3E3.0.co%3B2-m" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2000&pages=465-473&author=J.+Wangauthor=P.+Louauthor=J.+Henkin&title=Selective+inhibition+of+endothelial+cell+proliferation+by+fumagillin+is+not+due+to+differential+expression+of+methionine+aminopeptidases&doi=10.1002%2F%28sici%291097-4644%2820000601%2977%3A3%3C465%3A%3Aaid-jcb11%3E3.0.co%3B2-m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2F%28sici%291097-4644%2820000601%2977%3A3%3C465%3A%3Aaid-jcb11%3E3.0.co%3B2-m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528sici%25291097-4644%252820000601%252977%253A3%253C465%253A%253Aaid-jcb11%253E3.0.co%253B2-m%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLou%26aufirst%3DP.%26aulast%3DHenkin%26aufirst%3DJ.%26atitle%3DSelective%2520inhibition%2520of%2520endothelial%2520cell%2520proliferation%2520by%2520fumagillin%2520is%2520not%2520due%2520to%2520differential%2520expression%2520of%2520methionine%2520aminopeptidases%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2000%26volume%3D77%26spage%3D465%26epage%3D473%26doi%3D10.1002%2F%28sici%291097-4644%2820000601%2977%3A3%3C465%3A%3Aaid-jcb11%3E3.0.co%3B2-m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="note"><p class="first last">We investigated the general chelation potential of the ligand and could prove that in solution none of the metal ions which are discussed to be putative MetAP-2 co-factors is bound to the oxygen-triade. The results will be published in a separated paper.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clardy, J.</span></span> <span> </span><span class="NLM_article-title">Structure of human methionine aminopeptidase-2 complexed with fumagillin</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">1324</span>– <span class="NLM_lpage">1327</span>, <span class="refDoi"> DOI: 10.1126/science.282.5392.1324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1126%2Fscience.282.5392.1324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=9812898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADyaK1cXnsFenurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=1324-1327&author=S.+Liuauthor=J.+Widomauthor=C.+W.+Kempauthor=C.+M.+Crewsauthor=J.+Clardy&title=Structure+of+human+methionine+aminopeptidase-2+complexed+with+fumagillin&doi=10.1126%2Fscience.282.5392.1324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human methionine aminopeptidase-2 complexed with fumagillin</span></div><div class="casAuthors">Liu, Shenping; Widom, Joanne; Kemp, Christopher W.; Crews, Craig M.; Clardy, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">5392</span>),
    <span class="NLM_cas:pages">1324-1327</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The fungal metabolite fumagillin suppresses the formation of new blood vessels, and a fumagillin analog is currently in clin. trials as an anticancer agent.  The mol. target of fumagillin is methionine aminopeptidase-2 (MetAP-2).  A 1.8 Å resoln. crystal structure of free and inhibited human MetAP-2 shows a covalent bond formed between a reactive epoxide of fumagillin and histidine-231 in the active site of MetAP-2.  Extensive hydrophobic and water-mediated polar interactions with other parts of fumagillin provide addnl. affinity.  Fumagillin-based drugs inhibit MetAP-2 but not MetAP-1, and the three-dimensional structure also indicates the likely determinants of this specificity.  The structural basis for fumagillin's potency and specificity forms the starting point for structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJXNoI5W-nqbVg90H21EOLACvtfcHk0lgQiuZ7BdBAMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnsFenurY%253D&md5=729e37df06b4055f246753a544b6ee18</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1126%2Fscience.282.5392.1324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.282.5392.1324%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DWidom%26aufirst%3DJ.%26aulast%3DKemp%26aufirst%3DC.%2BW.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26aulast%3DClardy%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520human%2520methionine%2520aminopeptidase-2%2520complexed%2520with%2520fumagillin%26jtitle%3DScience%26date%3D1998%26volume%3D282%26spage%3D1324%26epage%3D1327%26doi%3D10.1126%2Fscience.282.5392.1324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">Asymmetric synthesis of the clinical compound M8891 was optimized and will be reported in due course.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eberhardt, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raines, R. T.</span></span> <span> </span><span class="NLM_article-title">Amide-amide and amide-water hydrogen bonds: Implications for protein folding and stability</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">2149</span>– <span class="NLM_lpage">2150</span>, <span class="refDoi"> DOI: 10.1021/ja00084a067</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00084a067" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADyaK2cXhsFOjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1994&pages=2149-2150&author=E.+S.+Eberhardtauthor=R.+T.+Raines&title=Amide-amide+and+amide-water+hydrogen+bonds%3A+Implications+for+protein+folding+and+stability&doi=10.1021%2Fja00084a067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Amide-Amide and Amide-Water Hydrogen Bonds: Implications for Protein Folding and Stability</span></div><div class="casAuthors">Eberhardt, Eric S.; Raines, Ronald T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2149-50</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Amide-amide hydrogen bonds have been implicated in directing protein folding and enhancing protein stability.  Inversion transfer 13C NMR spectroscopy and IR spectroscopy were used to compare the ability of various amide solvents and water to alter the rate of the cis-trans isomerization of the prolyl peptide bond of Ac-Gly-[β,δ-13C]Pro-OMe and the amide I vibrational mode of [13C:O]Ac-Pro-OMe.  The results indicate that secondary amides are significantly weaker hydrogen bond donors than is formamide or water.  These results are most consistent with models for protein folding in which the formation of secondary structure is a cooperative process that follows hydrophobic collapse.  These results also suggest that a hydrogen bond between a main chain oxygen and an asparagine or glutamine side chain may contribute more to protein stability than does a main chain-main chain hydrogen bond.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRUHpJBmFerrVg90H21EOLACvtfcHk0lgoNj744_qwaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhsFOjtb4%253D&md5=12976af286eeea5ea096e950d35e2539</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fja00084a067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00084a067%26sid%3Dliteratum%253Aachs%26aulast%3DEberhardt%26aufirst%3DE.%2BS.%26aulast%3DRaines%26aufirst%3DR.%2BT.%26atitle%3DAmide-amide%2520and%2520amide-water%2520hydrogen%2520bonds%253A%2520Implications%2520for%2520protein%2520folding%2520and%2520stability%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1994%26volume%3D116%26spage%3D2149%26epage%3D2150%26doi%3D10.1021%2Fja00084a067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schönherr, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wollatz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haznar-Garbacz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanke, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weitschies, W.</span></span> <span> </span><span class="NLM_article-title">Characterisation of selective active agents regarding pKa values, solubility concentrations and pH profiles by SiriusT3</span>. <i>Eur. J. Pharm. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1016/j.ejpb.2015.02.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1016%2Fj.ejpb.2015.02.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=25758123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A280%3ADC%252BC2MnivVKlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2015&pages=155-170&author=D.+Sch%C3%B6nherrauthor=U.+Wollatzauthor=D.+Haznar-Garbaczauthor=U.+Hankeauthor=K.+J.+Boxauthor=R.+Taylorauthor=R.+Ruizauthor=S.+Beatoauthor=D.+Beckerauthor=W.+Weitschies&title=Characterisation+of+selective+active+agents+regarding+pKa+values%2C+solubility+concentrations+and+pH+profiles+by+SiriusT3&doi=10.1016%2Fj.ejpb.2015.02.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Characterisation of selected active agents regarding pKa values, solubility concentrations and pH profiles by SiriusT3</span></div><div class="casAuthors">Schonherr D; Wollatz U; Haznar-Garbacz D; Hanke U; Box K J; Taylor R; Ruiz R; Beato S; Becker D; Weitschies W</div><div class="citationInfo"><span class="NLM_cas:title">European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">155-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The aim of this work was to determine pKa values and solubility properties of 34active agents using the SiriusT3 apparatus.  The selected drug substances belong to the groups of ACE-inhibitors, β-blockers, antidiabetics and lipid lowering substances.  Experimentally obtained pKa and intrinsic solubility values were compared to calculated values (program ACD/ChemSketch) and pKa values to published data as well.  Solubility-pH profiles were generated to visualise the substance solubility over the gastrointestinal pH range.  The relationship between the solubility characteristic of a substance, its bioavailability and categorisation according to the Biopharmaceutics Classification System (BCS) was examined as well.  The results showed a good agreement between experimentally obtained, calculated and published pKa values.  The measured and calculated intrinsic solubility values indicated several major deviations.  All solubility-pH profiles showed the expected shape and appearance for acids, bases or zwitterionic substances.  The obtained results for the pKa and solubility measurements of the examined active agents may help to predict their physicochemical behaviour in vivo, and to understand the bioavailability of the substances according to their BCS categorisation.  The easy and reproducible determination of pKa and solubility values makes the SiriusT3 apparatus a useful tool in early stages of drug and formulation development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR0tGrDkvlZJ-2qxNLjzXe8fW6udTcc2eaCkWbNXvAmgLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnivVKlsw%253D%253D&md5=02100c72ca191e1039faa3b20d5714d8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpb.2015.02.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpb.2015.02.028%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25B6nherr%26aufirst%3DD.%26aulast%3DWollatz%26aufirst%3DU.%26aulast%3DHaznar-Garbacz%26aufirst%3DD.%26aulast%3DHanke%26aufirst%3DU.%26aulast%3DBox%26aufirst%3DK.%2BJ.%26aulast%3DTaylor%26aufirst%3DR.%26aulast%3DRuiz%26aufirst%3DR.%26aulast%3DBeato%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DD.%26aulast%3DWeitschies%26aufirst%3DW.%26atitle%3DCharacterisation%2520of%2520selective%2520active%2520agents%2520regarding%2520pKa%2520values%252C%2520solubility%2520concentrations%2520and%2520pH%2520profiles%2520by%2520SiriusT3%26jtitle%3DEur.%2520J.%2520Pharm.%2520Biopharm.%26date%3D2015%26volume%3D92%26spage%3D155%26epage%3D170%26doi%3D10.1016%2Fj.ejpb.2015.02.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gulyaeva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaslavsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lechner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chlenov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chait, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaslavsky, B.</span></span> <span> </span><span class="NLM_article-title">Relative hydrophobicity and lipophilicity of β-blockers and related compounds as measured by aqueous two-phase partitioning, octanol–buffer partitioning, and HPLC</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/s0928-0987(02)00146-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1016%2Fs0928-0987%2802%2900146-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=12356423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVaisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2002&pages=81-93&author=N.+Gulyaevaauthor=A.+Zaslavskyauthor=P.+Lechnerauthor=M.+Chlenovauthor=A.+Chaitauthor=B.+Zaslavsky&title=Relative+hydrophobicity+and+lipophilicity+of+%CE%B2-blockers+and+related+compounds+as+measured+by+aqueous+two-phase+partitioning%2C+octanol%E2%80%93buffer+partitioning%2C+and+HPLC&doi=10.1016%2Fs0928-0987%2802%2900146-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Relative hydrophobicity and lipophilicity of β-blockers and related compounds as measured by aqueous two-phase partitioning, octanol-buffer partitioning, and HPLC</span></div><div class="casAuthors">Gulyaeva, Nellie; Zaslavsky, Alexander; Lechner, Pamela; Chlenov, Michael; Chait, Arnon; Zaslavsky, Boris</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">81-93</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Partitioning of 15 β-blockers and structurally related compds. was examd. in aq. dextran-PEG two-phase systems and octanol-buffer systems at pH from 2.0 up to 12.5.  The same compds. were examd. by gradient RP-HPLC at pH 2.0, 7.4, and 11.0.  The differences between the hydrophobic character of the phases in all three systems at different pH values were characterized using a homologous series of dinitrophenyl-amino acids by measuring the free energy of transfer of a methylene group.  Ests. of the relative hydrophobicity, N(CH2), and lipophilicity, logD, of the compds. obtained by the three techniques employed were compared.  The data indicate that while similar pH profiles for a given compd. were established by all these techniques, the information provided is different.  It is suggested that the combination of the two descriptors, logD and N(CH2), may be useful for quant. structure-activity relation anal. of the biol. activities involving distribution and/or transport of chem. compds. in biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBHSGZgntIPbVg90H21EOLACvtfcHk0lhDnYFsApWcHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVaisLk%253D&md5=2493b60a911c1ba2dac9f5c89184fb5a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fs0928-0987%2802%2900146-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0928-0987%252802%252900146-x%26sid%3Dliteratum%253Aachs%26aulast%3DGulyaeva%26aufirst%3DN.%26aulast%3DZaslavsky%26aufirst%3DA.%26aulast%3DLechner%26aufirst%3DP.%26aulast%3DChlenov%26aufirst%3DM.%26aulast%3DChait%26aufirst%3DA.%26aulast%3DZaslavsky%26aufirst%3DB.%26atitle%3DRelative%2520hydrophobicity%2520and%2520lipophilicity%2520of%2520%25CE%25B2-blockers%2520and%2520related%2520compounds%2520as%2520measured%2520by%2520aqueous%2520two-phase%2520partitioning%252C%2520octanol%25E2%2580%2593buffer%2520partitioning%252C%2520and%2520HPLC%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2002%26volume%3D17%26spage%3D81%26epage%3D93%26doi%3D10.1016%2Fs0928-0987%2802%2900146-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ingber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishimoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanamaru, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folkman, J.</span></span> <span> </span><span class="NLM_article-title">Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">557</span>, <span class="refDoi"> DOI: 10.1038/348555a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1038%2F348555a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=1990&pages=555-557&author=D.+Ingberauthor=T.+Fujitaauthor=S.+Kishimotoauthor=K.+Sudoauthor=T.+Kanamaruauthor=H.+Bremauthor=J.+Folkman&title=Synthetic+analogues+of+fumagillin+that+inhibit+angiogenesis+and+suppress+tumour+growth&doi=10.1038%2F348555a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2F348555a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F348555a0%26sid%3Dliteratum%253Aachs%26aulast%3DIngber%26aufirst%3DD.%26aulast%3DFujita%26aufirst%3DT.%26aulast%3DKishimoto%26aufirst%3DS.%26aulast%3DSudo%26aufirst%3DK.%26aulast%3DKanamaru%26aufirst%3DT.%26aulast%3DBrem%26aufirst%3DH.%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DSynthetic%2520analogues%2520of%2520fumagillin%2520that%2520inhibit%2520angiogenesis%2520and%2520suppress%2520tumour%2520growth%26jtitle%3DNature%26date%3D1990%26volume%3D348%26spage%3D555%26epage%3D557%26doi%3D10.1038%2F348555a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. Q. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">6099</span>– <span class="NLM_lpage">6103</span>, <span class="refDoi"> DOI: 10.1073/pnas.94.12.6099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1073%2Fpnas.94.12.6099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=9177176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADyaK2sXjvFCnsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=6099-6103&author=N.+Sinauthor=L.+Mengauthor=M.+Q.+W.+Wangauthor=J.+J.+Wenauthor=W.+G.+Bornmannauthor=C.+M.+Crews&title=The+anti-angiogenic+agent+fumagillin+covalently+binds+and+inhibits+the+methionine+aminopeptidase%2C+MetAP-2&doi=10.1073%2Fpnas.94.12.6099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2</span></div><div class="casAuthors">Sin, Ny; Meng, Lihao; Wang, Margaret Q. W.; Wen, James J.; Bornmann, William G.; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6099-6103</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The inhibition of new blood vessel formation (angiogenesis) is an effective means of limiting both the size and metastasis of solid tumors.  The leading antiangiogenic compd., TNP-470, has proven to be effective in in vitro and in animal model studies, and is currently being tested in phase III antitumor clin. trials.  Despite many detailed pharmacol. studies, little is known of the mol. mode of action of TNP-470.  Using a deriv. of the TNP-470 parent compd., the fungal metabolite, fumagillin, we have purified a mammalian protein that is selectively and covalently bound by this natural product.  This fumagillin binding protein was found to be a metalloprotease, methionine aminopeptidase (MetAP-2), that is highly conserved between human and Saccharomyces cerevisiae.  In the absence of MetAP-1, a distantly related methionine aminopeptidase, MetAP-2 function is essential for vegetative growth in yeast.  We demonstrate that fumagillin selectively inhibits the S. cerevisiae MetAP-2 protein in vivo.  The binding is highly specific as judged by the failure of fumagillin to inhibit MetAP-1 in vivo.  Hence, these results identify MetAP-2 as an important target of study in the anal. of the potent biol. activities of fumagillin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHTZpt2wUOq7Vg90H21EOLACvtfcHk0lhDnYFsApWcHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjvFCnsb0%253D&md5=511f1751897559a60ccd9f814315c355</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.12.6099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.12.6099%26sid%3Dliteratum%253Aachs%26aulast%3DSin%26aufirst%3DN.%26aulast%3DMeng%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DM.%2BQ.%2BW.%26aulast%3DWen%26aufirst%3DJ.%2BJ.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DThe%2520anti-angiogenic%2520agent%2520fumagillin%2520covalently%2520binds%2520and%2520inhibits%2520the%2520methionine%2520aminopeptidase%252C%2520MetAP-2%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D6099%26epage%3D6103%26doi%3D10.1073%2Fpnas.94.12.6099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':[],'ref22':['cit22'],'ref23':[],'ref24':['cit24'],'ref25':[],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Junping Pei, Guan Wang, Lu Feng, Jifa Zhang, Tingting Jiang, Qiu Sun, <span class="NLM_string-name hlFld-ContribAuthor">Liang Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Lysosomal Degradation Pathways: New Strategies and Techniques for Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (7)
                                     , 3493-3507. <a href="https://doi.org/10.1021/acs.jmedchem.0c01689" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01689</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01689%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BLysosomal%252BDegradation%252BPathways%25253A%252BNew%252BStrategies%252Band%252BTechniques%252Bfor%252BDrug%252BDiscovery%26aulast%3DPei%26aufirst%3DJunping%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26092020%26date%3D25032021%26volume%3D64%26issue%3D7%26spage%3D3493%26epage%3D3507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Steven Dajnowicz, Delaram Ghoreishi, Kalyan Modugula, Wolfgang Damm, Edward D. Harder, Robert Abel, Lingle Wang, <span class="NLM_string-name hlFld-ContribAuthor">Haoyu S. Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Advancing Free-Energy Calculations of Metalloenzymes in Drug Discovery via Implementation of LFMM Potentials. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2020,</strong> <em>16 </em>
                                    (11)
                                     , 6926-6937. <a href="https://doi.org/10.1021/acs.jctc.0c00615" title="DOI URL">https://doi.org/10.1021/acs.jctc.0c00615</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.0c00615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.0c00615%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DAdvancing%252BFree-Energy%252BCalculations%252Bof%252BMetalloenzymes%252Bin%252BDrug%252BDiscovery%252Bvia%252BImplementation%252Bof%252BLFMM%252BPotentials%26aulast%3DDajnowicz%26aufirst%3DSteven%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16062020%26date%3D08102020%26date%3D10092020%26volume%3D16%26issue%3D11%26spage%3D6926%26epage%3D6937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Matthew D. Lloyd</span>. </span><span class="cited-content_cbyCitation_article-title">High-Throughput Screening for the Discovery of Enzyme Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10742-10772. <a href="https://doi.org/10.1021/acs.jmedchem.0c00523" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00523%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHigh-Throughput%252BScreening%252Bfor%252Bthe%252BDiscovery%252Bof%252BEnzyme%252BInhibitors%26aulast%3DLloyd%26aufirst%3DMatthew%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30032020%26date%3D10062020%26date%3D20052020%26volume%3D63%26issue%3D19%26spage%3D10742%26epage%3D10772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Timo Heinrich, Jeyaprakashnarayanan Seenisamy, Frank Becker, Beatrix Blume, Jörg Bomke, Melanie Dietz, Uwe Eckert, Manja Friese-Hamim, Jakub Gunera, Kerrin Hansen, Birgitta Leuthner, Djordje Musil, Jens Pfalzgraf, Felix Rohdich, Christian Siegl, Dieter Spuck, Ansgar Wegener, <span class="NLM_string-name hlFld-ContribAuthor">Frank T. Zenke</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Methionine Aminopeptidase-2 (MetAP-2) Inhibitor M8891: A Clinical Compound for the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (24)
                                     , 11119-11134. <a href="https://doi.org/10.1021/acs.jmedchem.9b01070" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01070%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BMethionine%252BAminopeptidase-2%252B%252528MetAP-2%252529%252BInhibitor%252BM8891%25253A%252BA%252BClinical%252BCompound%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DHeinrich%26aufirst%3DTimo%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26072019%26date%3D03122019%26date%3D14112019%26volume%3D62%26issue%3D24%26spage%3D11119%26epage%3D11134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabian H.  Knaup</span>, <span class="hlFld-ContribAuthor ">Christian  Meyners</span>, <span class="hlFld-ContribAuthor ">Anna  Charalampidou</span>, <span class="hlFld-ContribAuthor ">Patryk  Krajczy</span>, <span class="hlFld-ContribAuthor ">Patrick L.  Purder</span>, <span class="hlFld-ContribAuthor ">Tatjana  Ross</span>, <span class="hlFld-ContribAuthor ">Felix  Hausch</span>. </span><span class="cited-content_cbyCitation_article-title">Med Chem Remote: The Frontiers in Medicinal Chemistry 2021. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>157 </em><a href="https://doi.org/10.1002/cmdc.202100355" title="DOI URL">https://doi.org/10.1002/cmdc.202100355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100355%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DMed%252BChem%252BRemote%25253A%252BThe%252BFrontiers%252Bin%252BMedicinal%252BChemistry%252B2021%26aulast%3DKnaup%26aufirst%3DFabian%2BH.%26date%3D2021%26date%3D2021%26volume%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinghang  Xie</span>, <span class="hlFld-ContribAuthor ">Meghan A.  Rice</span>, <span class="hlFld-ContribAuthor ">Zixin  Chen</span>, <span class="hlFld-ContribAuthor ">Yunfeng  Cheng</span>, <span class="hlFld-ContribAuthor ">En-Chi  Hsu</span>, <span class="hlFld-ContribAuthor ">Min  Chen</span>, <span class="hlFld-ContribAuthor ">Guosheng  Song</span>, <span class="hlFld-ContribAuthor ">Liyang  Cui</span>, <span class="hlFld-ContribAuthor ">Kaixiang  Zhou</span>, <span class="hlFld-ContribAuthor ">Jessa B.  Castillo</span>, <span class="hlFld-ContribAuthor ">Chiyuan A.  Zhang</span>, <span class="hlFld-ContribAuthor ">Bin  Shen</span>, <span class="hlFld-ContribAuthor ">Frederick T.  Chin</span>, <span class="hlFld-ContribAuthor ">Christian A.  Kunder</span>, <span class="hlFld-ContribAuthor ">James D.  Brooks</span>, <span class="hlFld-ContribAuthor ">Tanya  Stoyanova</span>, <span class="hlFld-ContribAuthor ">Jianghong  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo
              Imaging of Methionine Aminopeptidase II for Prostate Cancer Risk Stratification. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2021,</strong> <em>81 </em>
                                    (9)
                                     , 2510-2521. <a href="https://doi.org/10.1158/0008-5472.CAN-20-2969" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-20-2969</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-20-2969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-20-2969%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DIn%252BVivo%252BImaging%252Bof%252BMethionine%252BAminopeptidase%252BII%252Bfor%252BProstate%252BCancer%252BRisk%252BStratification%26aulast%3DXie%26aufirst%3DJinghang%26date%3D2021%26date%3D2021%26volume%3D81%26issue%3D9%26spage%3D2510%26epage%3D2521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingfa  Yang</span>, <span class="hlFld-ContribAuthor ">Yunyun  Ma</span>, <span class="hlFld-ContribAuthor ">Mingxin  Song</span>, <span class="hlFld-ContribAuthor ">Heyun  Wu</span>, <span class="hlFld-ContribAuthor ">Qian  Jiang</span>, <span class="hlFld-ContribAuthor ">Jiasen  Liu</span>, <span class="hlFld-ContribAuthor ">Liandong  Qu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and biochemical characterisation of a novel methionine aminopeptidase from the taiga tick Ixodes persulcatus. </span><span class="cited-content_cbyCitation_journal-name">Ticks and Tick-borne Diseases</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 101554. <a href="https://doi.org/10.1016/j.ttbdis.2020.101554" title="DOI URL">https://doi.org/10.1016/j.ttbdis.2020.101554</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ttbdis.2020.101554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ttbdis.2020.101554%26sid%3Dliteratum%253Aachs%26jtitle%3DTicks%2520and%2520Tick-borne%2520Diseases%26atitle%3DIdentification%252Band%252Bbiochemical%252Bcharacterisation%252Bof%252Ba%252Bnovel%252Bmethionine%252Baminopeptidase%252Bfrom%252Bthe%252Btaiga%252Btick%252BIxodes%252Bpersulcatus%26aulast%3DYang%26aufirst%3DMingfa%26date%3D2021%26volume%3D12%26issue%3D1%26spage%3D101554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  Hirst</span>, <span class="hlFld-ContribAuthor ">Martin  Brandt</span>, <span class="hlFld-ContribAuthor ">Gordon  Bruton</span>, <span class="hlFld-ContribAuthor ">Erica  Christodoulou</span>, <span class="hlFld-ContribAuthor ">Leanne  Cutler</span>, <span class="hlFld-ContribAuthor ">Nigel  Deeks</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Goodacre</span>, <span class="hlFld-ContribAuthor ">Torquil  Jack</span>, <span class="hlFld-ContribAuthor ">Matthew  Lindon</span>, <span class="hlFld-ContribAuthor ">Afjal  Miah</span>, <span class="hlFld-ContribAuthor ">Kevin  Page</span>, <span class="hlFld-ContribAuthor ">Nigel  Parr</span>, <span class="hlFld-ContribAuthor ">Lena  Shukla</span>, <span class="hlFld-ContribAuthor ">Martin  Sims</span>, <span class="hlFld-ContribAuthor ">Pamela  Thomas</span>, <span class="hlFld-ContribAuthor ">James  Thorpe</span>, <span class="hlFld-ContribAuthor ">Duncan S.  Holmes</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based optimisation of orally active & reversible MetAP-2 inhibitors maintaining a tight ‘molecular budget’. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (21)
                                     , 127533. <a href="https://doi.org/10.1016/j.bmcl.2020.127533" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127533</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127533&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127533%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Boptimisation%252Bof%252Borally%252Bactive%252B%252526%252Breversible%252BMetAP-2%252Binhibitors%252Bmaintaining%252Ba%252Btight%252B%2525E2%252580%252598molecular%252Bbudget%2525E2%252580%252599%26aulast%3DHirst%26aufirst%3DDavid%2BJ.%26date%3D2020%26volume%3D30%26issue%3D21%26spage%3D127533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siwen  Yuan</span>, <span class="hlFld-ContribAuthor ">Jannu Vinay  Gopal</span>, <span class="hlFld-ContribAuthor ">Shuya  Ren</span>, <span class="hlFld-ContribAuthor ">Litong  Chen</span>, <span class="hlFld-ContribAuthor ">Lan  Liu</span>, <span class="hlFld-ContribAuthor ">Zhizeng  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer fungal natural products: Mechanisms of action and biosynthesis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>202 </em>, 112502. <a href="https://doi.org/10.1016/j.ejmech.2020.112502" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112502</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112502%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAnticancer%252Bfungal%252Bnatural%252Bproducts%25253A%252BMechanisms%252Bof%252Baction%252Band%252Bbiosynthesis%26aulast%3DYuan%26aufirst%3DSiwen%26date%3D2020%26volume%3D202%26spage%3D112502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Hu</span>, <span class="hlFld-ContribAuthor ">Fei  Chen</span>, <span class="hlFld-ContribAuthor ">Yuhong  Dong</span>, <span class="hlFld-ContribAuthor ">Yajing  Liu</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel dual c-Met/HDAC inhibitors as a promising strategy for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>101 </em>, 103970. <a href="https://doi.org/10.1016/j.bioorg.2020.103970" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103970</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103970%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bdual%252Bc-Met%25252FHDAC%252Binhibitors%252Bas%252Ba%252Bpromising%252Bstrategy%252Bfor%252Bcancer%252Btherapy%26aulast%3DHu%26aufirst%3DHao%26date%3D2020%26volume%3D101%26spage%3D103970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Zheng</span>, <span class="hlFld-ContribAuthor ">Wenqiang  Su</span>, <span class="hlFld-ContribAuthor ">Shinuo  Cao</span>, <span class="hlFld-ContribAuthor ">Zhaoxia  Zhang</span>, <span class="hlFld-ContribAuthor ">Cheng  Du</span>, <span class="hlFld-ContribAuthor ">Honglin  Jia</span>. </span><span class="cited-content_cbyCitation_article-title">TgMAP1c is involved in apicoplast biogenesis in Toxoplasma gondii. </span><span class="cited-content_cbyCitation_journal-name">International Journal for Parasitology</span><span> <strong>2020,</strong> <em>50 </em>
                                    (6-7)
                                     , 487-499. <a href="https://doi.org/10.1016/j.ijpara.2020.03.004" title="DOI URL">https://doi.org/10.1016/j.ijpara.2020.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijpara.2020.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijpara.2020.03.004%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520for%2520Parasitology%26atitle%3DTgMAP1c%252Bis%252Binvolved%252Bin%252Bapicoplast%252Bbiogenesis%252Bin%252BToxoplasma%252Bgondii%26aulast%3DZheng%26aufirst%3DJun%26date%3D2020%26volume%3D50%26issue%3D6-7%26spage%3D487%26epage%3D499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tana S.  Pottorf</span>, <span class="hlFld-ContribAuthor ">Micaella P.  Fagan</span>, <span class="hlFld-ContribAuthor ">Bryan F.  Burkey</span>, <span class="hlFld-ContribAuthor ">David J.  Cho</span>, <span class="hlFld-ContribAuthor ">James E.  Vath</span>, <span class="hlFld-ContribAuthor ">Pamela V.  Tran</span>. </span><span class="cited-content_cbyCitation_article-title">MetAP2 inhibition reduces food intake and body weight in a ciliopathy mouse model of obesity. </span><span class="cited-content_cbyCitation_journal-name">JCI Insight</span><span> <strong>2020,</strong> <em>5 </em>
                                    (2)
                                     <a href="https://doi.org/10.1172/jci.insight.134278" title="DOI URL">https://doi.org/10.1172/jci.insight.134278</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/jci.insight.134278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2Fjci.insight.134278%26sid%3Dliteratum%253Aachs%26jtitle%3DJCI%2520Insight%26atitle%3DMetAP2%252Binhibition%252Breduces%252Bfood%252Bintake%252Band%252Bbody%252Bweight%252Bin%252Ba%252Bciliopathy%252Bmouse%252Bmodel%252Bof%252Bobesity%26aulast%3DPottorf%26aufirst%3DTana%2BS.%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhihong  Liu</span>, <span class="hlFld-ContribAuthor ">Jiewen  Du</span>, <span class="hlFld-ContribAuthor ">Jiansong  Fang</span>, <span class="hlFld-ContribAuthor ">Yulong  Yin</span>, <span class="hlFld-ContribAuthor ">Guohuan  Xu</span>, <span class="hlFld-ContribAuthor ">Liwei  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">DeepScreening: a deep learning-based screening web server for accelerating drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Database</span><span> <strong>2019,</strong> <em>2019 </em><a href="https://doi.org/10.1093/database/baz104" title="DOI URL">https://doi.org/10.1093/database/baz104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/database/baz104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fdatabase%2Fbaz104%26sid%3Dliteratum%253Aachs%26jtitle%3DDatabase%26atitle%3DDeepScreening%25253A%252Ba%252Bdeep%252Blearning-based%252Bscreening%252Bweb%252Bserver%252Bfor%252Baccelerating%252Bdrug%252Bdiscovery%26aulast%3DLiu%26aufirst%3DZhihong%26date%3D2019%26date%3D2019%26volume%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reversible MetAP-2 inhibitors. X-ray structure analyses published. Metal cofactor binding atoms marked in red; PDB codes added: 1 (SB-587094) <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OAZ">2OAZ</a>; 2 (A-357300) <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R58">1R58</a>; 3 (LAF-153) <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QZY">1QZY</a>; 4—<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JFR">5JFR</a>; 5 (A-849519) <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YW9">1YW9</a>; and 6—<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LYX">5LYX</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Reversible MetAP-2 inhibitors. Synthesis and structural analyses performed in-house. PDB codes added: <b>7</b> (JNJ-4929821) <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEJ">6QEJ</a>, <b>8</b> (GSK-2229238) <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEI">6QEI</a>, and <b>9</b> (X = Cl; clioquinol) <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEH">6QEH</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Stored α-amidated pyrrolidinone <b>11</b> was oxidized to the cyclic tartronic diamide <b>11a</b> under storage in DMSO over approximately 2 years.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Screening hit <i>rac</i>-<b>11a</b> with indications of different parts of the molecule. The first optimization cycle focused on the amide residue highlighted by a blue circle; second improvement round considered the N-lactam residue marked with a red circle. The investigation of lactam size and additional substitutions (brown circle) as well as the heteroatoms (indicated with arrows) are not discussed here.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Approach to Optimize Amide Residue R<sub>1</sub>. Derivatives from <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) ACN, aniline, 60 °C, 12 h, 85%; (b) EtOH, SOCl<sub>2</sub>, 0 °C—reflux, 4 h, N<sub>2</sub>; 92% (c) CeCl<sub>3</sub>–(H<sub>2</sub>O)<sub>7</sub>, <sup><i>i</i></sup>PrOH, O<sub>2</sub>, 12 h, RT; Chiralpak AD-H; (d) LiOH, THF/H<sub>2</sub>O, 4 h, RT; 84% (e) R<sub>1</sub>-NH<sub>2</sub>, EDCI, HOBt, 160 °C, MW, 20 min 40–80%.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Approach to Optimize Lactam Residue R<sub>2</sub>; Derivatives from <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and Conditions: (a) BOC<sub>2</sub>O, DMAP, ACN, 3 h, RT, 70%; (b) benzyl chloroformate, LiHMDS, THF, 2 h, −78 °C—RT, 42%; (c) Pd/charcoal, methanol, H<sub>2</sub>, 2 bar, 2 h RT, 86%; (d) 3-F, 5-Cl benzylamine, T3P, TEA, DCM, 5 h, 0 °C—RT, 86%; (e) TFA, DCM, 3 h, 0 °C, 90%; (f) MMPP, DMF, 4 h, 70 °C, 37%; (g) R<sub>2</sub>-halide, K<sub>2</sub>CO<sub>3</sub>, CuI, <i>N</i>,<i>N</i>′-diemethyl-ethane-1,2-diamine, dioxane, 2 h, 140 °C, MW; (h) Chrialpak AD-H.</p></p></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray structure analysis of <b>11a</b> in MetAP-2; (A) 2D plot to show relevant polar interactions, indicated with dashed lines, oxygen-manganese contacts in purple, heteroatom-His<sup>imidazole</sup> in green, and distances are given in Ångstrom; (B) conformation of <b>11a</b> in the active site; interacting imidazoles of His331 and His339 and the manganese ions are pointed out (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEG">6QEG</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. X-ray structure analysis of <b>11a</b> in MetAP-2: (A) 2D plot to show relevant lipophilic interactions, indicated with dashed lines, and distances are given in Ångstrom; (B) identical view on the conformation of <b>11a</b> in the active site as in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B; the lipophilic trait of the protein surface is color-coded. Brown indicates a lipophilic surface and green, a polar one (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEG">6QEG</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. X-ray structure analysis of the optimized amide residue in <b>11r</b>. Depicted are only the distances of the halogens (F, cyan; Cl, light green) on the benzylamide to the amino acid side chains of MetAP-2 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEF">6QEF</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. X-ray structure analysis of <b>21</b> with focus on the additional polar interaction of the tetrahydroquinone-NH with the ASN329 side chain amide of MetAP-2 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QED">6QED</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Dose-normalized plasma concentrations of <b>21</b> after 0.2 mg/kg iv and 50 mg/kg post dosing.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/medium/jm-2019-000417_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0002.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. In vivo tumor growth inhibition of <b>21</b> in the human U87-MG glioblastoma model. Tumor volumes for the 12-day treatment period (volumes for the individual animals at the end of the study are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.9b00041/suppl_file/jm9b00041_si_002.pdf" class="ext-link">Supporting Information</a>, Figure S2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-10/acs.jmedchem.9b00041/20190516/images/large/jm-2019-000417_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00041&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i72">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42740" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42740" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-P.</span></span> <span> </span><span class="NLM_article-title">The development of MetAP-2 inhibitors in cancer treatment</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1021</span>– <span class="NLM_lpage">1035</span>, <span class="refDoi"> DOI: 10.2174/092986712799320709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.2174%2F092986712799320709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=22229417" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=1021-1035&author=S.-Q.+Yinauthor=J.-J.+Wangauthor=C.-M.+Zhangauthor=Z.-P.+Liu&title=The+development+of+MetAP-2+inhibitors+in+cancer+treatment&doi=10.2174%2F092986712799320709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The development of MetAP-2 inhibitors in cancer treatment</span></div><div class="casAuthors">Yin, S.-Q.; Wang, J.-J.; Zhang, C.-M.; Liu, Z.-P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1021-1035</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Methionine aminopeptidases (MetAPs), which remove methionine residue from newly synthesized polypeptide chains, are a class of metalloproteases ubiquitously distributed in both eukaryotes and prokaryotes.  MetAP-2 inhibition can induce G1 cell cycle arrest, cytostasis in tumor cells in vitro and inhibition of tumor growth in vivo.  The discovery of fumagillin with potent antiangiogenic and antiproliferative activities promoted the development of fumagillin analogs as a novel class of anticancer agents.  Early drug discovery efforts have focused on analogs of fumagillin, which irreversibly inhibit MetAP-2 through covalent modification of an epoxide.  Several fumagillin analogs, like CKD-732, TNP-470, and PPI-2458, were found to be potent selective inhibitors of MetAP-2 (proteolytic activity) and endothelial cell proliferation.  Further, they have entered in clin. trials for the treatment of different types of tumors.  Recently, attention was paid to reversible human MetAP-2 inhibitors, such as bengamides, 2-hydroxy-3-aminoamides, anthranilic acid sulfonamides, and triazole analogs, which have demonstrated their potential to inhibit angiogenesis and tumor growth in vivo as well.  This review article mainly discussed the development of MetAP-2 inhibitors in cancer therapy and also summarized their structure-activity relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9_jcycw6lErVg90H21EOLACvtfcHk0lhnXF28HCUOVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSqtro%253D&md5=6bd1db81df9913ecd2b4cf14f3567677</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F092986712799320709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712799320709%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DS.-Q.%26aulast%3DWang%26aufirst%3DJ.-J.%26aulast%3DZhang%26aufirst%3DC.-M.%26aulast%3DLiu%26aufirst%3DZ.-P.%26atitle%3DThe%2520development%2520of%2520MetAP-2%2520inhibitors%2520in%2520cancer%2520treatment%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D1021%26epage%3D1035%26doi%3D10.2174%2F092986712799320709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ehlers, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furness, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philip Robinson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aribser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillip
Bowen, J.</span></span> <span> </span><span class="NLM_article-title">Methionine aminopeptidase type-2 inhibitors targeting angiogenesis</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1478</span>– <span class="NLM_lpage">1488</span>, <span class="refDoi"> DOI: 10.2174/1568026615666150915121204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.2174%2F1568026615666150915121204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=26369821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BC28XktlCgs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=1478-1488&author=T.+Ehlersauthor=S.+Furnessauthor=T.+Philip+Robinsonauthor=H.+A.+Zhongauthor=D.+Goldsmithauthor=J.+Aribserauthor=J.+Phillip%0ABowen&title=Methionine+aminopeptidase+type-2+inhibitors+targeting+angiogenesis&doi=10.2174%2F1568026615666150915121204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Methionine AminoPeptidase Type-2 Inhibitors Targeting Angiogenesis</span></div><div class="casAuthors">Ehlers, Tedman; Furness, Scott; Robinson, Thomas Philip; Zhong, Haizhen A.; Goldsmith, David; Aribser, Jack; Bowen, J. Phillip</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1478-1488</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Angiogenesis has been identified as a crucial process in the development and spread of cancers.  There are many regulators of angiogenesis which are not yet fully understood.  Methionine aminiopeptidase is a metalloenzyme with two structurally distinct forms in humans, Type-1 (MetAP-1) and Type-2 (MetAP-2).  It has been shown that small mol. inhibitors of MetAP-2 suppress endothelial cell proliferation.  The initial discovery by Donald Ingber of MetAP-2 inhibition as a potential target in angiogenesis began with a fortuitous observation similar to the discovery of penicillin activity by Sir Alexander Fleming.  From a drug design perspective, MetAP-2 is an attractive target.  Fumagillin and ovalicin, known natural products, bind with IC50 values in low nanomolar concns.  Crystal structures of the bound complexes provide 3-dimensional coordinates for advanced computational studies.  More recent discoveries have shown other biol. activities for MetAP-2 inhibition, which has generated new interests in the design of novel inhibitors.  Semisynthetic fumagillin derivs. such as AGM-1470 (TNP-470) have been shown to have better drug properties, but have not been very successful in clin. trials.  The rationale and development of novel multicyclic analogs of fumagillin are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpug7-9kSnRkLVg90H21EOLACvtfcHk0limDveqqYFMfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktlCgs74%253D&md5=8d7bec6aeacb7f9d75cfab8372cf4c7e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F1568026615666150915121204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026615666150915121204%26sid%3Dliteratum%253Aachs%26aulast%3DEhlers%26aufirst%3DT.%26aulast%3DFurness%26aufirst%3DS.%26aulast%3DPhilip%2BRobinson%26aufirst%3DT.%26aulast%3DZhong%26aufirst%3DH.%2BA.%26aulast%3DGoldsmith%26aufirst%3DD.%26aulast%3DAribser%26aufirst%3DJ.%26aulast%3DPhillip%2BBowen%26aufirst%3DJ.%26atitle%3DMethionine%2520aminopeptidase%2520type-2%2520inhibitors%2520targeting%2520angiogenesis%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2016%26volume%3D16%26spage%3D1478%26epage%3D1488%26doi%3D10.2174%2F1568026615666150915121204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCandless, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanovski, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salehi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stafford, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abuzzahab, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viskochil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitman, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Styne, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roof, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dykens, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheimann, A. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malloy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, M. G.</span></span> <span> </span><span class="NLM_article-title">Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial</span>. <i>Diabetes, Obes. Metab.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1751</span>– <span class="NLM_lpage">1761</span>, <span class="refDoi"> DOI: 10.1111/dom.13021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1111%2Fdom.13021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=28556449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslyhsbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2017&pages=1751-1761&author=S.+E.+McCandlessauthor=J.+A.+Yanovskiauthor=J.+Millerauthor=C.+Fuauthor=L.+M.+Birdauthor=P.+Salehiauthor=C.+L.+Chanauthor=D.+Staffordauthor=M.+J.+Abuzzahabauthor=D.+Viskochilauthor=M.+Anguloauthor=S.+E.+Myersauthor=B.+Y.+Whitmanauthor=D.+Styneauthor=E.+Roofauthor=E.+M.+Dykensauthor=A.+O.+Scheimannauthor=J.+Malloyauthor=D.+Zhuangauthor=K.+Taylorauthor=T.+E.+Hughesauthor=D.+D.+Kimauthor=M.+G.+Butler&title=Effects+of+MetAP2+inhibition+on+hyperphagia+and+body+weight+in+Prader-Willi+syndrome%3A+A+randomized%2C+double-blind%2C+placebo-controlled+trial&doi=10.1111%2Fdom.13021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial</span></div><div class="casAuthors">McCandless, Shawn E.; Yanovski, Jack A.; Miller, Jennifer; Fu, Cary; Bird, Lynne M.; Salehi, Parisa; Chan, Christine L.; Stafford, Diane; Abuzzahab, M. Jennifer; Viskochil, David; Barlow, Sarah E.; Angulo, Moris; Myers, Susan E.; Whitman, Barbara Y.; Styne, Dennis; Roof, Elizabeth; Dykens, Elisabeth M.; Scheimann, Ann O.; Malloy, Jaret; Zhuang, Dongliang; Taylor, Kristin; Hughes, Thomas E.; Kim, Dennis D.; Butler, Merlin G.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, Obesity and Metabolism</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1751-1761</span>CODEN:
                <span class="NLM_cas:coden">DOMEF6</span>;
        ISSN:<span class="NLM_cas:issn">1462-8902</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aims : There are no treatments for the extreme hyperphagia and obesity in Prader-Willi syndrome (PWS).  The bestPWS clin. trial assessed the efficacy, safety and tolerability of the methionine aminopeptidase 2 (MetAP2) inhibitor, beloranib.  Materials and Methods : Participants with PWS (12-65 years old) were randomly assigned (1:1:1) to biweekly placebo, 1.8 mg beloranib or 2.4 mg beloranib injection for 26 wk at 15 US sites.  Co-primary endpoints were the changes in hyperphagia [measured by Hyperphagia Questionnaire for Clin. Trials (HQ-CT); possible score 0-36] and wt. by intention-to-treat. registration: NCT02179151.  Results : One-hundred and seven participants were included in the intention-to-treat anal.: placebo (n = 34); 1.8 mg beloranib (n = 36); or 2.4 mg beloranib (n = 37).  Improvement (redn.) in HQ-CT total score was greater in the 1.8 mg (mean difference -6.3, 95% CI -9.6 to -3.0; P = .0003) and 2.4 mg beloranib groups (-7.0, 95% CI -10.5 to -3.6; P = .0001) vs placebo.  Compared with placebo, wt. change was greater with 1.8 mg (mean difference - 8.2%, 95% CI -10.8 to -5.6; P < .0001) and 2.4 mg beloranib (-9.5%, 95% CI -12.1 to -6.8; P < .0001).  Injection site bruising was the most frequent adverse event with beloranib.  Dosing was stopped early due to an imbalance in venous thrombotic events in beloranib-treated participants (2 fatal events of pulmonary embolism and 2 events of deep vein thrombosis) compared with placebo.  Conclusions : MetAP2 inhibition with beloranib produced statistically significant and clin. meaningful improvements in hyperphagia-related behaviors and wt. loss in participants with PWS.  Although investigation of beloranib has ceased, inhibition of MetAP2 is a novel mechanism for treating hyperphagia and obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp647p2aRQ4MrVg90H21EOLACvtfcHk0lj4cSzKAu_pRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslyhsbvJ&md5=682a6297a51b90a1cba2e06cf4c7d968</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fdom.13021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fdom.13021%26sid%3Dliteratum%253Aachs%26aulast%3DMcCandless%26aufirst%3DS.%2BE.%26aulast%3DYanovski%26aufirst%3DJ.%2BA.%26aulast%3DMiller%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DC.%26aulast%3DBird%26aufirst%3DL.%2BM.%26aulast%3DSalehi%26aufirst%3DP.%26aulast%3DChan%26aufirst%3DC.%2BL.%26aulast%3DStafford%26aufirst%3DD.%26aulast%3DAbuzzahab%26aufirst%3DM.%2BJ.%26aulast%3DViskochil%26aufirst%3DD.%26aulast%3DAngulo%26aufirst%3DM.%26aulast%3DMyers%26aufirst%3DS.%2BE.%26aulast%3DWhitman%26aufirst%3DB.%2BY.%26aulast%3DStyne%26aufirst%3DD.%26aulast%3DRoof%26aufirst%3DE.%26aulast%3DDykens%26aufirst%3DE.%2BM.%26aulast%3DScheimann%26aufirst%3DA.%2BO.%26aulast%3DMalloy%26aufirst%3DJ.%26aulast%3DZhuang%26aufirst%3DD.%26aulast%3DTaylor%26aufirst%3DK.%26aulast%3DHughes%26aufirst%3DT.%2BE.%26aulast%3DKim%26aufirst%3DD.%2BD.%26aulast%3DButler%26aufirst%3DM.%2BG.%26atitle%3DEffects%2520of%2520MetAP2%2520inhibition%2520on%2520hyperphagia%2520and%2520body%2520weight%2520in%2520Prader-Willi%2520syndrome%253A%2520A%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520trial%26jtitle%3DDiabetes%252C%2520Obes.%2520Metab.%26date%3D2017%26volume%3D19%26spage%3D1751%26epage%3D1761%26doi%3D10.1111%2Fdom.13021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kudelka, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verschraegen, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piamsomboon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Termrungruanglert, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieback, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeckle, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loyer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mante, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mavligit, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Killian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutterman, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavanagh, J. J.</span></span> <span> </span><span class="NLM_article-title">A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix</span>. <i>Clin Cancer Res</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1501</span>– <span class="NLM_lpage">1505</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1997&pages=1501-1505&author=A.+P.+Kudelkaauthor=T.+Levyauthor=C.+F.+Verschraegenauthor=C.+L.+Edwardsauthor=S.+Piamsomboonauthor=W.+Termrungruanglertauthor=R.+S.+Freedmanauthor=A.+L.+Kaplanauthor=D.+G.+Kiebackauthor=C.+A.+Meyersauthor=K.+A.+Jaeckleauthor=E.+Loyerauthor=M.+Stegerauthor=R.+Manteauthor=G.+Mavligitauthor=A.+Killianauthor=R.+A.+Tangauthor=J.+U.+Guttermanauthor=J.+J.+Kavanagh&title=A+phase+I+study+of+TNP-470+administered+to+patients+with+advanced+squamous+cell+cancer+of+the+cervix"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKudelka%26aufirst%3DA.%2BP.%26aulast%3DLevy%26aufirst%3DT.%26aulast%3DVerschraegen%26aufirst%3DC.%2BF.%26aulast%3DEdwards%26aufirst%3DC.%2BL.%26aulast%3DPiamsomboon%26aufirst%3DS.%26aulast%3DTermrungruanglert%26aufirst%3DW.%26aulast%3DFreedman%26aufirst%3DR.%2BS.%26aulast%3DKaplan%26aufirst%3DA.%2BL.%26aulast%3DKieback%26aufirst%3DD.%2BG.%26aulast%3DMeyers%26aufirst%3DC.%2BA.%26aulast%3DJaeckle%26aufirst%3DK.%2BA.%26aulast%3DLoyer%26aufirst%3DE.%26aulast%3DSteger%26aufirst%3DM.%26aulast%3DMante%26aufirst%3DR.%26aulast%3DMavligit%26aufirst%3DG.%26aulast%3DKillian%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DR.%2BA.%26aulast%3DGutterman%26aufirst%3DJ.%2BU.%26aulast%3DKavanagh%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520phase%2520I%2520study%2520of%2520TNP-470%2520administered%2520to%2520patients%2520with%2520advanced%2520squamous%2520cell%2520cancer%2520of%2520the%2520cervix%26jtitle%3DClin%2520Cancer%2520Res%26date%3D1997%26volume%3D9%26spage%3D1501%26epage%3D1505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figg, W. D.</span></span> <span> </span><span class="NLM_article-title">TNP-470: an angiogenesis inhibitor in clinical development for cancer</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1383</span>– <span class="NLM_lpage">1396</span>, <span class="refDoi"> DOI: 10.1517/13543784.9.6.1383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1517%2F13543784.9.6.1383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=11060750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktFWjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2000&pages=1383-1396&author=E.+A.+Krugerauthor=W.+D.+Figg&title=TNP-470%3A+an+angiogenesis+inhibitor+in+clinical+development+for+cancer&doi=10.1517%2F13543784.9.6.1383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">TNP-470: an angiogenesis inhibitor in clinical development for cancer</span></div><div class="casAuthors">Kruger, Erwin A.; Figg, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1383-1396</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review with 100 refs.  TNP-470, an analog of fumagillin, has been shown to inhibit angiogenesis in vitro and in vivo.  In 1992, TNP-470 entered clin. development for cancer as an anti-angiogenic agent.  It is currently in Phase I/II trials in Kaposi's sarcoma, renal cell carcinoma, brain cancer, breast cancer, cervical cancer and prostate cancer.  Terminal half-life values are short and have shown intermittent and intrapatient variation (range: 0.05 - 1.07 h).  Recently, mechanistic studies have identified cell cycle mediators and the protein methionine aminopeptidase-2 (MetAP-2) as mol. targets of TNP-470 and fumagillin.  In early clin. reports, TNP-470 is tolerated up to 177 mg/m2 with neurotoxic effects (fatigue, vertigo, ataxia, and loss of concn.) being the principal dose limiting toxicity (DLT).  Animal studies confirm some toxic effects on normal angiogenic processes such as the female reproductive system and wound healing, which will require caution and close monitoring in the clinic.  TNP-470 is one of the first anti-angiogenic compds. to enter clin. trials, making it a valuable prototype for future trials of angiogenesis inhibitors in oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6wwOg1czqDbVg90H21EOLACvtfcHk0lgqnoSwXTMLcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktFWjsb4%253D&md5=9963aa3a5d14aaccbbb22a8c4bfdd85f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1517%2F13543784.9.6.1383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.9.6.1383%26sid%3Dliteratum%253Aachs%26aulast%3DKruger%26aufirst%3DE.%2BA.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26atitle%3DTNP-470%253A%2520an%2520angiogenesis%2520inhibitor%2520in%2520clinical%2520development%2520for%2520cancer%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2000%26volume%3D9%26spage%3D1383%26epage%3D1396%26doi%3D10.1517%2F13543784.9.6.1383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniewski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkin, J.</span></span> <span> </span><span class="NLM_article-title">Physiologically relevant metal cofactor for methionine aminopeptidase-2 is manganese</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">5035</span>– <span class="NLM_lpage">5042</span>, <span class="refDoi"> DOI: 10.1021/bi020670c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi020670c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislSitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=5035-5042&author=J.+Wangauthor=G.+S.+Sheppardauthor=P.+Louauthor=M.+Kawaiauthor=C.+Parkauthor=D.+A.+Eganauthor=A.+Schneiderauthor=J.+Bouskaauthor=R.+Lesniewskiauthor=J.+Henkinauthor=J.+Henkin&title=Physiologically+relevant+metal+cofactor+for+methionine+aminopeptidase-2+is+manganese&doi=10.1021%2Fbi020670c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Physiologically Relevant Metal Cofactor for Methionine Aminopeptidase-2 Is Manganese</span></div><div class="casAuthors">Wang, Jieyi; Sheppard, George S.; Lou, Pingping; Kawai, Megumi; Park, Chang; Egan, David A.; Schneider, Andrew; Bouska, Jennifer; Lesniewski, Rick; Henkin, Jack</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5035-5042</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identity of the physiol. metal cofactor for human methionine aminopeptidase-2 (MetAP2) has not been established.  To examine this question, we first investigated the effect of eight divalent metal ions, including Ca2+, Co2+, Cu2+, Fe2+, Mg2+, Mn2+, Ni2+, and Zn2+, on recombinant human methionine aminopeptidase apoenzymes in releasing N-terminal methionine from three peptide substrates: MAS, MGAQFSKT, and 3H-MASK(biotin)G.  The activity of MetAP2 on either MAS or MGAQFSKT was enhanced 15-25-fold by Co2+ or Mn2+ metal ions in a broad concn. range (1-1000 μM).  In the presence of reduced glutathione to mimic the cellular environment, Co2+ and Mn2+ were also the best stimulators (∼30-fold) for MetAP2 enzyme activity.  To det. which metal ion is physiol. relevant, we then tested inhibition of intracellular MetAP2 with synthetic inhibitors selective for MetAP2 with different metal cofactors.  A-310840 below 10 μM did not inhibit the activity of MetAP2-Mn2+ but was very potent against MetAP2 with other metal ions including Co2+, Fe2+, Ni2+, and Zn2+ in the in vitro enzyme assays.  In contrast, A-311263 inhibited MetAP2 with Mn2+, as well as Co2+, Fe2+, Ni2+, and Zn2+.  In cell culture assays, A-310840 did not inhibit intracellular MetAP2 enzyme activity and did not inhibit cell proliferation despite its ability to permeate and accumulate in cytosol, while A-311263 inhibited both intracellular MetAP2 and proliferation in a similar concn. range, indicating cellular MetAP2 is functioning as a manganese enzyme but not as a cobalt, zinc, iron, or nickel enzyme.  We conclude that MetAP2 is a manganese enzyme and that therapeutic MetAP2 inhibitors should inhibit MetAP2-Mn2+.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnOVJL9uJhw7Vg90H21EOLACvtfcHk0lgqnoSwXTMLcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislSitrY%253D&md5=cb8ddc7017dc11f1327a0d83fcb2d417</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fbi020670c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi020670c%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DLou%26aufirst%3DP.%26aulast%3DKawai%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DEgan%26aufirst%3DD.%2BA.%26aulast%3DSchneider%26aufirst%3DA.%26aulast%3DBouska%26aufirst%3DJ.%26aulast%3DLesniewski%26aufirst%3DR.%26aulast%3DHenkin%26aufirst%3DJ.%26aulast%3DHenkin%26aufirst%3DJ.%26atitle%3DPhysiologically%2520relevant%2520metal%2520cofactor%2520for%2520methionine%2520aminopeptidase-2%2520is%2520manganese%26jtitle%3DBiochemistry%26date%3D2003%26volume%3D42%26spage%3D5035%26epage%3D5042%26doi%3D10.1021%2Fbi020670c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marino, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkpatrick, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janson, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattern, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tew, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomazek, T. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veber, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, S. K.</span></span> <span> </span><span class="NLM_article-title">Highly Potent Inhibitors of Methionine Aminopeptidase-2 Based on a 1,2,4-Triazole Pharmacophore†</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3777</span>– <span class="NLM_lpage">3785</span>, <span class="refDoi"> DOI: 10.1021/jm061182w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061182w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3777-3785&author=J.+P.+Marinoauthor=P.+W.+Fisherauthor=G.+A.+Hofmannauthor=R.+B.+Kirkpatrickauthor=C.+A.+Jansonauthor=R.+K.+Johnsonauthor=C.+Maauthor=M.+Matternauthor=T.+D.+Meekauthor=M.+D.+Ryanauthor=C.+Schulzauthor=W.+W.+Smithauthor=D.+G.+Tewauthor=T.+A.+Tomazekauthor=D.+F.+Veberauthor=W.+C.+Xiongauthor=Y.+Yamamotoauthor=K.+Yamashitaauthor=G.+Yangauthor=S.+K.+Thompson&title=Highly+Potent+Inhibitors+of+Methionine+Aminopeptidase-2+Based+on+a+1%2C2%2C4-Triazole+Pharmacophore%E2%80%A0&doi=10.1021%2Fjm061182w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm061182w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061182w%26sid%3Dliteratum%253Aachs%26aulast%3DMarino%26aufirst%3DJ.%2BP.%26aulast%3DFisher%26aufirst%3DP.%2BW.%26aulast%3DHofmann%26aufirst%3DG.%2BA.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DJohnson%26aufirst%3DR.%2BK.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DMattern%26aufirst%3DM.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DRyan%26aufirst%3DM.%2BD.%26aulast%3DSchulz%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DTomazek%26aufirst%3DT.%2BA.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DXiong%26aufirst%3DW.%2BC.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DThompson%26aufirst%3DS.%2BK.%26atitle%3DHighly%2520Potent%2520Inhibitors%2520of%2520Methionine%2520Aminopeptidase-2%2520Based%2520on%2520a%25201%252C2%252C4-Triazole%2520Pharmacophore%25E2%2580%25A0%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3777%26epage%3D3785%26doi%3D10.1021%2Fjm061182w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burley, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipscomb, W. N.</span></span> <span> </span><span class="NLM_article-title">Leucine aminopeptidase: bestatin inhibition and a model for enzyme-catalyzed peptide hydrolysis</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">6916</span>– <span class="NLM_lpage">6920</span>, <span class="refDoi"> DOI: 10.1073/pnas.88.16.6916</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1073%2Fpnas.88.16.6916" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=6916-6920&author=S.+K.+Burleyauthor=P.+R.+Davidauthor=W.+N.+Lipscomb&title=Leucine+aminopeptidase%3A+bestatin+inhibition+and+a+model+for+enzyme-catalyzed+peptide+hydrolysis&doi=10.1073%2Fpnas.88.16.6916"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.88.16.6916&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.88.16.6916%26sid%3Dliteratum%253Aachs%26aulast%3DBurley%26aufirst%3DS.%2BK.%26aulast%3DDavid%26aufirst%3DP.%2BR.%26aulast%3DLipscomb%26aufirst%3DW.%2BN.%26atitle%3DLeucine%2520aminopeptidase%253A%2520bestatin%2520inhibition%2520and%2520a%2520model%2520for%2520enzyme-catalyzed%2520peptide%2520hydrolysis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1991%26volume%3D88%26spage%3D6916%26epage%3D6920%26doi%3D10.1073%2Fpnas.88.16.6916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BaMaung, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Searle, X. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniewski, R.</span></span> <span> </span><span class="NLM_article-title">3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">865</span>– <span class="NLM_lpage">868</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2003.12.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1016%2Fj.bmcl.2003.12.031" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=865-868&author=G.+S.+Sheppardauthor=J.+Wangauthor=M.+Kawaiauthor=N.+Y.+BaMaungauthor=R.+A.+Craigauthor=S.+A.+Ericksonauthor=L.+Lynchauthor=J.+Patelauthor=F.+Yangauthor=X.+B.+Searleauthor=P.+Louauthor=C.+Parkauthor=K.+H.+Kimauthor=J.+Henkinauthor=R.+Lesniewski&title=3-Amino-2-hydroxyamides+and+related+compounds+as+inhibitors+of+methionine+aminopeptidase-2&doi=10.1016%2Fj.bmcl.2003.12.031"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2003.12.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2003.12.031%26sid%3Dliteratum%253Aachs%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKawai%26aufirst%3DM.%26aulast%3DBaMaung%26aufirst%3DN.%2BY.%26aulast%3DCraig%26aufirst%3DR.%2BA.%26aulast%3DErickson%26aufirst%3DS.%2BA.%26aulast%3DLynch%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DSearle%26aufirst%3DX.%2BB.%26aulast%3DLou%26aufirst%3DP.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DHenkin%26aufirst%3DJ.%26aulast%3DLesniewski%26aufirst%3DR.%26atitle%3D3-Amino-2-hydroxyamides%2520and%2520related%2520compounds%2520as%2520inhibitors%2520of%2520methionine%2520aminopeptidase-2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D865%26epage%3D868%26doi%3D10.1016%2Fj.bmcl.2003.12.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Towbin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bair, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeCaprio, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinder, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morollo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schindler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Oostrum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Versace, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voshol, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zabludoff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, P. E.</span></span> <span> </span><span class="NLM_article-title">Proteomics-based Target Identification</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">52964</span>– <span class="NLM_lpage">52971</span>, <span class="refDoi"> DOI: 10.1074/jbc.m309039200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1074%2Fjbc.m309039200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=52964-52971&author=H.+Towbinauthor=K.+W.+Bairauthor=J.+A.+DeCaprioauthor=M.+J.+Eckauthor=S.+Kimauthor=F.+R.+Kinderauthor=A.+Morolloauthor=D.+R.+Muellerauthor=P.+Schindlerauthor=H.+K.+Songauthor=J.+van+Oostrumauthor=R.+W.+Versaceauthor=H.+Vosholauthor=J.+Woodauthor=S.+Zabludoffauthor=P.+E.+Phillips&title=Proteomics-based+Target+Identification&doi=10.1074%2Fjbc.m309039200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.m309039200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.m309039200%26sid%3Dliteratum%253Aachs%26aulast%3DTowbin%26aufirst%3DH.%26aulast%3DBair%26aufirst%3DK.%2BW.%26aulast%3DDeCaprio%26aufirst%3DJ.%2BA.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DKinder%26aufirst%3DF.%2BR.%26aulast%3DMorollo%26aufirst%3DA.%26aulast%3DMueller%26aufirst%3DD.%2BR.%26aulast%3DSchindler%26aufirst%3DP.%26aulast%3DSong%26aufirst%3DH.%2BK.%26aulast%3Dvan%2BOostrum%26aufirst%3DJ.%26aulast%3DVersace%26aufirst%3DR.%2BW.%26aulast%3DVoshol%26aufirst%3DH.%26aulast%3DWood%26aufirst%3DJ.%26aulast%3DZabludoff%26aufirst%3DS.%26aulast%3DPhillips%26aufirst%3DP.%2BE.%26atitle%3DProteomics-based%2520Target%2520Identification%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D52964%26epage%3D52971%26doi%3D10.1074%2Fjbc.m309039200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Q.-Z.</span></span> <span> </span><span class="NLM_article-title">Structural analysis of bengamide derivatives as inhibitors of methionine aminopeptidases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8021</span>– <span class="NLM_lpage">8027</span>, <span class="refDoi"> DOI: 10.1021/jm3008695</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3008695" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8021-8027&author=W.+Xuauthor=J.-P.+Luauthor=Q.-Z.+Ye&title=Structural+analysis+of+bengamide+derivatives+as+inhibitors+of+methionine+aminopeptidases&doi=10.1021%2Fjm3008695"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm3008695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3008695%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DJ.-P.%26aulast%3DYe%26aufirst%3DQ.-Z.%26atitle%3DStructural%2520analysis%2520of%2520bengamide%2520derivatives%2520as%2520inhibitors%2520of%2520methionine%2520aminopeptidases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8021%26epage%3D8027%26doi%3D10.1021%2Fjm3008695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenney, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, P.</span></span> <span> </span><span class="NLM_article-title">The bengamides: A mini-review of natural sources, analogues, biological properties, biosynthetic origins, and future prospects</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">740</span>– <span class="NLM_lpage">755</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.6b00970</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.6b00970" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitlGksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2017&pages=740-755&author=K.+N.+Whiteauthor=K.+Tenneyauthor=P.+Crews&title=The+bengamides%3A+A+mini-review+of+natural+sources%2C+analogues%2C+biological+properties%2C+biosynthetic+origins%2C+and+future+prospects&doi=10.1021%2Facs.jnatprod.6b00970"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The Bengamides: A Mini-Review of Natural Sources, Analogues, Biological Properties, Biosynthetic Origins, and Future Prospects</span></div><div class="casAuthors">White, Kimberly N.; Tenney, Karen; Crews, Phillip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">740-755</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A review.  This review focuses entirely on the natural bengamides and selected synthetic analogs that have inspired decades of research.  Bengamide A was first reported in 1986 from the sponge Jaspis cf. coriacea, and bengamide-contg. sponges have been gathered from many biogeog. sites.  In 2005, a terrestrial Gram-neg. bacterium, Myxococcus virescens, was added as a source for bengamides.  Biol. activity data using varying bengamide-based scaffolds has enabled fine-tuning of structure-activity relationships.  Mol. target finding contributed to the creation of a synthetic "lead" compd., LAF389, that was the subject of a phase I anticancer clin. trial.  Despite clin. trial termination, the bengamide compd. class is still attracting worldwide attention.  Future breakthroughs based on the bengamide scaffold are possible and could build on their nanomolar in vitro and pos. in vivo antiproliferative and antiangiogenic properties.  Bengamide mol. targets include methionine aminopeptidases (MetAP1 and MetAP2) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB).  A mixed PKS/NRPS biosynthetic gene cluster appears to be responsible for creation of the bengamides.  This review highlights that the bengamides have driven inspirational studies and that they will remain relevant for future research, even 30 years after the discovery of the first structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo05ZANtPfNc7Vg90H21EOLACvtfcHk0liK6mqnuARE0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitlGksLY%253D&md5=99921eaff0fdbd23dcba1d9289856c4c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.6b00970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.6b00970%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DK.%2BN.%26aulast%3DTenney%26aufirst%3DK.%26aulast%3DCrews%26aufirst%3DP.%26atitle%3DThe%2520bengamides%253A%2520A%2520mini-review%2520of%2520natural%2520sources%252C%2520analogues%252C%2520biological%2520properties%252C%2520biosynthetic%2520origins%252C%2520and%2520future%2520prospects%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2017%26volume%3D80%26spage%3D740%26epage%3D755%26doi%3D10.1021%2Facs.jnatprod.6b00970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McBride, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheruvallath, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komandla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderpool, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plonowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holub, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larson, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent, reversible MetAP-2 inhibitors via fragment-based drug discovery and structure-based drug design—Part 2</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2779</span>– <span class="NLM_lpage">2783</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.04.072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1016%2Fj.bmcl.2016.04.072" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=2779-2783&author=C.+McBrideauthor=Z.+Cheruvallathauthor=M.+Komandlaauthor=M.+Tangauthor=P.+Farrellauthor=J.+D.+Lawsonauthor=D.+Vanderpoolauthor=Y.+Wuauthor=D.+R.+Douganauthor=A.+Plonowskiauthor=C.+Holubauthor=C.+Larson&title=Discovery+of+potent%2C+reversible+MetAP-2+inhibitors+via+fragment-based+drug+discovery+and+structure-based+drug+design%E2%80%94Part+2&doi=10.1016%2Fj.bmcl.2016.04.072"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.04.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.04.072%26sid%3Dliteratum%253Aachs%26aulast%3DMcBride%26aufirst%3DC.%26aulast%3DCheruvallath%26aufirst%3DZ.%26aulast%3DKomandla%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DM.%26aulast%3DFarrell%26aufirst%3DP.%26aulast%3DLawson%26aufirst%3DJ.%2BD.%26aulast%3DVanderpool%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DPlonowski%26aufirst%3DA.%26aulast%3DHolub%26aufirst%3DC.%26aulast%3DLarson%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520potent%252C%2520reversible%2520MetAP-2%2520inhibitors%2520via%2520fragment-based%2520drug%2520discovery%2520and%2520structure-based%2520drug%2520design%25E2%2580%2594Part%25202%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D2779%26epage%3D2783%26doi%3D10.1016%2Fj.bmcl.2016.04.072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidanze, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BaMaung, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedrow, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolaczkowski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasudevan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantei, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palazzo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tucker-Garcia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olejniczak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettesheim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajduk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesniewski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidsen, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, R. L.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: A structural basis for the reduction of albumin binding</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3832</span>– <span class="NLM_lpage">3849</span>, <span class="refDoi"> DOI: 10.1021/jm0601001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0601001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFent74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3832-3849&author=G.+S.+Sheppardauthor=J.+Wangauthor=M.+Kawaiauthor=S.+D.+Fidanzeauthor=N.+Y.+BaMaungauthor=S.+A.+Ericksonauthor=D.+M.+Barnesauthor=J.+S.+Tedrowauthor=L.+Kolaczkowskiauthor=A.+Vasudevanauthor=D.+C.+Parkauthor=G.+T.+Wangauthor=W.+J.+Sandersauthor=R.+A.+Manteiauthor=F.+Palazzoauthor=L.+Tucker-Garciaauthor=P.+Louauthor=Q.+Zhangauthor=C.+H.+Parkauthor=K.+H.+Kimauthor=A.+Petrosauthor=E.+Olejniczakauthor=D.+Nettesheimauthor=P.+Hajdukauthor=J.+Henkinauthor=R.+Lesniewskiauthor=S.+K.+Davidsenauthor=R.+L.+Bell&title=Discovery+and+optimization+of+anthranilic+acid+sulfonamides+as+inhibitors+of+methionine+aminopeptidase-2%3A+A+structural+basis+for+the+reduction+of+albumin+binding&doi=10.1021%2Fjm0601001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Anthranilic Acid Sulfonamides as Inhibitors of Methionine Aminopeptidase-2: A Structural Basis for the Reduction of Albumin Binding</span></div><div class="casAuthors">Sheppard, George S.; Wang, Jieyi; Kawai, Megumi; Fidanze, Steve D.; BaMaung, Nwe Y.; Erickson, Scott A.; Barnes, David M.; Tedrow, Jason S.; Kolaczkowski, Lawrence; Vasudevan, Anil; Park, David C.; Wang, Gary T.; Sanders, William J.; Mantei, Robert A.; Palazzo, Fabio; Tucker-Garcia, Lora; Lou, Pingping; Zhang, Qian; Park, Chang H.; Kim, Ki H.; Petros, Andrew; Olejniczak, Edward; Nettesheim, David; Hajduk, Phillip; Henkin, Jack; Lesniewski, Richard; Davidsen, Steven K.; Bell, Randy L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3832-3849</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Methionine aminopeptidase-2 (MetAP2) is a novel target for cancer therapy.  As part of an effort to discover orally active reversible inhibitors of MetAP2, a series of anthranilic acid sulfonamides with micromolar affinities for human MetAP2 were identified using affinity selection by mass spectrometry (ASMS) screening.  These micromolar hits were rapidly improved to nanomolar leads on the basis of insights from protein crystallog.; however, the compds. displayed extensive binding to human serum albumin and had limited activity in cellular assays.  Modifications based on structural information on the binding of lead compds. to both MetAP2 and domain III of albumin allowed the identification of compds. with significant improvements in both parameters, which showed good cellular activity in both proliferation and methionine processing assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogG0eQ-sDeVrVg90H21EOLACvtfcHk0ljiIcJ6KuRF9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFent74%253D&md5=3d1a68c7397d9483647b0e099f3885cc</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm0601001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0601001%26sid%3Dliteratum%253Aachs%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKawai%26aufirst%3DM.%26aulast%3DFidanze%26aufirst%3DS.%2BD.%26aulast%3DBaMaung%26aufirst%3DN.%2BY.%26aulast%3DErickson%26aufirst%3DS.%2BA.%26aulast%3DBarnes%26aufirst%3DD.%2BM.%26aulast%3DTedrow%26aufirst%3DJ.%2BS.%26aulast%3DKolaczkowski%26aufirst%3DL.%26aulast%3DVasudevan%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DG.%2BT.%26aulast%3DSanders%26aufirst%3DW.%2BJ.%26aulast%3DMantei%26aufirst%3DR.%2BA.%26aulast%3DPalazzo%26aufirst%3DF.%26aulast%3DTucker-Garcia%26aufirst%3DL.%26aulast%3DLou%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DPetros%26aufirst%3DA.%26aulast%3DOlejniczak%26aufirst%3DE.%26aulast%3DNettesheim%26aufirst%3DD.%26aulast%3DHajduk%26aufirst%3DP.%26aulast%3DHenkin%26aufirst%3DJ.%26aulast%3DLesniewski%26aufirst%3DR.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26aulast%3DBell%26aufirst%3DR.%2BL.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520anthranilic%2520acid%2520sulfonamides%2520as%2520inhibitors%2520of%2520methionine%2520aminopeptidase-2%253A%2520A%2520structural%2520basis%2520for%2520the%2520reduction%2520of%2520albumin%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3832%26epage%3D3849%26doi%3D10.1021%2Fjm0601001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heinrich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchstaller, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cezanne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bomke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friese-Hamim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knöchel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuthner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenke, F.</span></span> <span> </span><span class="NLM_article-title">Novel reversible methionine aminopeptidase-2 (MetAP-2) inhibitors based on purine and related bicyclic templates</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">556</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.12.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1016%2Fj.bmcl.2016.12.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=27998678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFamtLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=551-556&author=T.+Heinrichauthor=H.-P.+Buchstallerauthor=B.+Cezanneauthor=F.+Rohdichauthor=J.+Bomkeauthor=M.+Friese-Hamimauthor=M.+Krierauthor=T.+Kn%C3%B6chelauthor=D.+Musilauthor=B.+Leuthnerauthor=F.+Zenke&title=Novel+reversible+methionine+aminopeptidase-2+%28MetAP-2%29+inhibitors+based+on+purine+and+related+bicyclic+templates&doi=10.1016%2Fj.bmcl.2016.12.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Novel reversible methionine aminopeptidase-2 (MetAP-2) inhibitors based on purine and related bicyclic templates</span></div><div class="casAuthors">Heinrich, Timo; Buchstaller, Hans-Peter; Cezanne, Bertram; Rohdich, Felix; Bomke, Joerg; Friese-Hamim, Manja; Krier, Mireille; Knoechel, Thorsten; Musil, Djordje; Leuthner, Birgitta; Zenke, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">551-556</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The natural product fumagillin 1 and derivs. like TNP-470 2 or beloranib 3 bind to methionine aminopeptidase 2 (MetAP-2) irreversibly.  This enzyme is crit. for protein maturation and plays a key role in angiogenesis.  In this paper we describe the synthesis, MetAP-2 binding affinity and structural anal. of reversible MetAP-2 inhibitors.  Optimization of enzymic activity of screening hit 10 (IC50: 1 μM) led to the most potent compd. 27 (IC50: 0.038 μM), with a concomitant improvement in LLE from 2.1 to 4.2.  Structural anal. of these MetAP-2 inhibitors revealed an unprecedented conformation of the His339 side-chain imidazole ring being co-planar sandwiched between the imidazole of His331 and the aryl-ether moiety, which is bound to the purine scaffold.  Systematic alteration and redn. of H-bonding capability of this metal binding moiety induced an unexpected 180° flip for the triazolo[1,5-a]pyrimdine bicyclic template.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_0XQ7H4uUXLVg90H21EOLACvtfcHk0ljiIcJ6KuRF9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFamtLrN&md5=fb10c549d94343a4cc37da474b609b65</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.12.019%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DT.%26aulast%3DBuchstaller%26aufirst%3DH.-P.%26aulast%3DCezanne%26aufirst%3DB.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DBomke%26aufirst%3DJ.%26aulast%3DFriese-Hamim%26aufirst%3DM.%26aulast%3DKrier%26aufirst%3DM.%26aulast%3DKn%25C3%25B6chel%26aufirst%3DT.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DLeuthner%26aufirst%3DB.%26aulast%3DZenke%26aufirst%3DF.%26atitle%3DNovel%2520reversible%2520methionine%2520aminopeptidase-2%2520%2528MetAP-2%2529%2520inhibitors%2520based%2520on%2520purine%2520and%2520related%2520bicyclic%2520templates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D551%26epage%3D556%26doi%3D10.1016%2Fj.bmcl.2016.12.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garrabrant, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludovici, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tominovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoneaux, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galemmo, R.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. L.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibitors of methionine aminopeptidase type 2 (MetAP-2) fail to inhibit endothelial cell proliferation or formation of microvessels from rat aortic rings in vitro</span>. <i>Angiogenesis</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">91</span>, <span class="refDoi"> DOI: 10.1007/s10456-004-6089-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1007%2Fs10456-004-6089-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=91&author=T.+Garrabrantauthor=R.+Tumanauthor=D.+Ludoviciauthor=R.+Tominovichauthor=R.+Simoneauxauthor=R.+Galemmoauthor=D.+L.+Johnson&title=Small+molecule+inhibitors+of+methionine+aminopeptidase+type+2+%28MetAP-2%29+fail+to+inhibit+endothelial+cell+proliferation+or+formation+of+microvessels+from+rat+aortic+rings+in+vitro&doi=10.1007%2Fs10456-004-6089-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs10456-004-6089-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10456-004-6089-7%26sid%3Dliteratum%253Aachs%26aulast%3DGarrabrant%26aufirst%3DT.%26aulast%3DTuman%26aufirst%3DR.%26aulast%3DLudovici%26aufirst%3DD.%26aulast%3DTominovich%26aufirst%3DR.%26aulast%3DSimoneaux%26aufirst%3DR.%26aulast%3DGalemmo%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DD.%2BL.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520methionine%2520aminopeptidase%2520type%25202%2520%2528MetAP-2%2529%2520fail%2520to%2520inhibit%2520endothelial%2520cell%2520proliferation%2520or%2520formation%2520of%2520microvessels%2520from%2520rat%2520aortic%2520rings%2520in%2520vitro%26jtitle%3DAngiogenesis%26date%3D2004%26volume%3D7%26spage%3D91%26doi%3D10.1007%2Fs10456-004-6089-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cowley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hales, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S.</span></span> <span> </span><span class="NLM_article-title">Highlights from the society for medicines research symposium held on December 9, 2010 at Nhli, London UK</span>. <i>Drugs Future</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">549</span>, <span class="refDoi"> DOI: 10.1358/dof.2011.036.07.1622065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1358%2Fdof.2011.036.07.1622065" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=543-549&author=P.+Cowleyauthor=N.+Halesauthor=S.+Ward&title=Highlights+from+the+society+for+medicines+research+symposium+held+on+December+9%2C+2010+at+Nhli%2C+London+UK&doi=10.1358%2Fdof.2011.036.07.1622065"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1358%2Fdof.2011.036.07.1622065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2011.036.07.1622065%26sid%3Dliteratum%253Aachs%26aulast%3DCowley%26aufirst%3DP.%26aulast%3DHales%26aufirst%3DN.%26aulast%3DWard%26aufirst%3DS.%26atitle%3DHighlights%2520from%2520the%2520society%2520for%2520medicines%2520research%2520symposium%2520held%2520on%2520December%25209%252C%25202010%2520at%2520Nhli%252C%2520London%2520UK%26jtitle%3DDrugs%2520Future%26date%3D2011%26volume%3D36%26spage%3D543%26epage%3D549%26doi%3D10.1358%2Fdof.2011.036.07.1622065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naber, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niggemann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, G.</span></span> <span> </span><span class="NLM_article-title">Review of the literature and individual patients’ data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infections</span>. <i>BMC Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">628</span>, <span class="refDoi"> DOI: 10.1186/s12879-014-0628-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1186%2Fs12879-014-0628-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=25427651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisV2nsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=628&author=K.+G.+Naberauthor=H.+Niggemannauthor=G.+Steinauthor=G.+Stein&title=Review+of+the+literature+and+individual+patients%E2%80%99+data+meta-analysis+on+efficacy+and+tolerance+of+nitroxoline+in+the+treatment+of+uncomplicated+urinary+tract+infections&doi=10.1186%2Fs12879-014-0628-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Review of the literature and individual patients' data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infections</span></div><div class="casAuthors">Naber, Kurt G.; Niggemann, Hiltrud; Stein, Gisela; Stein, Guenter</div><div class="citationInfo"><span class="NLM_cas:title">BMC Infectious Diseases</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">628/1-628/31, 31 pp.</span>CODEN:
                <span class="NLM_cas:coden">BIDMBJ</span>;
        ISSN:<span class="NLM_cas:issn">1471-2334</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Nitroxoline, a hydroxychinoline derivate, has been used for many years to treat urinary tract infections (UTI).  Many uncontrolled, but only few controlled clin. studies have been published.  Four so far unpublished, controlled clin. studies were meta-analyzed.  Methods: A narrative literature review was performed.  In addn. the individual patient data (IPD) of 466 females with uncomplicated UTI of four prospective, single blind, randomized, clin. studies with similar protocols using nitroxoline (250 mg tid) vs. cotrimoxazole (960 mg bid) or norfloxacin (400 mg bid) as controls for 5 days (sporadic UTI) or 10 days (recurrent UTI) were meta-analyzed.  The primary aim was eradication of bacteriuria 7-13 days after end of therapy (test of cure).  Clin. efficacy was detd. by elimination of symptoms and safety by adverse events and lab. tests.  Results: Reviewing a total of 26 uncontrolled, 2 controlled and one postmarketing studies including more than 11,000 patients, good efficacy and safety of nitroxoline could be confirmed.  In the four unpublished controlled studies a total of 234 patients were treated orally with nitroxoline and 232 with controls.  The safety of nitroxoline was very good and comparable to the controls (adverse events 9.4% vs 7.8%; p = 0.360).  In the mMITT set (at least one outcome result), in the PP set (test of cure outcome) and in the modified PP set (missing test of cure rated failure) more than 90% of the patients showed eradication of bacteriuria with nitroxoline, which also met statistical non-inferiority compared to the controls (10% non-inferiority margin) in all three evaluation sets.  The clin. efficacy was similar between the two treatment groups.  Conclusion: The IPD meta-anal. using objective parameters (elimination of bacteriuria) demonstrated equiv. efficacy (non-inferiority) of nitroxoline with the controls tested (cotrimoxazole, norfloxacin) in the treatment of uncomplicated UTI.  Considering the good safety and efficacy of nitroxoline as also shown in many uncontrolled and observational studies and the world wide increase of resistance of uropathogens against cotrimoxazole and fluoroquinolones, but not against nitroxoline within the last 20 years, nitroxoline should be reconsidered as one of the first line antibiotics for the treatment of uncomplicated UTI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1Bhs1PcsazrVg90H21EOLACvtfcHk0lg1U2FwC9kvfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisV2nsro%253D&md5=850d3c4d28604d6b0d8b305957716886</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1186%2Fs12879-014-0628-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12879-014-0628-7%26sid%3Dliteratum%253Aachs%26aulast%3DNaber%26aufirst%3DK.%2BG.%26aulast%3DNiggemann%26aufirst%3DH.%26aulast%3DStein%26aufirst%3DG.%26aulast%3DStein%26aufirst%3DG.%26atitle%3DReview%2520of%2520the%2520literature%2520and%2520individual%2520patients%25E2%2580%2599%2520data%2520meta-analysis%2520on%2520efficacy%2520and%2520tolerance%2520of%2520nitroxoline%2520in%2520the%2520treatment%2520of%2520uncomplicated%2520urinary%2520tract%2520infections%26jtitle%3DBMC%2520Infect.%2520Dis.%26date%3D2014%26volume%3D14%26spage%3D628%26doi%3D10.1186%2Fs12879-014-0628-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shim, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nacev, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhang, H.-e. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomper, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. O.</span></span> <span> </span><span class="NLM_article-title">Effect of nitroxoline on angiogenesis and growth of human bladder cancer</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">1855</span>– <span class="NLM_lpage">1873</span>, <span class="refDoi"> DOI: 10.1093/jnci/djq457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1093%2Fjnci%2Fdjq457" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=21088277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2ku7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=1855-1873&author=J.+S.+Shimauthor=Y.+Matsuiauthor=S.+Bhatauthor=B.+A.+Nacevauthor=J.+Xuauthor=H.-e.+C.+Bhangauthor=S.+Dharaauthor=K.+C.+Hanauthor=C.+R.+Chongauthor=M.+G.+Pomperauthor=A.+Soauthor=J.+O.+Liu&title=Effect+of+nitroxoline+on+angiogenesis+and+growth+of+human+bladder+cancer&doi=10.1093%2Fjnci%2Fdjq457"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Nitroxoline on Angiogenesis and Growth of Human Bladder Cancer</span></div><div class="casAuthors">Shim, Joong Sup; Matsui, Yoshiyuki; Bhat, Shridhar; Nacev, Benjamin A.; Xu, Jing; Bhang, Hyo-eun C.; Dhara, Surajit; Han, Kee Chung; Chong, Curtis R.; Pomper, Martin G.; So, Alan; Liu, Jun O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">1855-1873</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Angiogenesis plays an important role in tumor growth and metastasis; therefore, inhibition of angiogenesis is a promising strategy for developing new anticancer drugs.  Type 2 methionine aminopeptidase (MetAP2) protein is likely a mol. target of angiogenesis inhibitors.  Methods: Nitroxoline, an antibiotic used to treat urinary tract infections, was identified from a high-throughput screen of a library of 175 000 compds. for MetAP2 inhibitors and from a parallel screen using the Johns Hopkins Drug Library to identify currently used clin. drugs that can also inhibit human umbilical vein endothelial cells (HUVEC) proliferation.  To investigate the mechanism of action of nitroxoline, inhibition of MetAP2 activity and induction of senescence were assessed in HUVEC.  To test the antiangiogenic activity of nitroxoline, endothelial tube formation in Matrigel and microvessel formation in Matrigel plugs in vivo were assessed.  Antitumor efficacy of nitroxoline was evaluated in mouse models of human breast cancer xenograft (n = 10) and bladder cancer orthotopic xenograft (n = 11).  Furthermore, the mechanism of action of nitroxoline was investigated in vivo.  Results: Nitroxoline inhibited MetAP2 activity in vitro (half maximal inhibitory concn. [IC50] = 54.8 nM, 95% confidence interval [CI] = 22.6 to 132.8 nM) and HUVEC proliferation (IC50 = 1.9 μM, 95% CI = 1.54 to 2.39 μM).  Nitroxoline inhibited MetAP2 activity in HUVEC in a dose-dependent manner and induced premature senescence in a biphasic manner.  Nitroxoline inhibited endothelial tube formation in Matrigel and reduced microvessel d. in vivo.  Mice (five per group) treated with nitroxoline showed a 60% redn. in tumor vol. in breast cancer xenografts (tumor vol. on day 30, vehicle vs nitroxoline, mean = 215.4 vs 86.5 mm3, difference = 128.9 mm3, 95% CI = 32.9 to 225.0 mm3, P = .012) and statistically significantly inhibited growth of bladder cancer in an orthotopic mouse model (tumor bioluminescence intensities of vehicle [n = 5] vs nitroxoline [n = 6], P = .045).  Conclusion: Nitroxoline shows promise as a potential therapeutic antiangiogenic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWiEsBSL4ijrVg90H21EOLACvtfcHk0lg1U2FwC9kvfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2ku7nK&md5=d9e652ba7ac541b50198c7b6fe7eab69</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjq457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjq457%26sid%3Dliteratum%253Aachs%26aulast%3DShim%26aufirst%3DJ.%2BS.%26aulast%3DMatsui%26aufirst%3DY.%26aulast%3DBhat%26aufirst%3DS.%26aulast%3DNacev%26aufirst%3DB.%2BA.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DBhang%26aufirst%3DH.-e.%2BC.%26aulast%3DDhara%26aufirst%3DS.%26aulast%3DHan%26aufirst%3DK.%2BC.%26aulast%3DChong%26aufirst%3DC.%2BR.%26aulast%3DPomper%26aufirst%3DM.%2BG.%26aulast%3DSo%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26atitle%3DEffect%2520of%2520nitroxoline%2520on%2520angiogenesis%2520and%2520growth%2520of%2520human%2520bladder%2520cancer%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2010%26volume%3D102%26spage%3D1855%26epage%3D1873%26doi%3D10.1093%2Fjnci%2Fdjq457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, S.</span></span> <span> </span><span class="NLM_article-title">Preclinical pharmacodynamic evaluation of antibiotic nitroxoline for anticancer drug repurposing</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3265</span>– <span class="NLM_lpage">3272</span>, <span class="refDoi"> DOI: 10.3892/ol.2016.4380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.3892%2Fol.2016.4380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=27123101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmsVKkt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=3265-3272&author=Q.+Zhangauthor=S.+Wangauthor=D.+Yangauthor=K.+Panauthor=L.+Liauthor=S.+Yuan&title=Preclinical+pharmacodynamic+evaluation+of+antibiotic+nitroxoline+for+anticancer+drug+repurposing&doi=10.3892%2Fol.2016.4380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacodynamic evaluation of antibiotic nitroxoline for anticancer drug repurposing</span></div><div class="casAuthors">Zhang, Qi; Wang, Shanshan; Yang, Dexuan; Pan, Kevin; Li, Linna; Yuan, Shoujun</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3265-3272</span>CODEN:
                <span class="NLM_cas:coden">OLNEB5</span>;
        ISSN:<span class="NLM_cas:issn">1792-1082</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">The established urinary antibiotic nitroxoline has recently regained considerable attention, due to its potent activities in inhibiting angiogenesis, inducing apoptosis and blocking cancer cell invasion.  These features make nitroxoline an excellent candidate for anticancer drug repurposing.  To rapidly advance nitroxoline repurposing into clin. trials, the present study performed systemic preclin. pharmacodynamic evaluation of its anticancer activity, including a Me thiazolyl tetrazolium assay in vitro and an orthotopic urol. tumor assay in vivo.  The current study detd. that nitroxoline exhibits dose-dependent anti-cancer activity in vitro and in urol. tumor orthotopic mouse models.  In addn., it was demonstrated that the routine nitroxoline administration regimen used for urinary tract infections was effective and sufficient for urol. cancer treatment, and 2 to 4-fold higher doses resulted in obvious enhancement of anticancer efficacy without corresponding increases in toxicity.  Furthermore, nitroxoline sulfate, one of the most common metabolites of nitroxoline in the urine, effectively inhibited cancer cell proliferation.  This finding increases the feasibility of nitroxoline repurposing for urol. cancer treatment.  Due to the excellent anticancer activity demonstrated in the present study, and its well-known safety profile and pharmacokinetic properties, nitroxoline has been approved to enter into a phase II clin. trial in China for non-muscle invasive bladder cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoDjFV6BtN3LVg90H21EOLACvtfcHk0lg1U2FwC9kvfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmsVKkt70%253D&md5=d989f6769bee8bd9f3e0fb382f3253a9</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3892%2Fol.2016.4380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2016.4380%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DPan%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DYuan%26aufirst%3DS.%26atitle%3DPreclinical%2520pharmacodynamic%2520evaluation%2520of%2520antibiotic%2520nitroxoline%2520for%2520anticancer%2520drug%2520repurposing%26jtitle%3DOncol.%2520Lett.%26date%3D2016%26volume%3D11%26spage%3D3265%26epage%3D3272%26doi%3D10.3892%2Fol.2016.4380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">Study of APL-1202 in non-muscle invasive bladder cancer patients who are resistant to one induction course of BCG treatment (NMIBC); NCT03672240.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkin, J.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">465</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.1002/(sici)1097-4644(20000601)77:3<465::aid-jcb11>3.0.co;2-m</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1002%2F%28sici%291097-4644%2820000601%2977%3A3%3C465%3A%3Aaid-jcb11%3E3.0.co%3B2-m" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2000&pages=465-473&author=J.+Wangauthor=P.+Louauthor=J.+Henkin&title=Selective+inhibition+of+endothelial+cell+proliferation+by+fumagillin+is+not+due+to+differential+expression+of+methionine+aminopeptidases&doi=10.1002%2F%28sici%291097-4644%2820000601%2977%3A3%3C465%3A%3Aaid-jcb11%3E3.0.co%3B2-m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2F%28sici%291097-4644%2820000601%2977%3A3%3C465%3A%3Aaid-jcb11%3E3.0.co%3B2-m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528sici%25291097-4644%252820000601%252977%253A3%253C465%253A%253Aaid-jcb11%253E3.0.co%253B2-m%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLou%26aufirst%3DP.%26aulast%3DHenkin%26aufirst%3DJ.%26atitle%3DSelective%2520inhibition%2520of%2520endothelial%2520cell%2520proliferation%2520by%2520fumagillin%2520is%2520not%2520due%2520to%2520differential%2520expression%2520of%2520methionine%2520aminopeptidases%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2000%26volume%3D77%26spage%3D465%26epage%3D473%26doi%3D10.1002%2F%28sici%291097-4644%2820000601%2977%3A3%3C465%3A%3Aaid-jcb11%3E3.0.co%3B2-m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="note"><p class="first last">We investigated the general chelation potential of the ligand and could prove that in solution none of the metal ions which are discussed to be putative MetAP-2 co-factors is bound to the oxygen-triade. The results will be published in a separated paper.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemp, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clardy, J.</span></span> <span> </span><span class="NLM_article-title">Structure of human methionine aminopeptidase-2 complexed with fumagillin</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">1324</span>– <span class="NLM_lpage">1327</span>, <span class="refDoi"> DOI: 10.1126/science.282.5392.1324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1126%2Fscience.282.5392.1324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=9812898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADyaK1cXnsFenurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=1324-1327&author=S.+Liuauthor=J.+Widomauthor=C.+W.+Kempauthor=C.+M.+Crewsauthor=J.+Clardy&title=Structure+of+human+methionine+aminopeptidase-2+complexed+with+fumagillin&doi=10.1126%2Fscience.282.5392.1324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human methionine aminopeptidase-2 complexed with fumagillin</span></div><div class="casAuthors">Liu, Shenping; Widom, Joanne; Kemp, Christopher W.; Crews, Craig M.; Clardy, Jon</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">5392</span>),
    <span class="NLM_cas:pages">1324-1327</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The fungal metabolite fumagillin suppresses the formation of new blood vessels, and a fumagillin analog is currently in clin. trials as an anticancer agent.  The mol. target of fumagillin is methionine aminopeptidase-2 (MetAP-2).  A 1.8 Å resoln. crystal structure of free and inhibited human MetAP-2 shows a covalent bond formed between a reactive epoxide of fumagillin and histidine-231 in the active site of MetAP-2.  Extensive hydrophobic and water-mediated polar interactions with other parts of fumagillin provide addnl. affinity.  Fumagillin-based drugs inhibit MetAP-2 but not MetAP-1, and the three-dimensional structure also indicates the likely determinants of this specificity.  The structural basis for fumagillin's potency and specificity forms the starting point for structure-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJXNoI5W-nqbVg90H21EOLACvtfcHk0lhUDkbzk32iYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnsFenurY%253D&md5=729e37df06b4055f246753a544b6ee18</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1126%2Fscience.282.5392.1324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.282.5392.1324%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DWidom%26aufirst%3DJ.%26aulast%3DKemp%26aufirst%3DC.%2BW.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26aulast%3DClardy%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520human%2520methionine%2520aminopeptidase-2%2520complexed%2520with%2520fumagillin%26jtitle%3DScience%26date%3D1998%26volume%3D282%26spage%3D1324%26epage%3D1327%26doi%3D10.1126%2Fscience.282.5392.1324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">Asymmetric synthesis of the clinical compound M8891 was optimized and will be reported in due course.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eberhardt, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raines, R. T.</span></span> <span> </span><span class="NLM_article-title">Amide-amide and amide-water hydrogen bonds: Implications for protein folding and stability</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">2149</span>– <span class="NLM_lpage">2150</span>, <span class="refDoi"> DOI: 10.1021/ja00084a067</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00084a067" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADyaK2cXhsFOjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1994&pages=2149-2150&author=E.+S.+Eberhardtauthor=R.+T.+Raines&title=Amide-amide+and+amide-water+hydrogen+bonds%3A+Implications+for+protein+folding+and+stability&doi=10.1021%2Fja00084a067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Amide-Amide and Amide-Water Hydrogen Bonds: Implications for Protein Folding and Stability</span></div><div class="casAuthors">Eberhardt, Eric S.; Raines, Ronald T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2149-50</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">Amide-amide hydrogen bonds have been implicated in directing protein folding and enhancing protein stability.  Inversion transfer 13C NMR spectroscopy and IR spectroscopy were used to compare the ability of various amide solvents and water to alter the rate of the cis-trans isomerization of the prolyl peptide bond of Ac-Gly-[β,δ-13C]Pro-OMe and the amide I vibrational mode of [13C:O]Ac-Pro-OMe.  The results indicate that secondary amides are significantly weaker hydrogen bond donors than is formamide or water.  These results are most consistent with models for protein folding in which the formation of secondary structure is a cooperative process that follows hydrophobic collapse.  These results also suggest that a hydrogen bond between a main chain oxygen and an asparagine or glutamine side chain may contribute more to protein stability than does a main chain-main chain hydrogen bond.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRUHpJBmFerrVg90H21EOLACvtfcHk0lhUDkbzk32iYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhsFOjtb4%253D&md5=12976af286eeea5ea096e950d35e2539</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fja00084a067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00084a067%26sid%3Dliteratum%253Aachs%26aulast%3DEberhardt%26aufirst%3DE.%2BS.%26aulast%3DRaines%26aufirst%3DR.%2BT.%26atitle%3DAmide-amide%2520and%2520amide-water%2520hydrogen%2520bonds%253A%2520Implications%2520for%2520protein%2520folding%2520and%2520stability%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1994%26volume%3D116%26spage%3D2149%26epage%3D2150%26doi%3D10.1021%2Fja00084a067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schönherr, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wollatz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haznar-Garbacz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanke, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weitschies, W.</span></span> <span> </span><span class="NLM_article-title">Characterisation of selective active agents regarding pKa values, solubility concentrations and pH profiles by SiriusT3</span>. <i>Eur. J. Pharm. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1016/j.ejpb.2015.02.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1016%2Fj.ejpb.2015.02.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=25758123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A280%3ADC%252BC2MnivVKlsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2015&pages=155-170&author=D.+Sch%C3%B6nherrauthor=U.+Wollatzauthor=D.+Haznar-Garbaczauthor=U.+Hankeauthor=K.+J.+Boxauthor=R.+Taylorauthor=R.+Ruizauthor=S.+Beatoauthor=D.+Beckerauthor=W.+Weitschies&title=Characterisation+of+selective+active+agents+regarding+pKa+values%2C+solubility+concentrations+and+pH+profiles+by+SiriusT3&doi=10.1016%2Fj.ejpb.2015.02.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Characterisation of selected active agents regarding pKa values, solubility concentrations and pH profiles by SiriusT3</span></div><div class="casAuthors">Schonherr D; Wollatz U; Haznar-Garbacz D; Hanke U; Box K J; Taylor R; Ruiz R; Beato S; Becker D; Weitschies W</div><div class="citationInfo"><span class="NLM_cas:title">European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">155-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The aim of this work was to determine pKa values and solubility properties of 34active agents using the SiriusT3 apparatus.  The selected drug substances belong to the groups of ACE-inhibitors, β-blockers, antidiabetics and lipid lowering substances.  Experimentally obtained pKa and intrinsic solubility values were compared to calculated values (program ACD/ChemSketch) and pKa values to published data as well.  Solubility-pH profiles were generated to visualise the substance solubility over the gastrointestinal pH range.  The relationship between the solubility characteristic of a substance, its bioavailability and categorisation according to the Biopharmaceutics Classification System (BCS) was examined as well.  The results showed a good agreement between experimentally obtained, calculated and published pKa values.  The measured and calculated intrinsic solubility values indicated several major deviations.  All solubility-pH profiles showed the expected shape and appearance for acids, bases or zwitterionic substances.  The obtained results for the pKa and solubility measurements of the examined active agents may help to predict their physicochemical behaviour in vivo, and to understand the bioavailability of the substances according to their BCS categorisation.  The easy and reproducible determination of pKa and solubility values makes the SiriusT3 apparatus a useful tool in early stages of drug and formulation development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR0tGrDkvlZJ-2qxNLjzXe8fW6udTcc2eYMM2_VIDi7kbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnivVKlsw%253D%253D&md5=02100c72ca191e1039faa3b20d5714d8</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpb.2015.02.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpb.2015.02.028%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25B6nherr%26aufirst%3DD.%26aulast%3DWollatz%26aufirst%3DU.%26aulast%3DHaznar-Garbacz%26aufirst%3DD.%26aulast%3DHanke%26aufirst%3DU.%26aulast%3DBox%26aufirst%3DK.%2BJ.%26aulast%3DTaylor%26aufirst%3DR.%26aulast%3DRuiz%26aufirst%3DR.%26aulast%3DBeato%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DD.%26aulast%3DWeitschies%26aufirst%3DW.%26atitle%3DCharacterisation%2520of%2520selective%2520active%2520agents%2520regarding%2520pKa%2520values%252C%2520solubility%2520concentrations%2520and%2520pH%2520profiles%2520by%2520SiriusT3%26jtitle%3DEur.%2520J.%2520Pharm.%2520Biopharm.%26date%3D2015%26volume%3D92%26spage%3D155%26epage%3D170%26doi%3D10.1016%2Fj.ejpb.2015.02.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gulyaeva, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaslavsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lechner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chlenov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chait, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaslavsky, B.</span></span> <span> </span><span class="NLM_article-title">Relative hydrophobicity and lipophilicity of β-blockers and related compounds as measured by aqueous two-phase partitioning, octanol–buffer partitioning, and HPLC</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/s0928-0987(02)00146-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1016%2Fs0928-0987%2802%2900146-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=12356423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVaisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2002&pages=81-93&author=N.+Gulyaevaauthor=A.+Zaslavskyauthor=P.+Lechnerauthor=M.+Chlenovauthor=A.+Chaitauthor=B.+Zaslavsky&title=Relative+hydrophobicity+and+lipophilicity+of+%CE%B2-blockers+and+related+compounds+as+measured+by+aqueous+two-phase+partitioning%2C+octanol%E2%80%93buffer+partitioning%2C+and+HPLC&doi=10.1016%2Fs0928-0987%2802%2900146-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Relative hydrophobicity and lipophilicity of β-blockers and related compounds as measured by aqueous two-phase partitioning, octanol-buffer partitioning, and HPLC</span></div><div class="casAuthors">Gulyaeva, Nellie; Zaslavsky, Alexander; Lechner, Pamela; Chlenov, Michael; Chait, Arnon; Zaslavsky, Boris</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">81-93</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Partitioning of 15 β-blockers and structurally related compds. was examd. in aq. dextran-PEG two-phase systems and octanol-buffer systems at pH from 2.0 up to 12.5.  The same compds. were examd. by gradient RP-HPLC at pH 2.0, 7.4, and 11.0.  The differences between the hydrophobic character of the phases in all three systems at different pH values were characterized using a homologous series of dinitrophenyl-amino acids by measuring the free energy of transfer of a methylene group.  Ests. of the relative hydrophobicity, N(CH2), and lipophilicity, logD, of the compds. obtained by the three techniques employed were compared.  The data indicate that while similar pH profiles for a given compd. were established by all these techniques, the information provided is different.  It is suggested that the combination of the two descriptors, logD and N(CH2), may be useful for quant. structure-activity relation anal. of the biol. activities involving distribution and/or transport of chem. compds. in biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBHSGZgntIPbVg90H21EOLACvtfcHk0liupjbAJ1R1YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVaisLk%253D&md5=2493b60a911c1ba2dac9f5c89184fb5a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fs0928-0987%2802%2900146-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0928-0987%252802%252900146-x%26sid%3Dliteratum%253Aachs%26aulast%3DGulyaeva%26aufirst%3DN.%26aulast%3DZaslavsky%26aufirst%3DA.%26aulast%3DLechner%26aufirst%3DP.%26aulast%3DChlenov%26aufirst%3DM.%26aulast%3DChait%26aufirst%3DA.%26aulast%3DZaslavsky%26aufirst%3DB.%26atitle%3DRelative%2520hydrophobicity%2520and%2520lipophilicity%2520of%2520%25CE%25B2-blockers%2520and%2520related%2520compounds%2520as%2520measured%2520by%2520aqueous%2520two-phase%2520partitioning%252C%2520octanol%25E2%2580%2593buffer%2520partitioning%252C%2520and%2520HPLC%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2002%26volume%3D17%26spage%3D81%26epage%3D93%26doi%3D10.1016%2Fs0928-0987%2802%2900146-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ingber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kishimoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanamaru, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brem, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folkman, J.</span></span> <span> </span><span class="NLM_article-title">Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>348</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">557</span>, <span class="refDoi"> DOI: 10.1038/348555a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1038%2F348555a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=1990&pages=555-557&author=D.+Ingberauthor=T.+Fujitaauthor=S.+Kishimotoauthor=K.+Sudoauthor=T.+Kanamaruauthor=H.+Bremauthor=J.+Folkman&title=Synthetic+analogues+of+fumagillin+that+inhibit+angiogenesis+and+suppress+tumour+growth&doi=10.1038%2F348555a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2F348555a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F348555a0%26sid%3Dliteratum%253Aachs%26aulast%3DIngber%26aufirst%3DD.%26aulast%3DFujita%26aufirst%3DT.%26aulast%3DKishimoto%26aufirst%3DS.%26aulast%3DSudo%26aufirst%3DK.%26aulast%3DKanamaru%26aufirst%3DT.%26aulast%3DBrem%26aufirst%3DH.%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DSynthetic%2520analogues%2520of%2520fumagillin%2520that%2520inhibit%2520angiogenesis%2520and%2520suppress%2520tumour%2520growth%26jtitle%3DNature%26date%3D1990%26volume%3D348%26spage%3D555%26epage%3D557%26doi%3D10.1038%2F348555a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M. Q. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">6099</span>– <span class="NLM_lpage">6103</span>, <span class="refDoi"> DOI: 10.1073/pnas.94.12.6099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=10.1073%2Fpnas.94.12.6099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=9177176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;key=1%3ACAS%3A528%3ADyaK2sXjvFCnsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=6099-6103&author=N.+Sinauthor=L.+Mengauthor=M.+Q.+W.+Wangauthor=J.+J.+Wenauthor=W.+G.+Bornmannauthor=C.+M.+Crews&title=The+anti-angiogenic+agent+fumagillin+covalently+binds+and+inhibits+the+methionine+aminopeptidase%2C+MetAP-2&doi=10.1073%2Fpnas.94.12.6099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2</span></div><div class="casAuthors">Sin, Ny; Meng, Lihao; Wang, Margaret Q. W.; Wen, James J.; Bornmann, William G.; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6099-6103</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The inhibition of new blood vessel formation (angiogenesis) is an effective means of limiting both the size and metastasis of solid tumors.  The leading antiangiogenic compd., TNP-470, has proven to be effective in in vitro and in animal model studies, and is currently being tested in phase III antitumor clin. trials.  Despite many detailed pharmacol. studies, little is known of the mol. mode of action of TNP-470.  Using a deriv. of the TNP-470 parent compd., the fungal metabolite, fumagillin, we have purified a mammalian protein that is selectively and covalently bound by this natural product.  This fumagillin binding protein was found to be a metalloprotease, methionine aminopeptidase (MetAP-2), that is highly conserved between human and Saccharomyces cerevisiae.  In the absence of MetAP-1, a distantly related methionine aminopeptidase, MetAP-2 function is essential for vegetative growth in yeast.  We demonstrate that fumagillin selectively inhibits the S. cerevisiae MetAP-2 protein in vivo.  The binding is highly specific as judged by the failure of fumagillin to inhibit MetAP-1 in vivo.  Hence, these results identify MetAP-2 as an important target of study in the anal. of the potent biol. activities of fumagillin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHTZpt2wUOq7Vg90H21EOLACvtfcHk0liupjbAJ1R1YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjvFCnsb0%253D&md5=511f1751897559a60ccd9f814315c355</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.12.6099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.12.6099%26sid%3Dliteratum%253Aachs%26aulast%3DSin%26aufirst%3DN.%26aulast%3DMeng%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DM.%2BQ.%2BW.%26aulast%3DWen%26aufirst%3DJ.%2BJ.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DThe%2520anti-angiogenic%2520agent%2520fumagillin%2520covalently%2520binds%2520and%2520inhibits%2520the%2520methionine%2520aminopeptidase%252C%2520MetAP-2%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D6099%26epage%3D6103%26doi%3D10.1073%2Fpnas.94.12.6099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OAZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OAZ','PDB','2OAZ'); return false;">PDB: 2OAZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R58" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R58','PDB','1R58'); return false;">PDB: 1R58</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QZY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QZY','PDB','1QZY'); return false;">PDB: 1QZY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JFR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JFR','PDB','5JFR'); return false;">PDB: 5JFR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YW9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YW9','PDB','1YW9'); return false;">PDB: 1YW9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LYX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LYX','PDB','5LYX'); return false;">PDB: 5LYX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEJ','PDB','6QEJ'); return false;">PDB: 6QEJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEI','PDB','6QEI'); return false;">PDB: 6QEI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEH','PDB','6QEH'); return false;">PDB: 6QEH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEG','PDB','6QEG'); return false;">PDB: 6QEG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1wkm" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1wkm','PDB','1wkm'); return false;">PDB: 1wkm</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEF','PDB','6QEF'); return false;">PDB: 6QEF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QED" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QED','PDB','6QED'); return false;">PDB: 6QED</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i69"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00041">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_36483"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00041">10.1021/acs.jmedchem.9b00041</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00041/suppl_file/jm9b00041_si_001.csv">CSV</a>)</p></li><li><p class="inline">Additional graphics superimposition of <b>11a</b> with methionine; individual tumor volumes from the in vivo experiment; X-ray structure generation (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00041/suppl_file/jm9b00041_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00041/suppl_file/jm9b00041_si_001.csv">jm9b00041_si_001.csv (2.87 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00041/suppl_file/jm9b00041_si_002.pdf">jm9b00041_si_002.pdf (181.95 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last"><b>1</b> (SB-587094): <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OAZ">2OAZ</a>; <b>2</b> (A-357300): <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R58">1R58</a>; <b>3</b> (LAF-153): <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QZY">1QZY</a>; <b>4</b>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JFR">5JFR</a>; <b>5</b> (A-849519): <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YW9">1YW9</a>; <b>6</b>: 5LYX7 (JNJ-4929821): <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEJ">6QEJ</a>; <b>8</b> (GSK-2229238): <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEI">6QEI</a>; <b>9</b> (X = Cl; clioquinol): <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEH">6QEH</a>; <b>11a</b>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEG">6QEG</a>; 11r: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QEF">6QEF</a>; <b>21</b>: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QED">6QED</a> Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00041&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00041%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-10%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00041" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679916315dc62440","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
